Computer assisted detection and characterisation of breast cancer in MRI by Mcclymont, Darryl
Computer assisted detection and
characterisation of breast cancer in MRI
Darryl Graham McClymont
BE (Hons IIA)
A thesis submitted for the
degree of Doctor of Philosophy at
The University of Queensland in 2015
School of Information Technology and Electrical Engineering
Abstract
This thesis presents a novel set of CAD (computer assisted detection/diagnosis) tools to assist
the radiologist with the increasingly complex task of detecting and characterising breast lesions
using magnetic resonance imaging (MRI). Commercial CAD systems presently fall short of
automatically locating and classifying malignant lesions. Instead they automate many of the
image processing and analysis functions that would otherwise have to be performed manually
and visualise the data to aid interpretation. It is perhaps not surprising, therefore, that a recent
meta-study concluded that existing breast MRI CAD does not improve the sensitivity and spe-
cificity of experienced radiologists and their interpretation remains essential. A recent review
of breast MRI and MR spectroscopy concluded that what is needed are “quantitative features
extracted preferably from the automatically segmented 3D lesion” and a more comprehensive
assessment of lesions based on features/measurements “derived from MR multi-parametric ac-
quisitions”. This then was the motivation for the objectives of this thesis: (i) to develop an
automatic 3D lesion segmentation algorithm for multi-modal breast MRI data; (ii) to develop
features that quantitatively characterise the lesion (morphology, microvasculature, and micro-
structure) and other breast cancer signs from this data; and (iii) to evaluate these CAD tools
using clinical breast MRI data.
With regard to (i) a novel fully automatic method for segmentation (i.e., detection and delin-
eation) of suspicious tissue in breast MRI is presented and evaluated. The method is based on
mean-shift clustering and graph-cuts on a region adjacency graph. To the author’s knowledge
it is the first fully automatic method for breast lesion detection and delineation in breast MRI.
The method was tested on a total of 102 lesions from two different vendors’ scanner systems.
The regions of interest identified by the method were compared with the ground truth (manu-
ally delineated by an experienced radiographer) and the detection and delineation accuracies
quantitatively evaluated. One hundred percent of the lesions were detected with a mean of 4.5
± 1.2 false positives per subject. This false-positive rate is nearly 50% better than previously
reported for a fully automatic breast lesion detection system. The median Dice coefficient was
ii
0.76 (interquartile range, 0.17), and 0.75 (interquartile range, 0.16) for the two scanner systems
respectively.
With regard to (ii) several new features for breast MRI CAD—derived from anatomical T1w
and T2w images, DCE-MRI, and DW-MRI—are presented. They include features that charac-
terise vascularity, blooming, and centripetal/centrifugal enhancement; and features extracted
from the repartition of a lesion into mean-shift clusters. A new method for the fully automatic
segmentation and measurement of the internal mammary vessels is also presented and evalu-
ated. This was motivated by recent findings that the vascular cross-sectional area of internal
mammary vessels is significantly larger on the side of breast cancer compared to the contralat-
eral side. The method was developed on clinical MR data from 15 subjects, and tested on
a further 145. The results do not indicate any significant difference in cross-sectional area
between subjects with malignant lesions and those without (p > 0.05).
With regard to (iii) the efficacy of the proposed features was evaluated using both manual
and automatic segmentations of 74 malignant and 47 benign lesions. A superset of proposed
and state-of-the-art features was computed for each lesion. Random forest classification was
used to estimate classification performance—area under the receiver operating characteristic
curve (AUC)—and to identify the most important features. This was done independently for
mass-like lesions, non-mass-like lesions, and a combination of both. The results show that the
AUCs for the two segmentation approaches are on a par; the best AUC is for mass-like lesions:
0.874 ± 0.038 (manual) and 0.873 ± 0.039 (automatic); the worst AUC is for non-mass-like
lesions: 0.677 ± 0.081 and 0.663 ± 0.082 respectively; and the proportion of new features in
the top 10 features ranges from 20   60%. Results also show that the combination of T2w,
DCE-MRI, and DW-MRI features yields the best performance; i.e. T1w features offer little if
any improvement in performance.
In summary the CAD tools developed in this thesis permit fully automatic detection and delin-
eation of suspicious lesions, the extraction of lesion features—including several new features
characterising vascularity, blooming, and centripetal/centrifugal enhancement—from multi-
modal MR images, and the classification of lesions as benign or malignant. The experimental
results show that classification performance based on automatically segmented lesions is as
good as that for manually segmented lesions. This suggests that it is indeed possible for fully
automatic CAD to achieve the sensitivity/specificity of an experienced radiologist.
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Chapter1
Introduction
The detection and characterisation of breast lesions in MRI are increasingly complex tasks for
radiologists. This thesis presents a novel set of CAD (computer assisted detection/diagnosis)
tools to perform these tasks fully automatically. These tools are evaluated using clinical breast
MRI data. This chapter introduces the field, followed by the research hypothesis, aim and
objectives, and scope. It concludes with an overview of each chapter.
1.1 Breast Cancer
Breast cancer is the most common cancer affecting women, with almost 15000 women in Aus-
tralia diagnosed each year. The majority (69%) of these reported cases occur in women aged
40-69, and with an ageing population, the number of diagnoses each year is expected to reach
over 17000 by 2020 (Breast Cancer Network Australia 2012). In the 2004-2005 financial year
alone, health expenditure on breast cancer for females was $331 million (Cancer Australia
2012). Early detection is critical, as women diagnosed with small tumours have considerably
higher five-year survival rates than women diagnosed with large tumours1 (Australian Institute
of Health and Welfare 2007).
A national screening program was introduced in Australia in 1991. The program, called Breast-
Screen Australia, has resulted in a 21-28% reduction in breast cancer mortality with a national
screening participation rate of 56% of women aged 50-69 (Morrell et al. 2012). This program
utilises X-ray mammography for screening. Two advantages of X-ray mammography are its low
cost and fast acquisition times. However, X-ray mammography is known to have limitations.
Notably, according to the U.S. National Cancer Institute, X-ray mammograms have a 20% false
1 98% for women with small tumours smaller than 10mm versus 73% for women with large tumours larger
than 30mm
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negative rate (i.e. 1 in 5 cancers that are present at the time of screening are missed) (National
Cancer Institute 2012). X-ray mammography is also known to have a reduced sensitivity, par-
ticularly in younger women with dense breast tissue (Cancer Australia 2009). It is also worth
noting that the pain experienced by patients during X-ray mammograms is an important factor
when considering breast cancer screening modalities.
Among the many alternative imaging modalities available—positron emission tomography (PET),
single proton emission spectroscopy (SPECT), X-ray computed tomography, and ultrasound
(US)—magnetic resonance imaging (MRI) has emerged over the past 20 years as an important
tool for the analysis of breast cancer, particularly for the differential diagnosis of difficult cases
and for high-risk patients.
1.2 Breast MRI
In 1971, Raymond Damadian showed that measurements of T1 and T2 relaxation times differ
in malignant and benign tissue (Damadian 1971). In 1982, Ross et al. performed T1 measure-
ments of human mammary tissue, and found that T1 values of malignant tissue are elevated.
However, until the proliferation of paramagnetic contrast agents in the 1990s, MRI was not
widely employed for the analysis of breast cancer.
Dynamic contrast enhanced (DCE) MRI consists of T1-weighted images acquired before and
at several times after the injection of a gadolinium-based contrast agent. The contrast agent
alters the relaxation times of tissue, and increases signal intensity in T1-weighted MRI.
Early studies in DCE-MRI can be placed into two categories, the dynamic school (primarily in
Europe) and the static school (primarily in U.S.A). The dynamic school favoured high temporal
and low spatial resolution, and assessed breast lesions using their temporal characteristics. The
static school used low temporal resolution and high spatial resolution, characterising lesions
using morphology. With faster scanning techniques, modern MR sequences allow simultaneous
high temporal and high spatial resolution (Sinha & Sinha 2009).
Signal intensity time-curves are commonly used for breast lesion assessment/characterisation.
Malignant lesions are typically characterised by a high amount of initial uptake of contrast
agent, followed by fast washout. Benign lesions typically have shallower uptake, followed by a
plateau or slow continued uptake of contrast agent.
One significant factor initially inhibiting the utilisation of breast MRI was the non-standardisation
of protocols and interpretation of images (Ikeda et al. 2001). The American College of Radi-
ology’s (ACR) lexicon for breast MRI, known as BI-RADS (Breast Imaging Reporting and Data
System), provides a standardised mechanism for radiologists to report on breast MRI findings
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(see Appendix A). The lexicon includes definitions of lesion descriptors, such as “mass”, “re-
gional enhancement” and “focus”. It also includes an assessment form for reporting suspicious
lesions, including categories such as shape, margin, and signal intensity time-curve assessment.
A 2008 meta-analysis of MR imaging in the diagnosis of breast lesions (Peters & Rinkes 2008)
reported an estimate of sensitivity of 0.902 but a specificity of only 0.723. One reason for this
poor specificity is that many benign lesions exhibit similar enhancement behaviour to malignant
lesions.
While DCE-MRI remains the primary MRI technique/modality for breast cancer, particularly
because it helps to visualise malignant lesions that would otherwise be invisible or poorly
contrasted, there is considerable evidence to suggest that complimentary modalities, such T2-
weighted imaging, can be used to improve the sensitivity and in particular the specificity of
breast MRI (Bhooshan et al. 2011). In recent years, diffusion weighted (DW) imaging has
emerged providing complementary information about the microstructure of tissue. DW-MRI
can be used to assess the diffusion (random Brownian motion) of water molecules in tissue.
In general, malignant lesions are hypercellular, resulting in restricted/hindered diffusion. For
this reason, the apparent diffusion coefficient (ADC), a quantitative measure of this restric-
ted/hindered diffusion, within malignant lesions is typically lower than within benign lesions.
The problem in interpreting breast MR images is that they are invariably based on at least some
qualitative assessment of the data by an experienced reader. The subjectivity arises in tasks
such as lesion detection and the selection of regions-of-interest, as well as in qualitative assess-
ment of lesion features. Mussurakis et al. (1996) highlighted the amount of observer variability
in the interpretation of DCE-MRI, particularly between newly trained and experienced read-
ers. Kinkel et al. (2000) noted substantial interobserver variability in the assessment of lesion
margins. This subjectivity has led to the development of computer assisted detection/diagnosis
(CAD) tools, as described in the following section.
1.3 Breast CAD
CAD systems are software programs that use algorithms to assist radiologists in the analysis
of breast MRI data. Three commercial breast CAD packages are presented in Table 1.1. All
three packages offer similar features, including image fusion (for example ADC maps overlaid on
DCE-MRI images), multi-planar reformatting, image subtraction (for example, post-contrast
minus pre-contrast), maximum intensity projections, motion correction, interactive lesion seg-
2 Sensitivity 95% confidence interval: [0.88, 0.92]
3 Specificity 95% confidence interval: [0.67, 0.77]
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Table 1.1: Commercial Breast CAD Software
Software Vendor Target anatomy
CADstream1 Merge Healthcare, Chicago,
IL
Breast, liver and prostate
DynaCAD2 Invivo (Phillips), Gainsville,
FL
Breast, prostate
Aegis Breast Hologic, Bedford, MA Breast
1 Distributed by Confirma until 2009
2 Incorporating iCAD SpectraLook from March 2013
mentation, a BI-RADS reporting interface, time intensity curves (CADstream also includes the
“worst” curve) and colour-coded time-intensity curve maps.
A recent analysis of DynaCAD and CADstream found that there was no statistically significant
difference between the evaluation times or diagnostic performance of the two software packages,
although CADstream did perform better in terms of volume rendering and motion correction
(Pan et al. 2013). Renz et al. (2012) noted that an important limitation of all common CAD
systems in general is that T2-weighted sequences are not considered. They also noted that
CAD systems commonly do not allow evaluation of further imaging information, such as the
infiltration of pectoralis muscle or axillary lymph node invasion.
Currently, all of the aforementioned systems fall short of automatically locating and classifying
lesions. It is perhaps not surprising, therefore, that a recent meta-study concluded that “CAD
in breast MRI has little influence on the sensitivity and specificity of experienced radiologists
and therefore their interpretation remains essential” (Dorrius et al. 2011). A review of breast
MRI and MRS (Sinha & Sinha 2009) suggested that breast MRI CAD needs to be based on
“quantitative features extracted preferably from the automatically segmented 3D lesion” and a
more comprehensive assessment of lesions based on features “derived from MR multi-parametric
acquisitions”. The focus of this research is therefore based on addressing this need.
1.4 Research Hypothesis
The hypothesis of this research is that multi-modal magnetic resonance imaging coupled with
novel multi-parametric computer-assisted diagnosis (CAD) techniques can improve the sensit-
ivity and specificity of breast MRI and obviate the need for interpretation by an experienced
radiologist.
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1.5 Aim and Objectives
The aim of this research was to test the hypothesis above by developing a suite of CAD tools for
multi-modal (i.e. multi-technique) breast MRI data and evaluating their collective performance
using routine clinical data. To this end the research had the following objectives:
1. To develop an algorithm for automatically segmenting (i.e. detecting and delineating) sus-
picious tissue in spatially co-registered multi-modal MR images including anatomical T1-
and T2-weighted images, perfusion images (DCE-MRI), and diffusion-weighted images
(DW-MRI);
2. To develop features that quantitatively characterise the suspicious tissue (morphology,
microvasculature, and microstructure) and other breast cancer signs from these images;
and
3. To evaluate the resulting CAD tools using clinical breast MRI data.
1.6 Scope
The scope of this thesis was dictated by the data available in the clinical protocol used at
Queensland X-Ray4. For economic reasons the total time for each examination is limited
to thirty minutes. Consequently, it was not possible to extend the scan protocol to include
techniques such as SWI (susceptibility weighted imaging), DTI (diffusion tensor imaging) or
MRSI (magnetic resonance spectroscopic imaging). Additionally, given the relatively few time-
points in the DCE-MRI scan protocol (typically 2-3 post-contrast stacks), parametric modelling
of contrast enhancement was limited to simple empirical models and the pharmacokinetically-
inspired Hayton model. Similarly, given that the diffusion weighted scan protocol consists of
only two volumes (one with zero b-value and the other typically with a b-value of 600s/mm2),
only a mono-exponential model of of diffusion was fitted to the data.
The imaging protocol used to acquire the clinical data used in this research was changed several
times, to meet the requirements of the reporting radiologists, over the duration of the project.
For example, the upper b-value in the diffusion-weighted scan protocol ranged between 500
and 1000s/mm2. Consequently it was necessary to design algorithms and features as robust as
possible to these changes. Moreover it is possible that the classification results in Chapter 7,
although very good, may have been even better had it not been for these changes.
4 The largest diagnostic imaging practice in Queensland Australia.
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1.7 Overview of thesis
The remainder of this thesis is organised as follows.
Chapter 2 presents background material in support of later chapters. First, concepts in MRI are
introduced, followed by an overview of common breast MRI sequences. The chapter then con-
tains a section on breast cancer, and its appearance in MRI. Finally, a review of the statistical
pattern recognition tools that are used in later chapters is presented.
Chapter 3 presents two novel methods for the detection and segmentation of suspicious lesions
in breast MRI. The first method is an extension of a voxel-wise classification approach using
local spectral co-occurrence. The second method is based on mean-shift clustering and graph-
cuts segmentation applied to the region adjacency graph defined on mean-shift clusters. Both
methods were evaluated on clinical data in terms of lesion detection and delineation relative to
the “ground truth” segmentation of a radiographer.
Chapter 4 presents several novel quantitative features for the characterisation of breast lesions,
including features that characterise vascularity, blooming, and centripetal/centrifugal enhance-
ment; and features extracted from the repartition of a lesion into mean-shift clusters..
Chapter 5 presents several novel features derived from diffusion weighted imaging, and presents
a methodology for automatically selecting a region-of-interest for computing a representative
apparent diffusion coefficient (ADC) value for a suspicious lesion.
Chapter 6 describes a new method for automatic segmentation and measurement of the internal
mammary vessels. It also presents an investigation, using this method, of the veracity of recent
findings that the vascular cross-sectional area of internal mammary vessels is significantly larger
on the side of breast cancer compared to the contralateral side.
Chapter 7 presents an empirical evaluation, based on clinical breast MRI data from 107 subjects,
of the efficacy of the features developed in Chapters 4 and 5 and state-of-the-art features for
discriminating benign and malignant lesions. This includes separate experiments for features
extracted from both manually segmented (delineated) and automatically segmented lesions, as
well as mass-like and non-mass-like lesions, and for different combinations of MRI modalities.
Chapter 8 summarises the important findings of the research and draws conclusions from them.
It also outlines the limitations of the research and provides future directions.
Chapter2
Background
The research presented in this thesis draws upon several fields, including medicine, mathematics,
physics, image processing, image analysis, and pattern recognition. The purpose of this Chapter
is to provide the reader with the necessary background to support the material presented in later
chapters. In section 2.1, an introduction to magnetic resonance imaging (MRI) is presented.
Section 2.2 describes both the anatomy of the human breast and breast cancer. This section
is primarily based on Dunitz (2002). In section 2.3, the appearance of breast cancer in MRI is
presented. Finally, section 2.4 provides an overview of statistical pattern recognition.
2.1 Magnetic resonance imaging
The phenomenon of nuclear magnetic resonance (NMR) was first discovered independently by
Felix Bloch and Edward Purcell in 1946. NMR allows the observation of specific quantum
mechanical (magnetic) properties of the atomic nucleus. When certain nuclei are placed in an
external magnetic field, they resonate at a frequency that is proportional to the field strength.
The NMR method was initially applied in one-dimensional studies. In the 1970s Paul Lauterbur
and Sir Peter Mansfield employed magnetic field gradient coils to spatially localise resonating
nuclei to produce the first magnetic resonance images (MRI). In the following decades, MRI
has experienced tremendous advances and found a number of applications in fields such as
the medical sciences, biology, material sciences and engineering. Given its excellent contrast
between soft body tissues, non-ionizing nature and high spatial resolution, MRI has become
one of the most powerful tools in modern medical imaging.
2.1 Magnetic resonance imaging 8
Figure 2.1: An illustration of magnetic moment µ due to the proton’s spin-angular momentum
(right), and the analogy of a bar magnet (right). Figure reproduced with the permission of Trakic
(2007).
2.1.1 Spin and magnetisation
Atoms with an odd number of protons exhibit non-zero spin-angular momentum, which is
characterised by a weak magnetic moment (shown in Figure 2.1). Given the abundance of
water in the body, the hydrogen atom (with a single proton) is typically observed in MRI.
With a large number of nuclei (in the order of 1022 water molecules per millilitre of water),
the effect of individual atoms cannot be observed. Instead, it is the net effect that is observed.
Under normal conditions, magnetic moments of atoms point in random directions, and the net
magnetic moment is close to zero, as shown in Figure 2.2a. When a strong external magnetic
field B0 is applied, spins become aligned parallel to the field producing bulk magnetisation in
the direction of B0, as depicted in Figure 2.2b.
The number of spins aligned in the same direction as B0 is denoted Nparallel, and the num-
ber of spins in the opposite direction is denoted Nanti parallel. Nparallel must be greater than
Nanti parallel to achieve net magnetisation. The ratio of the number of spins in the parallel and
anti-parallel state is given by:
Nparallel
Nanti parallel
= e
~ B0
kT (2.1)
where ~ = h2⇡ = 1.05 · 10 34Js is the reduced Planck constant,   = 2.67 · 108rad/s/T is the
gyromagnetic ratio for 1H, B0 is the magnetic field strength (in T ), k = 1.38 · 10 23J/K is
the Boltzmann constant, and T is the temperature (in K). This ratio is higher with increased
magnetic field strength and lower temperatures. The magnitude of magnetisation, |M0|, is
therefore proportional to field strength and inversely proportional to temperature.
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Figure 2.2: The effect of a static magnetic field on magnetic moments of water hydrogen protons.
In (a), the spins are not influenced by any external magnetic field, and point in random directions.
This results in zero net magnetisation. In (b), magnetic field B0 is applied to the sample, resulting
in a non-zero net magnetic moment that points in the same direction as B0. Figure reproduced with
the permission of Trakic (2007).
2.1.2 Perturbation of spin
When the spin is perturbed from its alignment with B0, a torque is exerted on the spin which
is perpendicular to the spin and the B0 field. This results in the spin precessing around the B0
field (z axis), as illustrated in Figure 2.3. The angular frequency of the precession is known as
the Larmor frequency, and is related only to the strength of the magnetic field:
!0 =   |B0| (2.2)
2.1.3 B1 excitation
Unless otherwise perturbed, the net magnetisation is aligned with the magnetic field B0. How-
ever, it can be flipped away from the z axis by the application of an oscillating magnetic field
(RF pulse), denoted B1, perpendicular to B0. The angle of perturbation is related to the
strength and duration of this RF pulse. The strength of B1 is much smaller than B0, typic-
ally in the order of µT . In order to transfer the maximum energy to the hydrogen nuclei, the
frequency of the B1 field should be equal to the Larmor frequency.
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Figure 2.3: Magnetisation precession around the static magnetic field B0. Figure reproduced with
the permission of Trakic (2007).
Figure 2.4: The magnetisation being perturbed by the B1 pulse. In this example, the B1 pulse
flips the magnetisation by 90o. Figure reproduced with the permission of Trakic (2007).
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Figure 2.5: Relaxation after a 90o pulse. The longitudinal relaxation is shown in (a), the transverse
relaxation is shown in (b). Figure reproduced with the permission of Trakic (2007).
2.1.4 Spin relaxation
After the RF pulse, spins begin to re-align themselves with the static field B0, releasing the
energy that they absorbed during the pulse. The magnetisation along the z axis experiences
exponential recovery, the time constant of which is denoted T1. This T1 value is approximately
3s for pure water, and is shorter for soft tissue (see Table 2.2). It is known as spin-lattice or
longitudinal relaxation time.
At the same time, the amount of magnetisation in the transverse (x  y) plane decreases. This
follows exponential decay, with the time constant denoted T2. This is known as the spin-spin
or transverse relaxation time.
2.1.5 Spatial encoding
Spatial localisation in MRI requires exciting spins based on their location within the field of
view of the magnet. This is performed using a combination of three position encoding gradients;
the slice selection gradient, the frequency selection gradient, and the phase encoding gradient.
The slice selection gradient, as the name suggests, is used to select a single slice along the
z-axis. It is a position-dependant magnetic field that is applied in the z-axis, and has the form
Gz = dBz/dz. Thus, the total magnetic field in slice z is given by Bz,total = B0 + Gzz. The
change in magnetic field changes the Larmor frequency for each slice. The thickness of the slice
is defined by the bandwidth of the pulse (i.e. a smaller bandwidth will result in a thinner slice,
but the slice will contain fewer spins and result in a weaker signal).
The phase encoding gradient imparts phase offsets based on each voxel’s position on the y-axis.
The phase offset is proportional to the duration and intensity of the gradient, as well as the
position along the y-axis.
2.1 Magnetic resonance imaging 12
Low spatial
frequency
High spatial frequency
kx
ky
ky
kx
P
h
as
e 
en
co
d
in
g
Frequency encoding
Figure 2.6: Representation of k-space. kx and ky are the spatial frequencies in the x and y
dimensions respectively.
The frequency encoding (also known as read-out) gradient is applied after the slice selection
gradient in the direction of the x-axis, and is used to change the precessional frequency of spins
along the x-axis.
2.1.6 k-space
Through the application of the three gradients described above, each position in space is encoded
by a unique combination of frequency and phase. The raw data received by the RF receiver coil
is in a domain known as k-space. Frequency is encoded along the x-axis, and phase is encoded
along the y-axis, as shown in Figure 2.6. Trajectories for filling k-space include rectilinear (one
row at a time), radial, and spiral patterns, among others.
The centre of k-space corresponds to low spatial frequencies, containing most of the signal.
This region controls the image shape and contrast. The centre point (0, 0) corresponds to the
DC1 component, and is proportional to the mean intensity of the image. The higher spatial
frequencies correspond to the edges and fine details of the image. This is typically lower in
magnitude than the central region.
1 DC stands for "direct current," a reference back to the origins of much of Fourier theory in circuit analysis.
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Table 2.1: Explanation of imaging parameters
Parameter Description
Repetition time
(TR)
The time between successive RF pulses.
Echo time (TE) The time between RF excitation and signal acquisition.
Flip angle The angle to which the net magnetisation is tipped relative to the
static magnetic field after the application of an RF excitation pulse.
Slice thickness The thickness of an imaging slice, defined by the strength of the slice
selection gradient and the bandwidth of the RF excitation pulse. This
is often equal to the spacing between slices.
Spacing between
slices
The distance between successive image slices, defined by the strength
of the slice selection gradient.
Image plane The orientation of slices relative to the axes of the MR system. Axial
slices are in the x  y plane, coronal slices are in the x  z plane, and
sagittal slices are in the y   z plane.
Acquisition matrix The matrix containing k-space data, the size of which is defined by the
number of samples in the frequency encoding and phase encoding
directions.
Field of view
(FOV)
The image area that contains the object of interest to be measured. A
smaller FOV results in higher resolution (i.e. smaller voxels).
The resolution of the phase encoding measurements,  ky, is inversely proportional to the length
of the field of view in the y-direction, Ly. Similarly,  kx is inversely proportional to the length
of the field of view in the x-dimension, Lx.
A reconstruction algorithm—most commonly the Fourier transform—is used to convert k-space
data into an image. Without interpolation, the images produced by MRI have the same di-
mensions as the k-space data. Specifically, in order to form an image with M ⇥ N pixels, M
measurements in the phase encoding direction and N measurement in the frequency encoding
direction must be acquired.
Table 2.1 presents a brief introduction to MR imaging parameters. The reader is directed to
Paschal & Morris (2004) for more information on k-space.
2.1.7 Tissue contrast (T1- and T2-weighting)
Proton density images (i.e. images in which the intensity is proportional to the density of
protons in the imaging volume) are of limited clinical value, given that most soft tissues have
similar water content which is typically unchanged by disease (Dunitz 2002). Instead, T1- and
T2-weighted images are more commonly used to highlight the markedly different relaxation
times of soft tissue types.
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Figure 2.7: Basic representation of an MRI system. Figure adapted from Trakic (2007).
T1-weighted (T1w) images are formed with a short TE and a TR shorter than the T1 values of
the tissues being imaged, so that only a small degree of transverse relaxation can occur while
the magnetisation is in the transverse plane. In T1w imaging, fluids tend to appear dark, due
to their long T1 values.
T2-weighted (T2w) images are formed with a long TR and long TE, such that most tissues
recover their transverse magnetisation between successive RF pulses. This highlights differences
in T2 values in tissues. Tissues with long T2 therefore appear as hyperintense in T2w imaging.
2.1.8 MRI hardware
This section describes MRI hardware components and their roles. Figure 2.7 displays the major
components of MR imaging systems.
2.1.8.1 Main magnet
The main magnet generates the strong and uniform magnetic field B0, oriented along the z axis
(inferior to superior, i.e. feet to head, of the patient being imaged). The superconducting magnet
is formed from many kilometres of tightly wound wire, which is typically made of niobium
titanium alloy filaments embedded inside copper. Superconducting magnets are intrinsically
stable at low temperatures, where the resistance of the wire decreases to almost zero. As such,
the main magnet is kept at approximately 4.2 K using liquid helium cooling.
Field homogeneity has a significant impact on the SNR and resolution of MR images, and
the deviation is generally measured in parts-per-million (ppm) over a specific volume. Clinical
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scanners typically have homogeneities of less than 10 ppm over the field of view. Homogeneity
is improved not only by good coil design and manufacture, but also via shimming. Passive
shimming is achieved by placing iron plates at strategic locations in the vicinity of the inner
magnet surface. Active shimming is achieved using a set of coils fitted inside the magnet,
through which the current is adjusted to correct deviations in the static field.
Shielding is important not only to minimise any influence on the magnet from external sources
(such as large metallic elevators in the fringe field), but also to contain the area in which
the magnetic field has a potentially dangerous influence. One important risk is that metallic
objects become potential projectiles in the presence of a strong magnetic field. Passive shielding
involves placing large sheets of iron or steel around the magnet and examinations room. Active
shielding consists of additional superconducting coils called shielding coils. The current in the
shielding coils flows in the opposite direction to the inner coils, and partially negates the effect
of the inner coils outside of the magnet.
2.1.8.2 Gradient coils
Gradient coils produce linear field gradients that are superimposed on the main magnetic field.
They perform the following functions: phase and frequency encoding, slice selection, plane
definition, slice thickness definition, production of gradient echoes in gradient echo imaging
(see Section 2.1.9.5), and gradient spoiling. The strength of these coils (several mT/m) is
orders of magnitude smaller than the main magnet field strength (several T ), and is related to
spatial encoding as follows:
Gf =
2⇡ · BWread
  · FOV (2.3)
where Gf is the frequency encoding gradient, BWread is the bandwidth of the received signal,
  is the gyromagnetic ratio (see Equation 2.1) and FOV is the field of view.
2.1.8.3 RF coils
RF coils are used to generate the B1 field that perturbs the nuclear spins, and to detect the
RF signal that is generated while the spins decay back to equilibrium. Sensitivity is maximised
when the RF coils are oriented in a direction perpendicular to B0. Transmission must cease
while the coil is in receiving mode. Types of RF coils include surface coils, saddle coils, birdcage
coils, phased-array coils, and multi-turn solenoids. RF coils can be receive-only, transmit-only,
or transmit and receive.
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In breast MRI, dedicated bilateral breast surface coils are most commonly used, allowing ima-
ging of both breasts simultaneously.
2.1.9 Common pulse sequences
In this section, several common pulse sequences are described. These sequences, and variations
thereupon, are widely used in research and clinics, as well as in this thesis. Generally, these
sequences fall into two categories: spin-echo and gradient-echo. Variations on spin-echo include
turbo spin-echo, inversion recovery, and short tau inversion recovery (used for the T2w sequences
in this thesis). A variation on gradient echo-sequences is the spoiled gradient-echo sequence
(used for the DCE-MRI sequences in this thesis).
2.1.9.1 Spin-echo (SE)
A spin-echo sequence is shown in Figure 2.8. First, a 90  pulse is used to convert the longitudinal
magnetisation into transverse magnetisation, as shown in subfigure a. In the x-y plane, the
spins begin to dephase, as shown in subfigure b. After half the echo time has elapsed, a 180 
refocusing pulse rotates the spin around the x-axis, where the spins continue to move in the
same direction at the same speed. At TE, the spins are again in phase (subfigure d). The
spin-echo signal is measured at this time.
2.1.9.2 Turbo spin-echo (TSE)
In a turbo spin-echo sequence, multiple 180  rephasing pulses are applied after the initial
excitation pulse, each followed by a spin-echo. The phase encoding gradient is different for
each rephasing pulse, filling a different row of k-space with each echo. The number of rephasing
pulses is called the echo train length (ETL), and is the factor by which the scan time is reduced.
The use of large echo train lengths with short TE results in blurring and loss of contrast. For
this reason, T2 weighted imaging benefits most from this technique.
Turbo spin-echo is also known as fast spin-echo or rapid spin-echo.
2.1.9.3 Inversion Recovery (IR)
The inversion recovery sequence begins with a 180  preparation pulse that rotates Mz into the
negative plane. After this, IR sequences follow the conventional spin-echo sequence described
above. Although the preparation pulse increases total scan time, IR sequences are popular for
the suppression of fat using short tau inversion recovery, as described in the following section.
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Figure 2.8: Spin-echo sequence. Figure reproduced with the permission of Trakic (2007).
2.1.9.4 Short tau inversion recovery (STIR)
Also known as “short T1 inversion recovery”, STIR sequences may be used for the suppression
of fat by timing the 90  pulse precisely when the z-magnetisation of fat is at zero. This is
shown in Figure 2.9. As fat has a very short T1 value, most other tissues will have negative
Mz values at this time. In a magnitude image, the sign of Mz is discarded. Hence, the image
will not include any signal from fat, but will have high contrast for other tissue types. STIR
images can be T1w, T2w, or proton density weighted.
Fluid Attenuation Inversion Recovery (FLAIR) is a similar technique used to suppress water.
2.1.9.5 Gradient-echo (GRE)
Rather than a 180  RF pulse, as used in spin-echo sequences, gradient echo sequences instead
dephase the spins with a negatively pulsed gradient, followed by rephasing with the opposite
gradient to generate the echo. The excitation pulse, which is necessarily 90  for spin-echo
sequences, can be shorter, leading to a shorter scan time but also decreased signal intensity.
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Figure 2.9: Fat suppression using short tau inversion recovery.
GRE sequences have a lower specific absorption rate (SAR)2 and are more sensitive to para-
magnetic contrast materials, but also more prone to artefacts due to greater sensitivity to field
inhomogeneities.
2.1.9.6 Spoiled gradient-echo
In spoiled gradient-echo sequences, a spoiler gradient is used to eliminate residual transverse
magnetisation after the readout gradient. Hence, only the z-magnetisation remains during the
next excitation. The reason for this is to reduce the repetition time. As a result, spoiled
gradient-echo sequences are commonly used in DCE-MRI.
2.1.10 Echo planar imaging (EPI)
Echo planar imaging is a method of acquiring multiple echoes from each excitation pulse,
yielding faster scan times.
As shown in Figure 2.10, the first MRI signal is acquired after the phase encoding gradient.
The subsequent echoes are acquired after the phase has been “undone” by the application of
smaller phase encoding gradients in the opposite direction. Each of these echoes corresponds
to a different row in k-space. After the next excitation pulse, a different set of rows will be
2 The specific absorption rate is a measure of the rate at which energy is absorbed by the human body in an
RF field, measured in W/kg
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Figure 2.10: The timing diagram for spin-echo EPI with an EPI factor of 4. RF: Radio frequency
pulses. Gs: Slice selecting gradient. Gp: phase selecting gradient. Gf: frequency selecting gradient.
Mxy: magnetisation in the x-y plane.
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acquired. In this way, multiple rows of k-space are filled at the same time, reducing scan times.
The parameter “EPI factor” refers to the number of rows acquired per excitation. For example,
an EPI factor of 8 means that the scan time is 8 times faster than the same sequence without
EPI.
Although EPI sequences reduce the total scan time, they require higher gradient amplitudes
and are demanding on scanner hardware. Additionally, EPI is extremely sensitive to image
artefacts and distortions.
2.1.11 Fat suppression
Given that fat is hyperintense on both T1w and T2w images, it can hinder image interpretation
and can cause artefacts (Dunitz 2002). Several methods may be used to suppress the fat signal.
A common method is short tau inversion recovery, which is described in section 2.1.9.4. Another
is chemical shift saturation, described below. The reader is directed to Delfaut & Beltran (1999)
for more information.
Chemical shift saturation suppresses fat based on the difference in Larmor frequency of fat and
water protons. A 90  pulse that is tuned to the frequency of fat is applied, effectively setting
the z-magnetisation of fat protons to zero but leaving water protons unchanged. Conventional
gradient-echo or spin-echo sequences (described in section 2.1.9) may then be applied.
Chemical shift saturation may be performed on any tissue or substance given sufficient separ-
ation in Larmor frequency. For example, silicone suppression is useful when imaging breasts
with implants, particularly for identifying leakage from ruptured implants.
2.1.12 Dynamic contrast enhanced MRI
Dynamic contrast enhanced (DCE) MRI consists of a series of T1-weighted images acquired
before and after the injection of a paramagnetic contrast agent. Parametric substances are
characterised by the presence of at least one unpaired electron. The unpaired electron has
a magnetic moment that is orders of magnitude greater than that of a proton, and essen-
tially shortens T1 and T2 relaxation times, resulting in increased signal intensity. Common
compounds used as contrast agents include Gadopentate dimeglumine, Gd-DTPA, Gd-DOTA,
Gadoterate-Meglumine, Gd-HP-DO3A Gadoteridol, and Gd-DTPA-BMA (Fischer 2004).
Intravenous administration of a contrast agent provides a mechanism for the imaging of the
circulatory properties of tissue, providing information about the uptake and washout of the
contrast agent. In clinical breast MRI, the images are typically acquired at a temporal resolution
of between 60 and 90s. High temporal resolution provides more detailed information about the
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temporal characteristics of the tissue being imaged, but with poorer image quality (for example,
lower resolution). Lower temporal resolution affords improved image quality, but the signal is
averaged over a longer time period, which has the effect of a low-pass filter (Heisen et al. 2010).
2.1.13 Diffusion-weighted MRI
Diffusion-weighted (DW) images provide information about the diffusive properties of tissue -
i.e. a measure of the displacement of water molecules due to random, thermally driven motion
(Brownian motion) over distances of 1   20µm. As shown in Figure 2.11, diffusion weighted
images are obtained using two equal but opposite gradients. The first diffusion gradient imparts
a phase offset to the spins that is dependent on their position in the direction of the pulse. The
second reverses this phase offset. In the case of water moving parallel to the diffusion gradient,
the phase offsets imparted by the two gradients are unbalanced, resulting in net dephasing
and attenuation in the signal. Typically DW-MRI is acquired individually in three orthogonal
planes.
The phase offset imparted by the diffusion gradients is denoted by the parameter b. The b value
is related to the intensity and duration of the pulse, as well as the time that elapses between
their application. A higher b value means that a greater phase offset, and more attenuation in
the signal. Typical b values are in the range of 0  2000s/mm2.
The apparent diffusion coefficient (ADC) is used to quantify the Brownian (incoherent) motion
of water molecules, and is computed as follows:
f(b) = f(0) · e b·ADC (2.4)
where f(0) and f(b) are the diffusion-weighted image intensities at b-values of 0 and b respect-
ively. The computation of the ADC requires a minimum of two diffusion-weighted images.
Often, but not necessarily, the baseline diffusion-weighted image is acquired with b = 0 (i.e. no
diffusion gradients).
A single-shot EPI pulse sequence can be used to acquire diffusion-weighted images (Bammer
2003). One benefit of the single shot sequence is that it is very fast, and therefore less sensitive
to motion. The quality of these images is limited by the T ⇤2 decay during acquisition. It is worth
noting that in these sequences, the polarity of the second diffusion gradient is not reversed (as
in Figure 2.11), because the two diffusion gradients are on either side of the 180  refocussing
pulse.
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Figure 2.11: Phase offset following the application of diffusion gradients
In the first scenario, the phase of the water protons is dephased by the first diffusion gradient,
and rephased exactly by the second. The degree of dephasing and consequent rephasing is
dependent on the position in the direction of the diffusion gradient.
In the second scenario, the red water proton moves perpendicularly to the diffusion gradient.
The amount of rephasing is therefore unchanged, and the phase is restored. The blue proton
moves in the direction of the diffusion gradients, and therefore the second diffusion gradient
imparts an unbalanced phase offset relative to the first gradient. The resulting dephasing causes
attenuation in the diffusion-weighted image.
This diagram and explanation was adapted with changes from Charles-Edwards & DeSouza
(2006).
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2.1.13.1 Choice of b values
Although a high number of b values means that there are more data points with which to
estimate the ADC, it also increases scan time and therefore there is a greater risk of patient
motion. Regarding the minimum b value, apparent water mobility can be elevated by perfusion
in diffusion-weighted images acquired with b = 0s/mm2. Padhani et al. (2009) recommend a
minimum b value   100s/mm2. Regarding the maximum b value, a trade-off must be made
between the contrast afforded by high b values and their poor signal to noise ratio.
2.1.14 Imaging artefacts
Many image artefacts may be observed in MRI, and may arise from hardware issues, user error
(such as the usage of inappropriate pulse sequences), physiological reasons (such as motion
from respiration) or from the material being imaged (such as magnetic susceptibility). Three
common artefacts are described below.
2.1.14.1 Motion artefacts
It is not always possible for a living person to remain stationary for the duration of an MRI
scan, which may last between less than a second and several minutes. In an examination with
several images being acquired, the patient may be in the scanner for half an hour or more.
Patient motion between scans can compromise the quality of, for example, subtraction images
in DCE-MRI (as shown in Figure 2.12).
As discussed above, the frequency encoding direction of k-space is acquired much more quickly
than the phase encoding direction. This is because typically each row is acquired from a single
echo. Therefore, patient motion introduces errors primarily in the phase encoding direction.
Measures may be taken to prevent motion artefacts. Cardiac motion artefacts in breast MRI
can be avoided by choosing a coronal or sagittal imaging plane. Respiratory motion artefacts
can be decreased by imaging the patient in the prone (face down) position. Intra-scan motion
(such as in DCE-MRI) can be corrected using image registration algorithms. Guo et al. (2006)
presents a review of such algorithms for breast MRI.
2.1.14.2 Bias field
The bias field is presented in MR images as a slow and varying intensity inhomogeneity, and
is caused by imperfections in the RF coil. The imperfections lead to low-pass filtering of the
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Figure 2.12: A subtraction image of a single slice of DCE-MRI breast data before and after motion
correction
The image on the left shows a single slice of DCE-MRI subtraction data (first post-contrast
minus pre-contrast). Significant motion artefacts are present, and are particularly visible at the
breast-air boundary. On the right, the same image is shown after motion correction. Much of
the motion artefact has been eliminated. Note that these images are displayed using different
intensity scales.
k-space representation of the B1 field. This corresponds to point-wise multiplication of the true
signal with the bias field in the image domain. This is also known as the coil effect.
Although this effect can typically be ignored by a human observer performing qualitative ana-
lysis, for quantitative analysis the field must be corrected. A large number of algorithms have
been suggested for this purpose (Gilles et al. 1996, Guillemaud & Brady 1997, Ahmed et al.
1999, Van Leemput et al. 1999, Styner et al. 2000, Gispert et al. 2004, Tustison et al. 2010).
2.1.14.3 Partial volume effect
The partial volume effect occurs when a pixel (or voxel) contains more than one tissue type. The
consequence of this is that the signals of the tissues are averaged, which can lead to diagnostic
misinterpretations. The partial volume effect may be avoided by acquiring thinner slices or
increasing the in-plane resolution.
2.2 Breast Anatomy and Cancer
The primary function of the breast is as an organ of lactation. Breast tissue consists of glandular
tissue, connective tissue, stroma and ligaments, fatty tissue, skin, blood vessels, lymphatics and
lymph nodes. There are 15-20 lobes of glandular tissue with ducts and lobules (see Figure 2.13)
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Figure 2.13: Breast anatomy (coronal view). Reproduced with changes from Ohio State University
(2013).
surrounded by connective tissue or stromal tissue. The stroma consists of adipose tissue and
ligaments that surround the lobules and ducts. A lobule comprises approximately 30 terminal
branches. Terminal ducts open into lactiferous ducts, which run towards the nipple. Although
there are no muscles in the breast, the breast tissue is connected to the pectoralis major, which
is situated between the breast and ribcage.
2.2.1 Benign breast disease
In this section, the benign lesions in this thesis are described.
2.2.1.1 Fibroadenomas
Fibroadenomas are among the most common benign tumour of the breast, particularly for
women aged younger than 30. They are mobile, and may up to 15cm in diameter. They
comprise delicate fibroelastic stroma with proliferation of ducts and acinar tissue, and may
contain fat, smooth muscle and calcification. They are typically round in shape, or are composed
of multiple round or oval shaped lobules (see Section 2.3.1.1).
In MRI they appear as well-circumscribed masses, with T1w intensity (see Section 2.3.2.1)
isointense or slightly hypointense relative to breast parenchyma (normal tissue). They have
high T2w signal intensity (see Section 2.3.3), similar to a cyst, when the lesion contains a
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high proportion of epithelial tissue (typically in younger women). In older women, there is
often a higher proportion of fibrotic tissue, and the T2w intensity may be isointense or slightly
hypointense relative to breast parenchyma.
In DCE-MRI, fibroadenomas with an abundance of epithelial tissue exhibit high initial contrast
enhancement, followed by continuous increase or plateau (see Section 2.3.4.1). Fibroadenomas
with a higher proportion of fibrotic tissue exhibit no or only slight contrast enhancement.
2.2.1.2 Cysts
Cysts develop from enlarged lactiferous ducts, and are usually found in women aged 30-50.
They are lined by a single layer of epithelium and usually contain yellow or clear fluid, or
blood. There is commonly more than one, and they are usually seen as well circumscribed
masses with a round or ovoid shape. In T1w imaging, cysts appear as hypointense. In T2w
imaging, they appear as hyperintense. They do not exhibit contrast enhancement.
2.2.1.3 Phyloides tumours
Phyloides tumours are rapidly growing masses, often found in women aged 30-50. They have
well-circumscribed or lobulated borders. They resemble large fibroademomas, but are more
cellular than fibroadenomas. In T1w imaging, they appear as isointense relative to the breast
parenchyma. In T2w imaging, they are iso- to hyper-intense. In DCE-MRI, they exhibit high
initial enhancement, followed by a continuous increase or plateau curve.
2.2.1.4 Papillomas
Papillomas typically occur within a dilated major duct in the subareola region. They are well-
circumscribed masses, usually round or oval-shaped. They most often occur in women aged
35-55, and may cause nipple discharge. Although they are not malignant, they are associated
with an increased risk of breast cancer. In T1w imaging, papillomas are iso-intense. In T2w
imaging, they are commonly hypointense. In DCE-MRI, they can display homogenous or
inhomogenous enhancement, typically with a continuous or plateau curve.
2.2.1.5 Adenomas
Adenomas are composed of benign epithelial elements with a sparse stromal component. Tu-
bular adenomas consist of a proliferation of small tubular structures separated from adjacent
breast tissue by an enveloping pseudocapsule. They are well-circumscribed, with a round or
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oval shape. In T1w imaging, they are iso- or slightly hypo-intense. In T2w imaging, they are
hyperintense. In DCE-MRI, they typically exhibit homogenous contrast enhancement, with
high initial enhancement and a continuous or plateau time-intensity curve.
2.2.1.6 Fat necrosis
Fat necrosis is a nonsuppurative3 lesion consisting of dead adipose tissue, which usually has the
characteristic benign appearance of a rounded mass. These lesions may also have similar ap-
pearance to malignancy; specifically the presence of microcalcifications, skin retraction and skin
thickening. In T1w imaging, fat necrosis lesions are isointense relative to the surrounding par-
enchyma. In T2w imaging, they are hyperintense due to reactive oedema. In DCE-MRI, they
exhibit moderate uptake followed by a continuous time-intensity curve. Several months after
necrosis, these lesions are isointense in T2w imaging and do not exhibit contrast enhancement.
2.2.1.7 Pseudoangiomatous stromal hyperplasia (PASH)
PASH refers to an overgrowth of myofibroblastic4 cells. They have a similar appearance to
fibroadenoma.
2.2.1.8 Fibrocystic change (FCC)
Fibrocystic change, also known as mammary displasia, describes the proliferation of hormone-
dependant mesenchymal5 and epithelial6 structures. These include cysts, lobular hyperplasia,
adenosis, ductal and alveolar hyperplasia, and stromal fibrosis. Fibrocystic change is typically
isointense in T1w and T2w imaging, but may contain hypo- or hyper-intense components. In
DCE-MRI, FCC exhibits patchy, diffuse enhancement.
2.2.2 Malignant breast disease
In this section, several types of malignant lesions are described. Figure 2.14 illustrates micro-
scopic changes to the duct that may lead to invasive breast cancer.
3 Nonsuppurative: pertaining to inflammation without the production of pus
4 A myofibroblast is a cell that is in between a fibroblast and a smooth muscle cell
5 Mesenchyme is a type of tissue characterised by loosely associated cells that are surrounded by a large
extracellular matrix
6 Epithelial tissues line the cavities and surfaces of structures
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Figure 2.14: Illustration of microscopic changes within the duct, adapted from Tanner (2005)
2.2.2.1 Invasive ductal carcinoma
Invasive ductal carcinoma (IDC, also known as infiltrative ductal carcinoma) are cancer cells
that originate in the terminal ducts, but have spread into other parts of the breast tissue. It
is the most common type of breast cancers, accounting for 70-80% of diagnoses. Typically
these lesions have poorly defined or irregular margins, due to haphazard tumour growth. In
T1w imaging, IDC is isointense. In T2w imaging, IDC is iso- or slightly hypo-intense. Micro-
calcifications may be observed. In DCE-MRI, IDC often exhibit high initial uptake, followed
by washout. Rim enhancement (see Section 2.3.4.4) may be present, and IDC often exhibit
centripetal enhancement (see Section 2.3.4.5).
2.2.2.2 Ductal carcinoma in situ
Ductal carcinoma in situ (DCIS) is the second most commonly detected malignancy (after IDC).
DCIS refers to cancer that has not yet started to invade surrounding tissue. As a consequence,
DCIS has typically poorly defined margins, and conforms to the structure of the ducts. It
is commonly branching, but may also be round or spiculated. In T1w and T2w imaging,
DCIS has no specific characteristics. In DCE-MRI, it typically exhibits low enhancement.
Microcalcifications are commonly observed in DCIS.
2.2.2.3 Invasive lobular carcinoma
Invasive lobular carcinoma (ILC) refers to cancer cells that originate in the lobules, and has
spread to other parts of the breast. Unlike most other types of breast cancer, ILC does not
result in a palpable lump, but rather a thickening of tissue. It tends to grow circumferentially
around ducts and lobules, and may be round, irregular or spiculated in shape. In T1w imaging,
ILC is iso-intense. In T2w imaging, ILC may be iso- or slightly hypo-intense. Peri-tumoral
oedema (see Section 2.3.3.2) may be observed in T2w imaging. In DCE-MRI, ILC most often
2.2 Breast Anatomy and Cancer 29
exhibits a plateau curve, but may also exhibit washout in the post-initial phase. It may also
exhibit rim enhancement.
2.2.2.4 Lobular carcinoma in situ
Lobular carinoma in situ (LCIS) refers to a proliferation of tumour cells in the terminal duct lob-
ules that has not yet infiltrated through the basement membrane into the surrounding stroma.
It has no specific intensity in T1w or T2w imaging, nor does it have a specific time-intensity
curve in DCE-MRI.
2.2.2.5 Mucinous carcinoma
Mucinous carcinoma is the accumulation of extracellular mucinous secretions around clusters
of tumour cells. They are well circumscribed, round or oval shaped masses. In T1w imaging,
they are hypo-intense. In T2w imaging, they are iso- or hypo-intense. In DCE-MRI, mucin-
ous carcinoma exhibit high initial enhancement, followed most commonly by a plateau curve.
Calcifications may be present, but they are rare.
2.2.2.6 Invasive papillary carcinoma
Invasive papillary carcinoma are rare, accounting for less than 1% of invasive breast cancers.
They consist of proliferations of cells arranged around fibrovascular cores. They are typically
well circumscribed, and round or oval shaped. In T1w imaging, they are hypo-intense. In T2w
imaging, they have no specific intensity. In DCE-MRI, they are characterised by high uptake
of contrast agent followed by a plateau or wash-out curve.
2.2.2.7 Inflammatory breast cancer
Inflammatory breast cancer (IBC) is a rare (less than 5% of cancer diagnoses) but aggressive
type of breast cancer. Breasts affected by IBC often look inflamed (swollen and red), and are
characterised by the presence of oedema. The majority of IBC is IDC, and is caused by cancer
cells blocking the lymph vessels in the skin of the breast.
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2.3 Signs of benign and malignant lesions in MR mammo-
graphy
In the previous section, the appearance of specific types of benign and malignant lesions is
described. In this section, signs of benign and malignant lesions are presented. Lesions are
classified as exhibiting or not exhibiting signs based on at least some degree of qualitative
assessment by a radiologist. Later chapters in this thesis focus on defining quantitative features
that describe these signs.
The BI-RADS lexicon (American College of Radiology 2008) for breast MRI provides a standard
method for reporting morphometric and kinetic signs. Similarly, Kaiser (2009) describes a
number of qualitative signs in the book “Signs of MR mammography”. Common signs are
described below.
2.3.1 Morphology
2.3.1.1 Shape
The presence of an irregular contour is a hallmark of malignancy. The reason for this is that
the biochemical enzyme apparatus of a malignancy enables the tumour to grow aggressively
into neighbouring tissues, destroying well-defined contours (Kaiser 2009). Irregular contours
are observed in invasive ductal and lobular carcinomas. However, this sign is also observed in
benign conditions such as fibrosis or perifocal inflammation around a percutaneously aspirated
cyst.
A round mass lesion is frequently a cyst, myxoid fibroadenoma, or papilloma. Elliptical or oval
shapes may occur with cysts, myxoid fibroadenomas, and papillomas. Lobulated contours are
common in complex cysts, complex papillomas, or myxoid fibroadenomas.
2.3.1.2 Taller than wide sign
First proposed for the field of sonography, the taller than wide sign is positive if a lesion is
larger in its anteroposterior dimension than its left-right dimension, indicating that the lesion
is growing parallel to the ductal system (toward the nipple). Stavros et al. (1995) found this
sign to have a sensitivity of 98.1% and a specificity of 41.6%. Kaiser (2009) warns that this sign
“should always be interpreted within the context of other signs” because of its poor specificity.
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2.3.1.3 Margin
Irregular margins are hallmarks of invasive cancers such as IDC and LCIS, whereas smooth con-
tours are more common among benign lesions. Lobulated margins are signs of cysts, papillomas
or myxoid fibroadenomas. Carcinomas are rarely truly well-circumscribed due to marginal in-
filtration (Kaiser 2009).
Spiculated margins (small, needle-like structures growing outwards from the lesion) are fre-
quently observed in malignant lesions. The presence of spicula presenting as irregularities in
the margins of a lesion without contact to the pectoral wall is known as the root sign. The root
sign has moderate sensitivity and relatively poor specificity (Baltzer et al. 2013).
The presence of spiculate dendrites from the lesion that make contact with the pectoral muscle
is known as the hook sign. The hook sign (also known as desmoplastic tethering) has been shown
to have poor sensitivity (19-33%) but high specificity (95-98%) (Dietzel, Baltzer, Vag, Gajda,
Camara & Kaiser 2010, Renz et al. 2006, Dietzel, Baltzer, Vag, Gröschel, Gajda, Camara &
Kaiser 2010, Malich et al. 2005), and is more common in large lesions (Dietzel, Baltzer, Vag,
Gajda, Camara & Kaiser 2010). Usually the dendrites show little or no enhancement after
contrast administration. The cause of this phenomenon is unknown (Kaiser 2009), although
Macura & Ouwerkerk (2006) speculate that this represents the invasion of the Cooper ligaments
in the direction of the pectoral muscle. The hook sign is best viewed on non-fat-suppressed
T2w images (Macura & Ouwerkerk 2006).
Thick, enhancing connections between the lesion and pectoral muscle, known as pectoral muscle
invasion, is highly indicative of malignancy. These connections are much larger than the hook
sign. This feature signifies carcinomatous lymphangiosis in an untreated breast (Kaiser 2009).
2.3.2 Non-contrast-enhanced T1-weighted images
2.3.2.1 Signal intensity
Increased signal intensity in a non-contrast-enhanced T1w image is almost always a benign sign
(Kaiser 2009). Lesions presenting with high T1w intensity include fat necrosis, haemorrhage
with methemoglobin formation, and intramammary lymph nodes.
In general there is poor separation between T1w intensity values between benign and malignant
lesions, as shown in Table 2.2.
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Table 2.2: T1 and T2 values for breast tissue
Tissue T1 range (ms) T2 range (ms) T1w relative
intensity
T2w relative
intensity
Fat 120 - 277 (215) 38 - 80 (57) High Medium - high
Fibroglandular 143 - 795 (524) 34 - 62 (46) Low - medium Medium
Fibrocystic
(fibrotic)
233 - 579 (388) 40 - 57 (49) Low - medium Medium
Fibrocystic
(cystic)
289 - 2227 (940) 61 - 141 (115) Low High
Fibroadenoma 200 - 1096 (821) 41 - 89 (66) Low - medium Medium - high
Carcinoma 175 - 800 (567) 40 - 150 (68) Low - medium Medium - high
Mean values are displayed in brackets. Reproduced from Santyr (1994).
2.3.2.2 Fat separation sign
The presence of a sharp, non-infiltrated, non-enhancing layer of fat between a lesion and the rest
of the parenchyma is known as a positive fat separation sign. This is common in benign lesions
such as fibroadenoma, phylloides tumour, or papilloma. In malignant lesions, the adjacent fatty
layer would be infiltrated by even a small carcinoma (Kaiser 2009).
2.3.2.3 Skin Thickening
Skin thickening is frequently observed after radiation therapy. In an untreated breast, the
presence of skin thickening in the ipsilateral breast is a sign of malignancy. This sign was
defined by Renz et al. (2008) as the presence of skin with a thickness greater than 3mm, and
with the absence of skin thickening on the contra-lateral breast.
Malich et al. (2005) found this sign to separate benign and malignant lesions with very low
sensitivity (9%) but high specificity (97%). Dietzel, Baltzer, Vag, Gröschel, Gajda, Camara
& Kaiser (2010) found that this sign was less sensitive to small (< 5mm) lesions, with a
sensitivity of only 3.7% (96.7% specificity). Skin thickening is more prevalent in the presence
of inflammatory breast cancer, with Renz et al. (2008) and Le-Petross et al. (2011) reporting
the presence of skin thickening in 93-94% of affected breasts. Renz et al. (2008) suggest that
the cause of skin thickening in inflammatory carcinomas is mainly “the typical obstruction of
lymphatic vessels by tumour emboli”.
This sign is most commonly assessed on non contrast-enhanced T1w images (Malich et al.
2005).
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2.3.3 T2-weighted images
2.3.3.1 Signal intensity
T2w images are are commonly used to identify objects with high fluid content, such as cysts,
myxoid fibroadenomas and lymph nodes. In general, malignant lesions are not hyperintense
on T2-weighted images, with the exception of those with high fluid content, such as mucinous
carcinomas, as well as those associated with necrosis, oedema and abscess. Overall, 98% of
malignant masses are iso- or hypointense (Kaiser 2009).
Lesions displaying hypo-intensity relative to glandular tissue in T2w imaging include invasive
ductal and invasive lobular carcinoma, fibrous fibroadenoma, scar tissue and necrotic tissue.
Hyper-intensity is observed in myxoid fibroadenomas, papilomas. Very high intensity is ob-
served in cysts and breast implants.
2.3.3.2 Oedema
Formerly known as dropsy, oedema is the accumulation of fluid in the body’s tissue, and is
observed in breast MRI as hyper-intensity in T2w imaging. Although it is commonly associated
with inflammatory breast cancer, it may also be caused by heart disease, particularly if the
oedema is bilateral (Cao et al. 2011).
Oedema in malignancies occurs as a result of capillaries induced by tumour neoangiogenesis
having less intact basal membranes. This causes the penetration of hydrophilic, low-weighted
substances and results in fluid retention. In inflammatory breast cancer, oedema is caused by
lymphatic obstruction (Renz et al. 2008).
The presence of perifocal oedema in a previously untreated breast is a strong indicator of
carcinoma, suggesting a high grade of malignancy and a relatively poor prognosis. Kaiser
(2009) recommends that oedema should be observed on STIR sequences, as they are more
sensitive than TSE sequences.
2.3.4 Dynamic contrast enhanced MRI
2.3.4.1 Time-intensity curve
As described in the previous section, DCE-MRI is the acquisition of images before and at several
times after the injection of an intravenous contrast agent. The resulting time-intensity curve
can be described using two phases, as shown in Figure 2.15. The early post-contrast phase
describes the wash-in characteristics, which are often categorised as slow, moderate and fast.
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Figure 2.15: Schematic drawing of the time-intensity curve types, adapted from Kuhl, Mielcareck,
Klaschik, Leutner & Wardelmann (1999). Type I is a straight (Ia) or curved (Ib) line. Type II is a
plateau curve. Type III is a washout curve.
The intermediate and late post-contrast phase describes the signal intensity after the initial
wash-in (typically from around two minutes after the injection), and can be categorised as type
Ia, Ib, II, or III.
Glandular tissue, fat and cysts typically do not exhibit any contrast enhancement. A slow
wash-in (<50% signal increase at the first post-contrast image relative to the pre-contrast
intensity) typically characterises benign lesions, including fibrous fibroadenoma, scar tissue, or
mild inflammation. It can also indicate the presence of DCIS. Moderate (50-90%) enhancement
is commonly observed in fibroadenomas, papilomas, or fresh scars. Fast (> 90%) enhancement
is common in invasive carcinoma and the focal components of DCIS. Some papillomas and
myxoid fibroadenomas also exhibit rapid enhancement.
Type Ia and Ib curves most often indicate a benign mass lesion such as myxoid fibroadenomas
or papilomas. This curve accounts for 84% of benign lesions and 9% of carcinomas, most
commonly ILC or DCIS. Type II curves are observed in 11.5% of benign and 34% of malignant
lesions. Type III curves are observed in 5.5% of benign and 57% of malignant lesions (Kuhl,
Mielcareck, Klaschik, Leutner & Wardelmann 1999).
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2.3.4.2 Internal enhancement pattern
Internal enhancement can be classified as homogenous or heterogenous. Homogenous enhance-
ment (uniform signal intensity in post-contrast images) is common in benign lesions. Hetero-
genous enhancement is a characteristic of malignant lesions.
2.3.4.3 Blooming sign
The blooming sign is characterised by sharply defined margins in the first post-contrast images,
followed by increasingly unsharp margins in the later post-contrast images. Fischer et al. (2004)
explain the occurrence of the blooming sign as follows. The increasing unsharpness and blurring
of borders is a result of neoangeogenesis, fibrosis and an expansive growth pattern combined
with a high marginal vessel density, increased vascular permeability and the absence of intact
lymphatic circulation. The high incidence of the blooming sign in benign lesions having a rather
high proliferation rate (i.e. papillomas and atypical ductal hyperplasia) can be explained by the
association of proliferation and subtle infiltration into the vascular wall.
2.3.4.4 Rim enhancement
Rim enhancement is the increase in signal in the peripheral regions of a lesion relative to
the centre. The sign is present not only in lesions with a necrotic core, but is a common
characteristic of malignant lesions, with a sensitivity of around 30% (Mussurakis et al. 1998).
During tumour growth, proliferation of tumour cells is faster than angiogenesis, leading to
the formation of poorly perfused hypoxic zones near the tumour centre. Intratumour pres-
sure gradients may also be a cause of the rim sign. Insufficient lymphatic drainage, increased
permeability to proteins and other macromolecules, continuous tumour cell proliferation in a
relatively confined and rigid space, and ischaemic cell swelling can increase the central inter-
stitial fluid pressure. This would reduce the Starling forces responsible for the extravasation of
gadopentetate dimeglumine.
2.3.4.5 Centripetal and centrifugal enhancement
Centripetal enhancement is related to rim enhancement, described above, and describes the
phenomenon in which the peripheral regions show high contrast uptake in the early post-
contrast phase, followed by the contrast agent slowly spreading towards the centre. This is
a typical enhancement pattern of carcinoma, occurring in 41% of malignancies (Montemurro
et al. 2007).
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Figure 2.16: A representation of a heterogenous lesion. On the highly cellular side, water molecules
are restricted and the path length L is shorter, resulting in less signal attenuation and a lower ADC.
This image was redrawn from Charles-Edwards & DeSouza (2006).
In centripetal enhancement, the signal is initially more pronounced in the centre of the mass,
before spreading towards the periphery, or “filling from the inside to the outside” (Kaiser 2009).
This pattern of enhancement is more common in benign lesions.
2.3.4.6 Vessel sign
The vessel sign is present when the concentration of blood vessels in an affected breast is
markedly increased relative to the contralateral breast, and is strongly suggestive of malignancy.
As tumour angiogenic factors are expressed, new blood vessels grow in the region surrounding
a lesion.
2.3.5 Diffusion-weighted MRI
Diffusion weighted imaging reflects the random Brownian motion of water molecules in tissue.
Assuming Gaussian diffusion, this can be characterised by the apparent diffusion coefficient
(ADC), a scalar quantity describing the net displacement of water in mm2/s. The ADC is
lower in regions in which motion is restricted, as shown in Figure 2.16.
In malignant lesions, the ADC tends to be low due to the increased cellularity, larger nuclei with
more abundant macromolecular proteins, and less extracellular space. In the discrimination of
benign and malignant lesions at 1.5T, ADC has a sensitivity of 85-91%, and a specificity of
69-84% (Tsushima et al. 2009). A review of breast ADC literature is presented in Chapter 5.
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2.4 Statistical Pattern Recognition
Sharma & Kaur (2013) define a pattern as “a set of objects of phenomena or concepts where the
elements of the set are similar to one another in certain ways or aspects”. Common examples
of patterns include fingerprints, faces, and handwriting. This section contains background
material in the field of statistical pattern recognition. The two classification algorithms used in
Chapter 7—logistic regression and random forests—are described in detail, along with a short
explanation of support vector machines and artificial neural networks.
2.4.1 Classification
Classification approaches may be separated into two classes - supervised and unsupervised. In
supervised classification, the input data is identified as a member of a predefined class. The
classification process consists of two stages - training and testing. Decision rules are generated
during the training stage, and new samples (feature vectors) are designated a class during the
testing stage. In unsupervised learning, class labels are unknown, and the problem is that
of trying to find the hidden structure. Examples of unsupervised learning include clustering
algorithms (such as mean-shift or k-means) and hidden Markov models.
In this thesis, supervised classification is used because the number of classes and the class labels
are known (i.e. benign and malignant classes).
2.4.2 Curse of dimensionality or the peaking phenomenon
Given a sufficiently large sample size and small number of features, classification performance
tends to increase with each additional feature. Intuitively, each feature may be thought of as
bringing in more information about each sample, and therefore increasing the performance of
the classifier on unseen data.
The curse of dimensionality or peaking phenomenon refers to the phenomenon in which clas-
sification performance increases with each additional feature only up to a point, at which it
begins to decrease. The reason for this is that the feature space increases in dimensionality
with each additional feature, and therefore the observations become less representative of their
class. Jain & Duin (2000) state that “a rule of thumb is that using at least ten times as many
training samples per class as the number of features is good practice. The more complex the
classier, the larger the ratio of sample size to dimensionality should be”.
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2.4.3 Logistic regression classifier
The logistic regression classifier is a relatively simple classifier for two class problems (Jain &
Duin 2000). This classifier maximises the following function:
max
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where qj(x; ✓) is the posterior probability of class !j, given x, ✓ denotes the set of unknown
parameters, and x(j)i denotes the i-th training sample from class !j, j = 1, 2. Given the
discriminant function D(x, ✓), where ✓ is the parameter vector, posterior probabilities can be
derived as logistic functions as follows:
q1(x; ✓) =
1
1 + e D(x;✓)
(2.6)
q2(x; ✓) =
1
1 + eD(x;✓)
(2.7)
Note that q1(x; ✓) + q2(x; ✓) = 1.
2.4.4 Random forests classifier
Random forests (RF) is an ensemble method for feature classification. A short introduction
to random forests is presented below. The reader is directed to Breiman (2001) for more
information.
The classifier consists of many (typically thousands of) simple tree classifiers. For the k-th tree,
a random vector ⇥k is generated. This random vector defines the weighting of the input data -
hence every tree will be constructed using different training data. The tree is grown using the
training set and ⇥k, resulting in the classifier h(x,⇥k) where x is an input vector. Given a new
sample, each tree yields a class label. The new sample is assigned by a majority vote among
the random trees. Posterior probabilities are given by the proportion of trees voting for each
label.
Although each classification tree is itself weak, as an ensemble random forests classifiers yield
high accuracy. The classifier construction and prediction steps are highly parallelisable, and
therefore RFs runs efficiently on large datasets. Random forests do not overfit as more trees are
added, but produce a limiting value of the generalisation error (Breiman 2001). As a result, it
is hard to over-train RF models (Touw et al. 2013).
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2.4.5 Support vector machines
Support vector machines (SVMs) are binary classifiers that operate by constructing a hyper-
plane (or set of hyperplanes) in between classes. This hyperplane is computed such that the two
classes are divided by as large a gap as possible. SVMs make use of mappings to higher dimen-
sional feature space than the original data, in order to effectively separate the data. Through
this “kernel trick”, SVMs become non-linear classifiers. One significant drawback of SVMs is
that the choice of kernel is not always obvious.
2.4.6 Artificial neural network
Artificial neural networks (ANNs) are biologically-inspired learning algorithms. While this term
covers a broad range of models for a wide range of applications, ANNs always have one or more
hidden layers of nodes in between their inputs and outputs. ANNs are highly customisable
and have been used to perform many tasks, but have the limitations of having many tuning
parameters and (like random forests) being difficult for the user to interpret.
2.4.7 Evaluating performance
The performance of a classifier is commonly summarised using a Receiver Operating Character-
istic (ROC) curve. An example is shown in Figure 2.17. The ROC curve describes a two-class
problem by plotting the sensitivity and specificity at a range of classification thresholds. The
area under the curve (AUC) gives an indication of the performance of the classifier. An AUC
of 1 means that, given the correct threshold, the classifier perfectly discriminates between the
two classes. An AUC of 0.5 means that the the classifier is no better than random. An AUC of
less than 0.5 means that the classifier will assign a sample the incorrect class label more often
than it will assign the correct class label (i.e. worse than random).
The AUC assumes that the cost of misclassification is equal for positive and negative classes. As
it is generated from the rank order of the data, it does not require knowledge of the distribution
of samples.
2.5 Conclusion
This chapter has presented a summary of the concepts that are central to this thesis. In
particular, it presented an introduction to MRI, breast anatomy, the appearance of breast
cancer in MR images, and statistical pattern recognition. In the next chapter, two new methods
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Figure 2.17: Example of a Receiver Operating Characteristic (ROC) curve. The curve shows the
performance of the logistic regression classifier on Fisher’s iris dataset. The area under the curve
(AUC) is 0.79. For reference, a curve with an AUC of 0.5 is also shown.
for automatic segmentation of breast lesions are presented. The first is based on voxelwise
classification, and the second is based on mean-shift clustering and graph-cuts.
Chapter3
Automatic breast lesion segmentation
This chapter deals with the problem of automatically segmenting (detecting and delineating/la-
belling) suspicious tissue in breast MRI data. As noted in a recent review of breast MRI and
MRS (Sinha & Sinha 2009), breast MRI CAD needs to be based on “quantitative features ex-
tracted preferably from the automatically segmented 3D lesion”. Indeed, there is evidence that
computerised delineation of lesions can result in improved discrimination between benign and
malignant lesions (Tanner et al. 2004). This chapter presents and evaluates two algorithms for
the automatic segmentation of suspicious breast lesions. The first is based on voxel-wise clas-
sification and the concept of multivariable co-occurence, and was presented at the Computed
Assisted Radiology and Surgery (CARS) conference McClymont et al. (2012b). The second
employs mean-shift clustering and graph-cuts, and was published in the Journal of Magnetic
Resonance Imaging (McClymont et al. 2013).
Segmentation is in essence a partitioning of the domain of an image into subsets corresponding
to the individual objects of interest. It remains one of the most difficult tasks in image processing
(Sonka et al. 1999, Russ 2012, Liu et al. 2011). Gonzalez & Woods (2007) formally define
segmentation as follows:
Let R represent the entire spatial region occupied by an image. We may view image
segmentation as a process that partitions R into n subregions R1, R2, . . . , Rn.
In the case of breast MRI the objects of interest are lesions (3D regions) exhibiting suspicious
enhancement. To date several algorithms (Vignati et al. 2011, Ertas et al. 2008, Twellmann
et al. 2004, Woods et al. 2007) have been proposed for automatic detection; i.e. finding sus-
picious regions but not seeking to accurately delineate them. Several algorithms, too, have
been proposed for the delineation step (Bahreini et al. 2010, Meinel et al. 2010, Ertas et al.
2007, Chen et al. 2007), but require the specification of a seed or region of interest. To the
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author’s knowledge no algorithm has been proposed to date that addresses both steps in a fully
automatic manner. The second of the two algorithms (employing mean-shift clustering and
graph-cuts) presented in this chapter is the first to do so.
The first approach (based on voxel-wise classification) in this chapter was presented at the
Computer Assisted Radiology and Surgery (CARS) Conference in Pisa, Italy in 2012. The
second approach (based on mean-shift clustering and graph-cuts) was published in the Journal
of Magnetic Resonance Imaging (JMRI) in 2013.
The remainder of this chapter is organised as follows. The next section reviews existing ap-
proaches to detecting/delineating lesions in the breast. Section 3.2 presents the proposed seg-
mentation method based on voxel-wise classification and multivariable co-occurrence, followed
by an empirical evaluation of performance. Section 3.4 presents the proposed segmentation
method based on mean-shift clustering and graph-cuts, again followed by an empirical evalu-
ation of the method in Section 3.3. Finally Section 3.6 provides a discussion and summary of
the chapter.
3.1 Review of existing approaches to lesion segmentation
in breast MRI
Two distinct approaches to lesion segmentation in breast MRI can be identified in the literature.
The first is based on voxel-wise classification. The idea is that each voxel in turn is classified as
normal or suspicious leading to a final partitioning of the image domain into suspicious regions
and non-suspicious tissue. The second approach is based on the idea of first detecting groups
of voxels that mark or locate suspicious regions and then accurately delineating the extent of
the lesion associated with each region. Methods belonging to these two different approaches
are reviewed in the following two subsections.
3.1.1 Methods based on voxel-wise classification
Methods based on the voxel-wise classification approach are presented in Table 3.1. In this
approach, a set of features is computed for each each voxel. These features are derived from
one or more MRI modalities and may also take into account the local neighbourhood around
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the voxel. Training data, consisting of labelled examples of normal and suspicious tissue, is
needed to construct a classification rule in the feature space. Once trained, this rule can be
used to classify previously unseen voxels in a new data set. All voxels in the new data set
are either assigned a classification score (for example, posterior probability of malignancy) or
given a class label (for example, benign or malignant). For the methods that assign a posterior
probability, the area under the ROC curve is commonly used as a measure of performance. The
methods that assign class labels to voxels are evaluated by the number of true positive (correctly
labelled suspicious/malignant voxels) and false positive (voxels that are incorrectly labelled as
suspicious/malignant) volume fractions. These methods report sensitivity and specificity for a
single operating point on the ROC curve (i.e. for a single classification threshold or cut-point),
as opposed to other methods that report sensitivity and specificity for all cut points.
The multispectral co-occurrence method of Kale et al. (2008) is the only one of those listed
in Table 3.1 that has been shown to possess any robustness to variations in MR protocol.
Kale et al. (2008) showed that a classifier trained and evaluated using axially-acquired data
achieved a similar level of performance when evaluated on unseen sagitally-acquired data. This
robustness likely stems from the fact that the algorithm assesses the co-occurence of fitted Brix
model parameters for neighbouring voxels, rather than assessing spatial co-occurrence as in
Fusco & Sansone (2012). A description of the multispectral co-occurrence method is presented
below.
The Brix model was fit to each voxel in turn, yielding three parameters A, kep, and kel. For
each voxel, a grey level co-occurence matrix (GLCM) was generated using counts of co-occurring
parameters, rather than the traditional method of co-occurring intensities in neighbouring spa-
tial co-ordinates. The GLCM was filled with co-occurring parameters in a neighbourhood of
5⇥ 5⇥ 2, in which the first two numbers indicate the row and column size, and the third indic-
ates the number of slices. The mis-match between the in-plane and through-plane dimensions
compensates for the non-isometric voxels (i.e. the window is approximately cubic when conver-
ted to real world dimensions). Twenty-one features were derived from the GLCM, including
entropy, contrast and correlation. Six of the features described all three parameters, and the
remaining 15 described two of the parameters. A feed-forward artificial neural network was
used for voxel-wise classification.
3.1.1.1 Motivation for method 1: Extension of multi-spectral co-occurrence
A weakness of this method is that the definition of 3-variable co-occurrence leads to a sparse co-
occurrence array containing very few counts. Whilst the number of counts can be increased by
increasing the window size used to compute the co-occurrence matrix, the resulting features are
less representative of local spatio-temporal contrast change. A novel variation of this method,
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in which distance-weighting is used to to address the problem of GLCM sparsity, is presented
in Section 3.2.
3.1.2 Methods based on detection and delineation
Table 3.2 describes several recent lesion detection approaches. All are initialised using threshold-
ing of DCE-MRI data, but vary in their approach. Tzacheva et al. (2003) performed user-defined
thresholding on post-contrast images in 2D. Wismüller et al. (2006) and Gal et al. (2007b) per-
formed thresholding at 50% and 40% relative enhancement respectively. Ertas et al. (2008)
used the intersection of three thresholds - 40% at 2 minutes, 60% at 3 minutes and 150% at
8 minutes. Vignati et al. (2011) performed thresholding based on parameters derived from
histograms of subtraction (mean post-contrast minus pre-contrast) images.
The performance of lesion detection algorithms is reported in an inconsistent manner. In the
case of Tzacheva et al. (2003), Gal et al. (2007b), Ertas et al. (2007), false positives are reported
as a fraction of the total breast volume. This approach does not provide any information about
the number of false positive connected components, only their total volume. In the work
of Vignati et al. (2011), the number of false positives is provided as a number of connected
components.
Table 3.3 provides a list of several recent lesion delineation approaches. In general, the methods
can be separated into the following categories: region growing (Fusco et al. 2011, Al-Faris et al.
2012, Meinel et al. 2010), edge detection/gradient flow methods (Gilhuijs et al. 2000, Bahreini
et al. 2010), and clustering methods (Chen et al. 2006).
Methods that focus on delineation (as opposed to detection) are typically seeded, usually by the
user clicking a central portion of the lesion (Lucas-Quesada et al. 1996, Meinel et al. 2010) or
defining a 3D bounding box around the lesion (Gilhuijs et al. 2000, Chen et al. 2006, Bahreini
et al. 2010). More recently, semi-automatic approaches for seeding lesions have been proposed
by Fusco et al. (2011) and Al-Faris et al. (2012).
Accuracy of delineation refers to how closely the automated segmentation, X, matches that of
the “ground truth”, Y , which is typically the manual delineation of one or more expert tracers.
There are a variety of metrics for measuring this, as shown in Table 3.4. The most common
method involves simply defining overlap as |X\Y ||X[Y | , where || denotes cardinality; and X and Y
are the binary masks corresponding to the segmentation mask and ground truth respectively.
This is 1 for X = Y and 0 if X and Y are disjoint. Chen et al. (2006) stated that an overlap
value of 0.4 or greater was acceptable. However, this metric does not indicate whether this
method under- or over-segmented relative to the ground truth. False negative volume fractions
are rarely reported, because this metric is dependent on breast volume. Fusco et al. (2011)
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Table 3.2: A list of approaches focussing on the detection of lesions.
Source Description Detection
accuracy1
False
positives
Number & type of
lesions
Tzacheva
et al.
(2003)
Detection based on intensity
threshold (110-140 on a
greyscale image 0-255)
91.9% 7.5%2 10 malignant, 4
benign
Wismüller
et al.
(2006)
Thresholding at 50% relative
enhancement, followed by
clustering using vector
quantisation.
100% Not
reported.
8 malignant, 5
benign
Gal et al.
(2007b)
Thresholding at 40% relative
enhancement, followed by region
growing.
100% Up to
8%2
14 malignant, 10
benign
Ertas et al.
(2008)
Thresholding at several
empirical values, followed by
template matching.
100% 10%2 20 malignant, 19
benign
Vignati
et al.
(2011)
Thresholding based on
histogram parameters, false
positive rejection through
vesselness filtering, size
thresholding and heuristics
relating to mean post-contrast
time curve
89%
(100% of
lesions >
20 mm)
10.9 con-
nected
compon-
ents per
subject
53 malignant, 12
benign
1 Detection accuracy refers to the number of true positive candidates divided by the total
number of ground truth lesions.
2 Percentages refer to the fraction of the breast volume occupied by false positive candidates.
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Table 3.3: A list of approaches focussing on the delineation of lesions. See Table 3.4 for definitions
of delineation accuracy metrics.
Source Description Delineation
accuracy
Number & type of
lesions
Gilhuijs
et al.
(2000)
Gradient flow approach and
morphological post-processing
Mean overlap =
0.66 ± 0.14
15 malignant, 13
benign
Chen
et al.
(2006)
Iterative fuzzy c-means
clustering
Overlap > 0.4 for
97% of lesions
77 malignant, 44
benign
Bahreini
et al.
(2010)
Gradient vector flow snake Overlap > 0.4 in
97.4% of
malignant lesions
and 91.8% of
benign lesions
38 malignant, 22
benign
Meinel
et al.
(2010)
Automatic threshold selection
and morphological processing
Median overlap =
0.64
24 malignant, 17
benign
Fusco
et al.
(2011)
Thresholding and hole filling Mean ACC =
0.879
5 malignant, 5 benign
Al-Faris
et al.
(2012)
Seeded region growing on
clusters
Mean RO = 0.704
TPF = 0.792
TNF = 0.851
MCR = 0.209
5 subjects (unknown
pathology)
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Table 3.4: Delineation evaluation metrics
Source True positive
definition
False positive
definition
True negative
definition
False negative
definition
Gilhuijs et al.
(2000), Chen et al.
(2004), Meinel
et al. (2010),
Bahreini et al.
(2010)
Overlap = |X\Y ||X[Y | - - -
Fusco et al. (2011) TPF = |X\Y ||Y | FPF =
|Y | |X\Y |
|B| |Y | TNF =|B| |X[Y |
|B| |Y |
FNF = |X
0\Y |
|Y |
Al-Faris et al.
(2012)
TPF = |X\Y ||Y | ,
Relative overlap =
|X\Y |
|X[Y |
Misclassification
rate, MCR =
1  |X\Y ||Y |
TNF =
1  |X\Y 0||Y |
-
Note that in this table, the terminology of the authors is used. For example, “relative overlap”
has exactly the same definition as “overlap”. For the benefit of the reader, the notation in each
of these equations has been standardised as follows:
X = automatic segmentation
Y = manual segmentation (ground truth)
B = breast segmentation
was the most thorough in reporting delineation accuracy, defining true and false positive and
negative volume fractions, and accuracy as TPF+TNFTPF+TNF+FPF+FNF .
3.1.2.1 Motivation for method 2: Mean-shift and graph-cuts
All methods to date focussing on lesion segmentation utilise only DCE-MRI data, and ig-
nore any additional scans such as anatomical T1-, or T2-weighted MRI. These scans can be
performed at higher spatial resolution than DCE-MRI, and may be particularly useful when
DCE-MRI is performed at low spatial resolution in favour of high temporal resolution.
Further to this, to the author’s knowledge no algorithm has been proposed to date that addresses
both detection and delineation in a fully automatic manner, and presents the results in terms
of detection (including the number of false positive candidates) and delineation accuracy.
3.2 Method 1: 3D segmentation by distance-weighted 3
variable multi-spectral co-occurence
This section presents an extension that addresses a weakness of the method of Kale et al.
(2008), in that the co-occurence array has many elements but only a few observations. In their
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Table 3.5: Model fit parameter limits
Parameter Minimum Maximum Unit
↵ 0 0.03 %/s
  -0.01 0.01 %/s
  70 120 s
work, co-occurence matrices were computed based on a neighbourhood around voxels of size
5 ⇥ 5 ⇥ 2 (50 entries). The size of the co-occurrence matrix (i.e. the number of bins for each
variable) is not stated, but even a conservative number of four bins per parameter results in a
3D co-occurence array with 64 (43) elements. Whilst the number of counts can be increased
by increasing the window size used to compute the co-occurrence, the resulting co-occurence
features are then less representative of local spatio-temporal change. In the proposed variation,
distance-weighting is used to address this.
The evaluation of our algorithm involved the following steps:
Step 1: Each data set was normalised to percentage enhancement relative to the pre-contrast
volume:
E(t) =
S(t)  S(0)
S(0)
(3.1)
where S(t) represents the signal intensity of each voxel at time t.
Step 2: A linear-slope model was fitted to each voxel-wise time series. The model has the
following definition:
E(t) =
8<:↵t t <  ↵  +  (t   ) t     (3.2)
Each parameter was then quantised into 4 equal-width bins for the three-variable features, and
8 equal-width bins for the two-variable parameters. The quantisation range for each parameter
was determined empirically using an additional data set (separate from the others), and is
presented in Table 3.5.
The choice of 4 and 8 bins for the three and two variable features respectively was deemed to
be a reasonable trade-off between the sparseness of the co-occurrence matrix (see Step 3) and
the discriminatory information lost through quantisation.
Step 3: A window of 7x7x3 (corresponding to a cube of side length 4.2mm) was centred on
each voxel within a breast volume. For each window a 3D co-occurrence volume, f, was defined,
where f(a,b,g) represents a penalised count of the number of times that the parameters a, b and
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g co-occur within the window. A given occurrence of a, b and g was penalised by multiplying
it by an exponentially decaying function of the Euclidean distance between the location of the
event, x, and the centre of the window, c, with a decay constant of 1 mm, as follows:
p(c,x) = e |c x|/1 (3.3)
Step 4: Twelve features were computed for each voxel including nine features obtained from the
voxel’s co-occurrence volume and the three linear slope parameters themselves. Three variable
co-occurrence features are presented in Table 3.6, and two variable co-occurence features are
presented in Table 3.7.
Step 5: A logistic regression classifier was trained on all twelve features using the training data
and applied independently to each data set in the testing data (voxel-wise classification). The
performance on each test data set was summarised using an ROC curve.
3.3 Empirical evaluation of method 1
3.3.1 Breast MRI data
Fifty breast DCE-MRI data sets, corresponding to 50 routine clinical breast MRI examinations,
were obtained from Queensland X-Ray. The cases were selected because each contained at least
one lesion verified by cyto- or histopathology. In total the data contained 25 malignant lesions
from 23 data sets, and one benign lesion each from the remaining 27 data sets. The malignant
lesions were divided into training data (17 lesions) used to train the proposed segmentation
algorithm and testing data (8 lesions) used to evaluate its performance.
Each DCE-MRI data set comprises one axial pre-contrast and three axial post-contrast volumes,
as well as one sagittal volume acquired before the final post-contrast volume. The sagittal
volume was discarded because of differences in field-of-view and other acquisition parameters
relative to the axial volumes. Typical scan parameters for the axial volumes are: acquisition
matrix: 512 x 512; pixel spacing: 0.61 x 0.61 mm; slice thickness: 1.4 mm; echo time: 1.95 ms;
repetition time: 4 ms.
Each lesion was manually segmented in 3D in the subtraction of the first post-contrast stack
by the pre-contrast stack. This segmentation was performed by an experienced radiographer
using the region growing tool in Osirix (http://www.osirix-viewer.com). The resulting regions
of interest (ROIs) were used as segmentation “ground truth”.
To avoid unnecessary computation the breast volume was first segmented in each data set. The
breast-air boundary segmentation was achieved using thresholding followed by binary closings
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Table 3.6: Three Random Variable features
Feature Formula
Angular
second
moment  1(↵,  ,  ) =
NG 1X
i=0
NG 1X
j=0
NG 1X
k=0
[f↵, , (i, j, k)]
2
Entropy
 2(↵,  ,  ) =  
NG 1X
i=0
NG 1X
j=0
NG 1X
k=0
f↵, , (i, j, k)⇥ log(f↵, , (i, j, k))
Sum
entropy
 3(↵,  ,  ) =
3NG 3X
l=0
f↵+ + (l)⇥ log(f↵+ + (l))
where
f↵+ + (l) =  
PNG 1
i=0
PNG 1
j=0
PNG 1
k=0 f↵, , (i, j, k), l = i+ j + k
Sum
Average
 4(↵,  ,  ) =
3NG 3X
l=0
(l + 3)⇥ f↵+ + (l)
Sum
Variance
 5(↵,  ,  ) =
3NG 3X
l=0
⇥
(l + 3)   3(↵,  ,  )2
⇤⇥ f↵+ + (l)
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Table 3.7: Two Random Variable Features
Feature Formula
Contrast
of ↵,  
 6(↵,  ) =
PNG 1
n=0 n
2
nPNG
i=1
PNG
j=1 f↵, (i, j)
o
, |i  j| = n
Contrast
of  ,  
 7( ,  ) =
PNG 1
n=0 n
2
nPNG
j=1
PNG
k=1 f , (j, k)
o
, |j   k| = n
Contrast
of ↵,  
 8(↵,  ) =
PNG 1
n=0 n
2
nPNG
i=1
PNG
k=1 f↵, (i, k)
o
, |i  k| = n
Correlation
of ↵,  
 9(↵,  ) =
PNG
i=1
PNG
j=1 i⇥ j ⇥ f↵, (i, j)  µ↵µ 
 ↵  
and connected component operations. The chest wall was segmented by a plane with a coronal
orientation situated approximately 1 cm towards the chest wall from the area between the
breasts.
For the training data collectively, and for each data set of the testing data separately, all of the
voxels in the malignant lesion ground-truth were assigned to the class “malignant” and 10%
of the remaining voxels (chosen randomly) were assigned to the class “normal”. The "normal"
class also included all voxels belonging to the ground truth segmentation of the benign lesions.
This yielded a total of 83 thousand malignant and 48 million normal voxels.
3.3.2 Results
In general, the output of the classifier closely matched the manually-drawn ground truth. Figure
3.1 displays the posterior probabilities from the classifier for a single slice of the test data.
Although small false positive regions are present, the lesion can be clearly discerned.
Figure 3.2 shows the ROC curve for one of the test data sets. The area under the curve is 0.956
± 0.001. The mean area under the curve for all cases is 0.915±0.001. The pooled AUC over all
subjects is lower (0.785± 0.001), indicating that although the method is effective when applied
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Figure 3.1: Posterior probabilities for a single slice
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Figure 3.2: ROC curve for a single case. AUC =0.956± 0.001
3.4 Method 2: 3D segmentation by mean-shift and graph-cuts 54
on individual subjects, probability thresholds cannot be applied universally. In contrast, the
results of Kale et al. (2008) indicated that a threshold of 40% - 50% is appropriate in general.
3.3.3 Discussion
In this section, a new method for the automatic segmentation of malignant breast tissue in DCE-
MRI data based on the notion of distance-weighted multi-variable co-occurrence was presented
and evaluated. The method extends that of Kale et al. (2008) permitting the definition of
larger windows and concomitantly less sparse multi-variable co-occurrence arrays from which
to generate statistics/features. Our results demonstrate the efficacy of the method and indicate
comparable performance to the original spectral co-occurrence method of Kale et al.
Generally, voxel-wise classification approach to segmentation is advantageous in that it does not
require heuristics (as in many detection/delineation approaches), and can readily be extended
to include multi-modal images such as T2- or DW-MRI. However, this family of approaches
has several limitations. Firstly, the methodology for evaluating performance is problematic, as
it is highly dependent on the breast volume (i.e. number of true negative voxels). Secondly,
our results show that a single posterior probability threshold is not suitable for every subject,
and further processing would be required in order to properly determine which voxels should
be labelled as suspicious. Thirdly, the compromise between the window size and accurate
characterisation of local properties remains an open problem. If the window is too large, lesion
borders will be blurred, however if it is too small lesion heterogeneity may cause “patchy”
classification.
An alternative approach to lesion segmentation is through detection followed by delineation, a
new method of which is presented in the next section.
3.4 Method 2: 3D segmentation by mean-shift and graph-
cuts
In this section, a method for completely automatic breast lesion segmentation is presented and
evaluated. The proposed method employs both mean-shift clustering (Comaniciu & Meer 1999)
and graph-cuts (Stawiaski & Decenciére 2008). We note that mean-shift has previously been
used in the analysis of breast MRI for clustering voxels within already segmented lesions for
the purpose of extracting features (Stoutjesdijk et al. 2007, 2012). The mean-shift algorithm is
attractive because it produces spatially contiguous regions, does not require training, and does
not require the number of clusters be set a priori. In our proposed segmentation method the
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MRI data is considered to be a single volume of vector-valued voxels. Mean-shift clustering is
then performed in the multi-dimensional feature space formed by concatenating voxel spatial
coordinates and several values from the range values, or functions of these values, from the
input volume. Graph-cuts segmentation is then applied to the region adjacency graph defined
on these clusters to identify sets of clusters that are likely to be suspicious tissue.
3.4.1 Overview of the proposed segmentation method
The proposed method conceptually takes as input a single volume with vector-valued voxels
(i.e. the pre-processed data) and outputs a single grey-scale volume of labels (each detected
lesion is given its own numeric label). The components of the vector-value for a given voxel in
the input volume are the corresponding MRI values in each image stack acquired in the breast
MRI exam (including each individual stack in the DCE-MRI data). Each label in the output
volume defines a single 3D connected component corresponding to a suspicious lesion.
The proposed algorithm has seven basic steps:
1. Cluster together similar voxels in the multi-dimensional feature space formed by concat-
enating voxel spatial coordinates and several values from the range values, or functions
of these values, from the input volume. Mean-shift is used because it does not require a
priori specification of the number of clusters, and it does not impose any restrictions on
the size and shape of clusters.
2. Construct a region adjacency graph (RAG) on the resulting regions (i.e. clusters from
step 1). Each vertex corresponds to a region and adjacent regions are denoted by an
edge.
3. Identify voxels in the input volume that are likely to belong to blood vessels.
4. Identify the set of vertices in the RAG that correspond to regions that demonstrate
significant mean post-contrast signal relative to pre-contrast, and are not blood vessels
(based on the information in step 3). Relative rather than absolute difference is used here
to provide normalisation between subjects.
5. For each of these vertices in turn, identify a set of vertices that define candidate suspicious
tissue. This is done using graph-cuts segmentation on the RAG using a dissimilarity
measure between vertices based on the mean post-contrast signal minus pre-contrast.
6. Discard those candidates that are too small; i.e. that are foci of enhancement according
to the ACR BI-RADS lexicon (American College of Radiology 2008).
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7. Rank each remaining candidate according to its mean post-contrast enhancement relative
to pre-contrast and retain only the most highly ranked candidates.
3.4.2 Detailed description of the proposed segmentation method
Let f : Z3 !Zd denote the vector-valued input volume such that f(x) is the d-dimensional
vector-value assigned to voxel x = (x1, x2, x3) and f = (f1, ..., fd).
In step 1, we define a feature vector of the form y = [x1 x2 x3 r1 . . . rn]where each ri is a
function of one or more fj. Mean-shift clustering (Comaniciu et al. 2002) is then performed in
this joint spatial-range domain space using a kernel defined to be the product of spatial and
range domain symmetric kernels (see Appendix B). Other than the choice of kernel, the only
parameters are the spatial domain and range domain bandwidths. The output from this step is
a volume of labels; one for each cluster. This can be equivalently represented as a set of regions
{Rj ⇢ Z3|j = 1, . . . ., N}.
Let the RAG (an undirected graph) in step 2 be denoted G = (V,E) where V = v1, v2, . . . , vN is
the set of vertices (one for each region detected in step 1) and E is a set of 2-multisets denoting
edges between vertices; e.g. v1, v2 denotes that vertices v1 and v2 are joined by an edge. We
define a vector-valued function g = (g1, . . . , gd) on the vertex set such that:
g(vi) =
1
|Ri|
X
x2Ri
f(x) (3.4)
i.e. each vertex is assigned an attribute vector that is identically the mean of the vector-valued
voxels in the corresponding region.
In step 3, the vector-valued input volume f(x) is used to define the following enhancement
image:
m(x) =
1
t2   t1
⌧2X
j=⌧1+1
fj(x)  ft1(x) (3.5)
where t1 denotes the first stack (pre-contrast) and t2 denotes the final stack in the dynamic
series. The set of voxels in this image belonging to tubular structures likely to be blood vessels
is defined:
X =
n
x F(m)(x) > d  B
o
(3.6)
where F is the Frangi vesselness filter (Frangi & Niessen 1998), d is a threshold value,   denotes
binary dilation, and B is a 3×3×3 cube. The Frangi filter computes a voxel-wise measure of
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vesselness in a 3D image based on the properties of the second derivatives of tubular structures.
More specifically for each voxel x, the local Hessian of m and its eigenvalues l1, l2, 3 are
computed over a set of scales, J. The vesselness function is computed voxel-wise as follows:
F(m)(x) =
8<:0 if  2 > 0 or  3 > 0⇣1  exp⇣  R2A2↵2⌘⌘ exp⇣ R2B2 2⌘⇣1  exp⇣ S22c2⌘⌘ otherwise (3.7)
where RA = |l2|/|l3|, distinguishing between plate-like and line-like structures, RB = |l1|/
p|l2l3|,
describing the deviation from a line-like pattern, S =
qP
j3l
2
j is a measure of second order
structureness, and ↵, b and c are constants. The maximum of the vesselness function over the
set of scales is returned for each voxel. Finally, in step 3 only those connected components
of X (Equation 3.6) that intersect the chest wall mask W are retained. This is achieved by
performing a binary reconstruction (Soille 2003) of X from Y = X
T
W , i.e.
X 0 = lim
n→+1
d(n)X (Y ) (3.8)
where d(1)X (Y ) = (Y  B)
T
X and B is a structuring element defining 26-neighbour connectivity
(i.e. a cuboid around the centre voxel).
In step 4, the enhancement at each vertex is defined:
e(vi) =
1
t2   t1
t2X
j=t1+1
gj(vi)  gt1(vi) (3.9)
The relative enhancement at each vertex is then defined:
r(vi) =
e(vi)
g⌧1(vi)
(3.10)
Finally the set of vertices that demonstrate significant enhancement and do not correspond to
blood vessels is defined:
V 0 =
⇢
vi 2 V | r(vi) > r, g⌧1(vi) > f and
|X 0 \Ri|
|Ri| > x
 
(3.11)
where r, f, and x are threshold values.
In step 5, RAG-based graph-cuts segmentation (Stawiaski & Decenciére 2008) is applied to
G = (V,E) of step 2. This involves obtaining a segmentation (graph labelling) for each vertex
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vi in V 0 in turn by: (i) defining the source to be vi and the sink to be the vertex associated
with the non-breast tissue (M c), and (ii) finding the cut that yields the minimum energy. A
cut is the set of edges:
Ec = {v, w|v 2 LA, w 2 LB} (3.12)
where LA is the set of vertices defining the suspicious tissue and LB is the set of all other
vertices. The energy of the cut is given by:
c(LA, LB) =
1
|Ec|
X
v,w2EC
c(v, w) (3.13)
The contribution of each edge is defined by:
c(v, w) = exp
✓
 d(v, w)
2
2sv2
◆
(3.14)
where sv is a free parameter and d(v, w) is a dissimilarity measure between vertices v and w
defined as:
d(v, w) =
X
k
  Ckv   Ckw   2 (3.15)
where Ckv is the value of the cumulative relative frequency histogram of m(x) at grey level k for
the region associated with vertex v. This histogram-based measure provides better segment-
ation performance than measures based purely on mean intensity within the region because
it incorporates the notion of ground distance (O’Callaghan & Bull 2005). It should be noted
that Equation 3.13 is a normalised version of that used by Stawiaski & Decenciére (2008) that
compensates for the tendency of graph-cuts towards cuts with fewer edges.
The exponentially large number of possible cuts makes an exhaustive search impractical. In-
stead, an initial solution is determined by applying a threshold mmin to the enhancement at
each vertex. The value of mmin is determined by:
mmin = argminm2[m1,m2][c(LA,m, LB,m)] (3.16)
where LA,m is the set of vertices (defining the suspicious tissue) consisting of the connected
vertices vj satisfying e(vj) > me(vi) and containing vi and LB,m = [LA,m]c.
The final solution is then obtained by applying the label-swap algorithm (Boykov et al. 2001)
to LA,mmin and LB,mmin . The set of vertices LA,final corresponds to a suspicious lesion. Let Li
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Table 3.8: Lesion Pathology
Pathology Number
Training Testing
Data from the GE Scanner
Benign Fibrocystic change 5 6
Fibroadenoma 4 5
Other 5 24
Total benign 14 35
Malignant Ductal carcinoma in situ 7 19
Invasive ductal carcinoma 9 19
Invasive lobular carcinoma 6 3
Other 5 17
Total malignant 27 58
Data from the Siemens scanner
Benign Intraductal papilloma 1
Malignant Ductal carcinoma in situ 1
Invasive ductal carcinoma 5
Invasive lobular carcinoma 1
Mucinous carcinoma 1
denote LA,final for the seed vertex vi. Each Li defines a candidate suspicious region S=[vj2LiRj
. Let the set of candidate regions, after merging overlapping or adjacent regions, be denoted
S = {S1, S2, . . .Sp}.
In step 6, small candidate regions are discarded to give:
S0 = {Si 2 S | |Si| > e} (3.17)
where e is a size threshold.
Finally in step 7, the relative uptake r(vi) of each candidate Si in S0 is used to rank the can-
didates in descending order of suspiciousness; i.e. rank 1 denotes the most suspicious. Finally,
only the h most highly ranked candidates are retained. The parameter h thus imposes an upper
limit on the number of false positives. In the case of multiple suspicious lesions it also imposes
an upper limit on the number of true positives.
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3.5 Empirical evaluation of method 2
3.5.1 Breast MRI Data
The MRI data used in this study were sourced from routine clinical breast MRI examinations
of 128 women performed by Queensland X-Ray. The examinations included screening cases
(high risk category), problem solving cases, as well as cases that had previous surgery. One
hundred and twenty examinations (women aged from 22–84 years with a mean age of 48 years)
were performed using a 1.5T GE Signa HDxt scanner and eight (women aged from 51-65 years
with a mean age of 56 years) using a 1.5T Siemens Avanto scanner. The examinations were
performed using an eight-channel breast coil with the patient lying in the prone position. They
were selected because in each case the reporting radiologist identified at least one suspiciously
enhancing lesion whose status was subsequently verified by cyto- or histopathology. Each
lesion was individually biopsied under either MRI or ultrasound guidance. Only the T1- and
T2-weighted anatomical scans and the DCE-MRI data from each examination were used in this
study. The approval of the Human Research Ethics Committee at the University of Queensland
was obtained for this study.
The imaging protocol for the GE scanner was as follows. The T1-weighted anatomical images
were acquired axially, without fat suppression, using a 2D tailored radio frequency sequence
(TE = 8ms, TR = 480ms and flip angle of 90°). The acquisition matrix was 512×512. The
T2-weighted anatomical images were acquired axially, with fat suppression, using a 2D short
time inversion recovery sequence (TE = 46ms, TR = 6600ms and flip angle of 90°). The
acquisition matrix was 320×224. In both cases the field of view was 32cm and slice thickness
was 4mm. The DCE-MRI images were acquired as either four or five stacks of T1-weighted
images, with fat suppression, using a 3D FSPGR sequence (TE = 3.4ms, TR = 6.5ms and
flip angle of 10°). The first stack contains baseline pre-contrast images and the remaining
correspond to post-contrast images acquired after injection of Gadopentate dimeglumine, 0.2
mmol/kg, administered at a rate of about 2 ml/s using a pressure injector. Each stack was
acquired in around 90 seconds with a 45 second delay between the pre-contrast and the first
post-contrast stack. All of the stacks, except the second last stack, were acquired axially with
a field of view of 32cm, a 360×360 acquisition matrix, and slice thickness of 1mm. The number
of slices ranged from 116 to 182 with a median of 150. The second last stack was discarded
because it was acquired sagittally with a different field of view to the axial stacks.
The imaging protocol for the Siemens scanner was as follows. The T1-weighted anatomical
images were acquired axially, without fat suppression, using a 3D tailored radio frequency
sequence (TE = 4.8ms, TR = 7.8ms and flip angle of 20 ). The acquisition matrix was 448×323
and the slice thickness 0.9mm. The T2-weighted anatomical images were acquired axially,
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with fat suppression, using a 3D short time inversion recovery sequence (TE = 175ms, TR =
1200ms and flip angle of 120 ). The acquisition matrix was 384×311 and the slice thickness was
1.3mm. The DCE-MRI images were acquired as five to six stacks of T1-weighted images, with
fat suppression, using a 3D oversampling phase sequence (TR=4.3ms, TE=1.3ms and flip angle
of 12°). The injection protocol and acquisition timing was the same as for the GE scanner. All
of the stacks, except the second last stack, were acquired axially with a field of view of 32cm,
a 384×384 acquisition matrix, and slice thickness of 1mm. The number of slices was 160. The
second last stack was discarded because it was acquired sagittally with a different field of view
to the axial stacks.
In total the data from the GE scanner contains 85 malignant and 49 benign lesions. These were
randomly split into training data (41 lesions from 35 patients) and testing data (93 lesions from
85 patients) as shown in Table 1. The former was used to develop the segmentation method
and to tune its parameters. The latter, hereinafter referred to as test set 1, was used to test
the tuned method.
In total the data from the Siemens scanner contains eight malignant lesions and one benign.
This data set, hereinafter referred to as data set 2, was used to evaluate the robustness of
the segmentation method trained on the GE scanner when applied to data acquired from the
Siemens scanner.
A radiographer, with more than 12 years experience in breast MRI, manually segmented each
lesion in 3D in both the training and two test data sets based on the findings of the original
reporting radiologist. This was performed on a subtraction volume (first post-contrast stack
minus the pre-contrast stack from the DCE-MRI scan) using the region-growing tool in Osirix
(http://www.osirix-viewer.com). In difficult cases, where region-growing yielded an overseg-
mentation (for example by including surrounding enhancing tissue or blood vessels), the lesion
was viewed using a 3D maximum intensity projection and the 3D region-growing mask cropped
using the freehand scissor tool. A morphological closing by a 3×3×3 cube was then performed
on each 3D connected component to fill small holes. The resulting 3D regions-of-interest (ROIs)
were taken to be the segmentation ground truth. Unless otherwise stated all of the processing
methods, including the proposed segmentation method described below, were implemented in
MATLAB (The MathWorks, Inc., Natick, MA).
3.5.2 Preprocessing of the breast MRI data
For each subject, the T1 anatomical, T2 anatomical, pre-contrast and the second and later post-
contrast volumes were spatially co-registered to the first post-contrast volume using the fast
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non-rigid B-spline registration module in 3D Slicer (www.slicer.org). Registration parameters
were as follows: spatial samples = 70,000; grid size = 5; and number of iterations = 20.
For each subject, a 3D mask of the breast tissue, M , was determined automatically from
the T1-weighted anatomical stack as follows. Firstly, an initial mask was obtained by simple
thresholding using Otsu’s method (Otsu 1979), followed by a binary opening by a spherical
structuring element of radius 5mm, and then binary hole filling (26 connectivity). Next a 3D
mask of the chest wall, W , was obtained using Hayton’s algorithm (Hayton et al. 1997). This
algorithm determines the optimal contour separating the breast tissue and the chest wall using
a dynamic programming approach. For each slice in turn, the dynamic programming problem
is set up by radially resampling the non fat-saturated T1-weighted data in the chest cavity
and pectoral muscle. The optimal contour is then determined by minimising a cost function
associated with the gradient of this image. The final mask M was then obtained from the
intersection of the initial mask and all of the voxels anterior to the chest wall. The purpose
of this mask was to restrict the domain on which the proposed breast lesion segmentation
algorithm (see below) would be applied. This both avoids false positive detections within the
chest cavity and reduces computation time.
3.5.3 Algorithm parameters
The particular choices of parameter values used in this study are given in Tables 3.9 and 3.10.
Table 3.9 lists values fixed at the outset based on recommendations in the literature. Table
3.10 lists values that were derived empirically from the training data.
In step 1, hr,i was defined to be the standard deviation of f 0i(x) in line with the method of
parameter normalisation of Stoutjesdijk et al. (2007). In step 4, the Frangi vesselness paramet-
ers were those recommended by Frangi & Niessen (1998). In step 6, the candidate region size
threshold was that used by Vignati et al. (2011).
The spatial bandwidth hs (step 1) was determined empirically using a small subset of the
training data. A range of values from 1 to 10 mm was investigated and a single value chosen
that (i) yielded distinct clusters in both the suspicious and non-suspicious tissues (i.e. no clusters
containing both tissue types) and (ii) yielded the largest such clusters.
The suspicious regions thresholds (r, f, x and d) were set one after the other. Each was set
to the maximum value required for 100% lesion detection in the training data. Similarly, the
parameter associated with the number of candidates, h, was set to the minimum number that
yielded 100% detection of the suspicious lesions. The relationship in the training data between
the lesion detection rate, the number of false positives, and h is shown in Figure 1.
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Table 3.9: Fixed Parameters
Step Description of parameter(s) Value
All Input volume f(x) f1(x) is the T1-weighted anatomical stack,
f2(x) is the T2-weighted anatomical stack,
f3(x) is the pre-contrast stack
f4(x) is the first post-contrast stack
f5(x) is the second post-contrast stack
...
fd(x) is the final post-contrast stack
1 Mean-shift feature vector
y = [x1 x2 x3 r1 . . . rn]T
ri(x) =
(
fi(x) i 6 2
fi+1(x)  f3(x) 3 6 i 6 d  1
Mean-shift kernel profile Gaussian
Mean-shift feature space
bandwidth
hr = [hr,1 hr,2 . . . hr,n]
hr,i is the standard deviation of ri(x)
2 Connectivity used to define
the RAG
26
4 Frangi vesselness
parameters
↵ = 0.5,   = 0.5, c is half the value of the
maximum Hessian norm
5 µmin search interval µ1 = 30%, µ2 = 70%
6 Candidate region size
threshold
✏ = 20mm3
Table 3.10: Tuned parameters
Step Description of parameter(s) Value
1 Spatial bandwidth,
hs = [hx hy hz]
hx = hy = hz = 3 (mm)
3 Vesselness filter scales J = 0.5, 1, 1.5, 2
Vesselness threshold   = 0.05
4 Suspicious region thresholds r = 50%,f = 300, x = 50%
5 Capacity function
parameter
  = 8
7 Number of candidates ⌘ = 6
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Figure 3.3: The relationship in the training data between the lesion detection rate, the number of
false positives, and h.
The range of vesselness filter scales, J, corresponds to typical vessel sizes in the training data
set. The mmin search interval was chosen based on the extreme values of mmin in the training
set. The capacity function parameter (step 5) was optimised using a gridded search between
0.1 and 100. The mean Dice coefficient of the training data set was used as the performance
metric for this optimisation.
3.5.4 Evaluation
The proposed method was applied independently to both of the pre-processed test data sets,
and the results were quantitatively compared to the ground truth. A ground truth ROI was
deemed to have been detected if its intersection with the segmentation candidates for that
volume was non-empty. For each detected ground truth ROI, Y, the rank corresponding to the
most highly ranked intersecting candidate was recorded (the detection rank), and the accuracy
of the segmentation was evaluated in terms of the Dice coefficient, the false positive volume
fraction (FPVF), and the false-negative volume fraction (FNVF) (Udupa et al. 2006). The
Dice coefficient is defined
s =
2 |XTY |
|X|+ |Y | (3.18)
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where X is the union of one or more intersecting segmentation candidates. The FPVF and
FNVF are defined:
FPV F =
|X \ Y 0|
|Y | (3.19)
FNV F =
|X 0 \ Y |
|Y | (3.20)
Finally, the false positive rate for each subject was determined.
3.5.5 Results
Figures 3.4 and 3.5 illustrate selected steps in the segmentation method.
3.5.5.1 Test set 1: Data from the same scanner
For test set 1 the overall true positive rate (sensitivity) of the method was 100%. For 56 of
the 93 lesions (60%), the ground truth ROI coincided with the highest ranked segmentation
candidate. In an additional 20 lesions (22%), the ground truth ROI coincided with the second
highest ranked candidate. In the two worst cases (one apocrine metaplasia and one DCIS), the
ground truth coincided with the lowest (sixth) ranked candidate. The mean number of false
positive lesion candidates per subject was 4.5± 1.2.
Table 4 presents the mean detection rank by lesion type for test set 1. From the table it can
be seen that the mean detection rank for DCIS is lower than for the other malignant types.
To determine whether this is statistically significant, a Mann-Whitney U test was performed
at the a = 5% level of significance, yielding a P value of 0.0034. Thus we conclude that the
detection ranks of DCIS lesions are lower than those for the collective set of other malignant
lesions.
The median Dice coefficient for data set 1 was 0.76 (inter-quartile range 0.17). Figure 3.6
presents box plots of the Dice coefficients for each lesion type. The median FPVF was 0.20
(inter-quartile range 0.28), and the median FNVF was 0.21 (inter-quartile range 0.26). Figure
3.7 presents box plots of the FPVF and FNVF for each lesion type. Three two-tailed Mann-
Whitney U tests were performed to test whether there is a significant difference between Dice
coefficients, FPVP values, and FNVF values respectively for malignant and benign lesions.
Each test was performed at the a = 5% level of significance, yielding P values of 0.28, 0.09 and
0.09 respectively. Thus we conclude that the method performs equally well for malignant and
benign lesions.
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Figure 3.4: Illustration of selected steps of the proposed method. (a) Sample slice from the T1-
weighted anatomical stack. (b) Corresponding slice from the T2-weighted anatomical stack. (c)
Corresponding slice in the stack obtained by subtracting the pre-contrast stack from the first post-
contrast stack. (d) Resulting clusters after mean-shift segmentation with the RAG superimposed
– the colour of a cluster reflects the mean of the corresponding voxels in (c). Note that the edges
associated with the vertex corresponding to the fatty tissue have been omitted for display purposes.
(e) The energy of the cut over a range of thresholds m. (f) The lesion candidate produced by our
method, displaying true positive, true negative, false positive and false negative voxels. Note: The
overlay shown in (a)-(c) is the ground truth ROI.
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Figure 3.5: Illustration of the vessel detection step, i.e. step 3, of the proposed method. (a)
Maximum intensity projection (MIP) of the mean post-contrast image, m(x). (b) MIP of the
vesselness image, F(m). (c) MIP of X; i.e. of (b) after thresholding and dilation. (d) MIP of X’,
i.e. of (c) after discarding connected components not connected to the chest wall, overlaid on (a).
Table 3.11: Mean detection rank for the test data
Pathology Rank
Benign Fibrocystic change 1.7
Fibroadenoma 1
Other 1.8
All benign types 1.7
Malignant Ductal carcinoma in situ 2.3
Invasive ductal carcinoma 1.2
Invasive lobular carcinoma 1.7
Other 1.6
All malignant types 1.7
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Figure 3.6: Box plots of the Dice coefficient for all lesion types in test data set 1
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Figure 3.7: Box plots of the false positive and false negative volume fraction for all lesion types in
test data set 1
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Figure 3.8: The relationship between the lesion detection rate (sensitivity) and the suspicious
region threshold
The thresholds on relative enhancement, pre-contrast intensity and vascularity were sufficiently
small to detect all of the lesions. However, as these thresholds increase, the detection rate (sens-
itivity) of the algorithm decreases. The lesion with the shallowest enhancement, of type DCIS,
exhibited a relative enhancement (r(vi)) of only 50.0%. The next shallowest enhancing lesion
was a benign hyperplasia, with relative enhancement of 52.2%. The rate of lesion detection
versus relative enhancement is show in Figure 3.8.
Regarding pre-contrast intensity (g⌧1(vi)), the two lesions with lowest pre-contrast intensity were
a benign fibrocystic change and malignant IDC, with intensities of 307 and 308 respectively.
The rate of lesion detection versus relative enhancement is shown in Figure 3.9.
Finally, regarding the vessel volume fraction, |X\Ri||Ri| , the lesion with the highest vessel volume
fraction was a benign lesion of a nonspecific type, with a vessel volume fraction of 49.3%. The
next highest was an invasive ductal carcinoma, with a vessel volume fraction of 42.7%. The
rate of detection versus the non-vessel volume fraction ( |X
0\Ri|
|Ri| ) is shown in Figure 3.10.
3.5.5.2 Test set 2: Data from another vendor’s scanner
For test set 2 the overall true positive rate was also 100%. For five of the nine lesions the ground
truth coincided with the highest-ranked segmentation candidate. All lesions were detected
within the highest ranked four candidates. The median Dice coefficient for all lesions was 0.75
(inter-quartile range 0.16). The median FPVF was 0.31 (inter-quartile range 0.38), and the
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Figure 3.9: The relationship between the lesion detection rate (sensitivity) and the precontrast
intensity threshold
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Figure 3.10: The relationship between the lesion detection rate (sensitivity) and the non-vesselness
volume fraction threshold
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Figure 3.11: Box plots of the Dice coefficient, false positive volume fraction and false negative
volume fraction for all lesions in data set 2.
median FNVF was 0.11 (inter-quartile range 0.23). Figure 3.11 presents box plots of the Dice
coefficient, FPVF and FNVF.
3.5.6 Discussion
The results of this study demonstrate the efficacy of our proposed method for fully automatic
segmentation (i.e. detection and delineation) of suspicious breast tissue using multi-modal MRI
data. The method achieved 100% sensitivity on unseen test data acquired using the same
protocol and scanner system used to acquire the training data. It achieved a mean of 4.5± 1.2
false positives per subject, and a segmentation accuracy (median Dice coefficient) of 0.76 (inter-
quartile range 0.17). The false positive rate is approximately half that recently reported for
a fully automatic breast lesion detection system (Vignati et al. 2011). The results also show
that: (i) there was no significant difference in the delineation accuracies for malignant and for
benign lesions, and (ii) that the detection ranks of DCIS lesions are lower than those for the
collective set of other malignant lesions. In the latter case this is not surprising given that
the detection of DCIS is known to be challenging (Kinkel & Hylton 2001). The method was
applied, without parameter re-tuning, to unseen test data acquired with a similar protocol
but on a different vendor’s scanner system. It achieved 100% sensitivity and a median Dice
coefficient of 0.75 (inter-quartile range 0.16), thus providing evidence that it can be applied
across different vendors’ systems.
Several limitations of the present study must be acknowledged. Firstly, all of the cases con-
tained one or more suspiciously enhancing lesions identified by the reporting radiologist. The
efficacy of the method for completely normal cases remains an open question. Secondly, the
tuning of parameters in the present study was performed for each parameter sequentially. It
3.5 Empirical evaluation of method 2 72
is possible that more sophisticated parameter optimisation strategies will yield better perform-
ance. Thirdly, the ranking procedure imposes an upper limit on the number of suspicious
regions that can be detected for a given subject. Whilst this sets an upper bound on the false
positive rate for each subject, should the number of suspicious lesions exceed this limit then
they will not be detected.
The proposed method does not seek to classify individual voxels. Rather, a hierarchical seg-
mentation approach is employed. In the first level of the hierarchy mean-shift segmentation
is applied to identify clusters of similar voxels in a joint spatial-range domain space. In the
second level a region adjacency graph is defined on these clusters, and graph-cuts segmentation
is applied to identify groups of clusters that are likely to be suspicious tissue. In this way
cluster-based statistics rather than voxel-based attributes are used making the approach less
sensitive to noise.
The spatial domain bandwidth value used in this study is significantly larger than that used by
Stoutjesdijk et al. (2007) (3mm versus 1mm). However the two studies have different purposes.
Stoutjesdijk et al. employ mean-shift to partition an already delineated lesion into clusters for
the purpose of extracting features to classify the lesion as benign or malignant. In contrast this
study identifies groups of mean-shift clusters that represent suspicious tissue.
The use of an adaptive bandwidth (Mayer & Greenspan 2009) was investigated as an alternative
to a globally determined bandwidth for the range domain. However, we did not find that it
afforded any significant improvement to merit the additional complexity.
The decision to use both the pre-contrast anatomical T1- and T2-weighted anatomical scans in
the mean-shift clustering step was influenced by the desire to characterise tissue in as many ways
as possible. The underlying idea here is that the more ways we can independently characterise
tissue, the better our chances of discriminating different tissue types. An additional justification
for including the T2 data was that the aim was to segment both malignant and benign lesions,
including cysts and fibroadenomas, which appear hyperintense on T2-weighted images (Orel
& Schnall 2001). Further research could focus on a selection strategy to determine optimal
subsets.
In this study, approximately one third of the data was used to tune the method parameters, and
the remaining two thirds was used to test performance. The value empirically determined for
the relative enhancement threshold in step 4 (Equations 3.10, 3.11) was 50%. According to the
ACR-BIRADS lexicon (American College of Radiology 2008), 50% constitutes the threshold
between mild and moderate enhancement. This value is consistent also with the recommend-
ation of Levman et al. (2009) that enhancement thresholds should be in the range of 50-60%
for CAD.
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Figure 3.12: Dice coefficient versus lesion size for the combined training and testing sets in data
set 1.
The algorithm yielded the highest similarity to the ground truth in lesions with clearly defined
borders and high contrast to the background tissue. For example, fibroadenomas in general have
well defined borders, and the median dice coefficient was higher for fibroadenomas than other
benign lesions. The delineation performance of the algorithm was not found to be influenced
by lesion volume, as shown in Figure 3.12.
In conclusion, we proposed and evaluated a method—based on mean-shift clustering and graph-
cuts on a region adjacency graph—for fully automatic segmentation (i.e. detection and delin-
eation) of suspicious breast lesions in multimodal breast MRI data. The need for such an
algorithm for MRI CAD was recently highlighted in a review of breast MRI and MRS (Sinha
& Sinha 2009). Our study demonstrates the efficacy and accuracy of the proposed method.
To the authors’ knowledge this is the first time that such a method has been proposed and
evaluated in terms of both detection and delineation accuracy.
3.6 Conclusion
In this chapter, two classes of methods for automatic segmentation of breast lesions have been
discussed. Two new algorithms, one from each class of methods, have been proposed and
evaluated on clinical data.
The first method was a novel extension to the multispectral co-occurence approach of Kale et al.
(2008). This extension addressed a weakness of the original approach, namely in the sparsity
of co-occurence matrices. However, multispectral co-occurence features are just a single type
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of feature that can be used within the class of voxel-wise classification. The framework of
these algorithms can trivially be extended to include multi-modal MRI, such as T2-weighted or
diffusion-weighted features. Additionally, these approaches do not require the heuristics that
are common in detection/delineation algorithms, because the classification rules are automat-
ically determined by the classifier. The method of Kale et al.—and the extension presented
in this chapter—include normalisation to pre-contrast intensity, and therefore do not require
re-training with changes in protocol (as demonstrated in the work by Kale et al.). Finally,
voxel-wise classification in general does not impose a limit on the number of candidates.
However, several limitations do remain. The choice of the optimal operating point on the ROC
curve remains an open problem, with our results indicating that a single threshold does not per-
form well universally. The requirement of training data is also problematic, since it is important
that the training data be representative of all types of lesions that the classifier will encounter.
Finally, this method of segmentation might not be appropriate for heterogeneous malignant
lesions, in which there may be a mixture of benign-appearing and malignant-appearing regions.
The second class of segmentation method that has been discussed in this chapter relates to the
simultaneous detection and delineation of suspicious lesions using graph cuts applied to a re-
gional adjacency graph generated by mean shift clustering. This method results in well-defined
separation between lesion and surrounding tissue (unlike the multispectral co-occurence tech-
nique), is robust to noise (through the mean shift clustering), and can intuitively be extended
to include additional MR modalities or features. For example the mean-shift feature vector
could include ADC values, or DCE temporal model parameters, or indeed, the multispectral
features described in the first method.
As mentioned earlier, the second method does have some limitations, the most significant of
which are that it relies on several heuristics that were set based on training data, and the
method itself imposes a limit on the number of candidates. Despite this, it was found to detect
all lesions, and delineate them with a high degree of accuracy. Therefore, it is the resulting VOIs
of this method that are used in the remainder of this thesis in order to address the question of
whether automatically segmented lesions result in better classification of benign and malignant
lesions than manually delineated lesions. This is addressed in Chapter 7.
Chapter4
Features derived from T1w, T2w and dynamic
contrast enhanced MRI
The preceding chapter focussed on fully automatic segmentation of suspicious breast lesions. In
this chapter and the chapter to follow, a number of quantitative features for lesion character-
isation are presented. This chapter focusses on features derived from T1w, T2w and DCE-MRI
data. The next focusses on features derived from diffusion-weighted MRI. An empirical eval-
uation of the efficacy and performance of these features for the discrimination of benign and
malignant lesions is presented in Chapter 7.
The material in this chapter, and chapters 5 and 7, form the basis of a paper submitted by the
author to the Journal of Medical Imaging on 6/5/2014 (McClymont et al. 2015). It should be
noted that the order of presentation of features in the paper is not the same as presented here.
However the feature identifiers are the same.
The remainder of this chapter is structured as follows. First, a review of existing qualitative and
quantitative features is presented. Next, a list of new and novel features for the classification of
breast lesions is presented. This list includes new features that characterise blooming, breast
vascularity, and centripetal enhancement; as well as features extracted from a repartition of a
lesions’s domain into clusters using mean-shift.
4.1 Qualitative versus quantitative features
A feature is a variable that describes some attribute of an image object. Features may be either
qualitative or quantitative. In the case of qualitative features, there is no explicit ordering in
the classes, and descriptive labels rather than numbers can be used to denote the classes.
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Qualitative features are also referred to as categorical or discrete variables, or factors (Hastie
et al. 2009). An example of a qualitative feature in breast MRI is the presence (or absence) of
a spiculated margin. Quantitative features describe the attribute numerically. An example of
this is the fractal dimension of the lesion margin. One of the goals of automatic quantitative
feature extraction is to eliminate the subjectivity that arises from human readers (i.e. inter-
and intra-reader variability).
In this chapter, features are derived from three MR modalities. Static image features are
derived from T1w and T2w images, whereas both static and dynamic features are derived
from DCE-MRI. Static features are those that describe the image at a single point in time
and include morphometric (shape and size), intensity, and structure (for example, textural
features). Dynamic features are those that are computed from DCE-MRI, and may include
quantification of contrast agent uptake, washout, and distribution over time (such as in the
centripetal/centrifugal enhancement features).
Unlike computed tomography, in which intensity is readily standardised between samples with
Hounsfield units, MR does not have standardised intensity (Nyúl & Udupa 1999). The reason for
this is that MR units can vary not only based on scan parameters but also the composition of the
object being imaged. It is therefore necessary to normalise the signal to some known intensity to
facilitate comparison between subjects. In DCE-MRI, the pre-contrast image is most commonly
used for normalisation, whereas in T1w and T2w images the methods of normalisation vary.
In this chapter, T1w and T2w images are normalised using a simple, fully-automatic approach
based on the intensity of fat.
4.2 Review of existing qualitative and quantitative fea-
tures for breast MRI
This section describes existing qualitative and quantitative features in breast MRI. A selection
of these features is used in Chapter 7 for the classification of lesions. Section 7.3 describes
which of these features are included.
4.2.1 Features derived from native T1-weighted MRI
In general, T1w signal intensity (SI) has not been found to provide sufficient discrimination
between malignant and benign lesions, but is useful in separating anatomical structures, such
as adipose tissue, skin, and lesions(Jacobs et al. 2003).
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In 1987, Heywang et al. measured the T1 relaxation times (TR) of several types of lesions. The
differences in T1 TR between lesion types was not significant, because of the “extraordinary
amount of overlap”. Subsequent studies by various groups support this conclusion (Santyr 1994,
Furman-Haran & Degani 2002, Morris & Liberman 2005). While signal intensity has not been
shown to be useful in two-class (i.e. benign and malignant) problems, the possibility exists
that it can be useful in more specific problems, such as characterisation of haemorrhages (Vos
et al. 2012). In 2005, T1w SI was investigated in the differentiation of phyllodes tumours from
fibroadenomas, but was not found to provide sufficient separation of classes (Wurdinger et al.
2005).
Early studies (Heywang et al. 1987, Santyr 1994) reported the T1 relaxation time of tissue,
which is fixed for a given tissue type in a magnetic field of a given strength. Modern MR
imaging uses T1-weighting instead of T1 relaxation times, and as a result the intensity cannot
be readily compared between subjects. Signal intensity must therefore be reported relative to
surrounding tissue (Wurdinger et al. 2005).
4.2.2 Features derived from T2-weighted MRI
Features derived from T2-weighted images can be classified into four categories: signal intensity,
the presence of oedema, the hook sign, and T2w intensity distribution.
4.2.2.1 Signal intensity
Early studies did not find that the image contrast in T2w un-enhanced MRI (even in fat
suppressed images) was adequate for determining the location, extent or nature of most lesions
(Kerslake et al. 1995). In 1999 Kuhl, Klaschik, Mielcarek, Gieseke, Wardelmann & Schild
reported significant discrimination between benign and malignant lesions in non-FS images,
but not in FS or T2* images.
Regarding qualitative fat suppressed T2w imaging, Liberman et al. (2002) and Morris et al.
(2003) did not find the signal intensity of T2w images to be a significant predictor of malignancy.
In 2006, Kelcz reported a large overlap in T2w intensities between benign and malignant classes.
Only the group of lesions with very high intensity (equal to or greater than that of cysts)
excluded malignancies. In the same year, Yabuuchi et al. reported that T2w SI correlates
well with histologic grade, and Schnall et al. reported that the SI odds ratio for prediction of
malignancy was significant.
Regarding qualitative non-fat-suppressed T2w imaging, in 2005 Malich et al., Fischer et al.
found T2 SI to be a “strong sign”, with 74% of malignant and 37% of benign lesions showing
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hypo-intensity, but only 2% of malignancies and 20% of benignancies showing hyper-intensity.
In the same year, Dietzel et al. reported that T2 SI shows statistical significance for the
discrimination of benign and malignant lesions. In 2010, Santamaría & Velasco reported that
the use of T2 SI helps narrow the differential diagnosis of benign and malignant lesions.
A number of quantitative studies have reported on T2w SI. Although Kelcz (2006), Klifa et al.
(2007) did not find the feature useful for discriminating benign and malignant lesions, several
other studies found this feature to be useful when used in conjunction with features derived
from DCE-MRI (Yuen et al. 2007, van Aalst et al. 2008, Ballesio et al. 2009, Bhooshan et al.
2011, Moran et al. 2013). In particular, Ballesio et al. (2009) reported that the inclusion of the
T2w signal intensity feature improved the area under the curve from 0.91± 0.04 to 0.97± 0.02
for mass-like enhancement.
In the work of Bhooshan et al., no intensity normalisation was performed. In the work of van
Aalst et al., the SI features were normalised by the mean intensity of the tissue surrounding
the lesion, or of the whole breast. However, neither of these approaches take breast anatomy
into account, and both are sensitive to the presence of breast implants, cysts or oedema. In all
other studies, manually drawn ROIs were used for intensity normalisation. These were drawn
in a variety of tissues, specifically in air and fat by Kelcz (2006), the pectoral muscle by Ballesio
et al. (2009), and fibroglandular tissue by Yuen et al. (2007), Klifa et al. (2007) and Moran
et al. (2013). Yuen et al. (2007) also proposed the feature “T2 SNR”, defined as the mean of
the lesion ROI divided by the standard deviation of an ROI drawn in air.
In the majority of studies, signal intensity is simply the mean of normalised intensities within
an ROI corresponding to the lesion. An exception to this is the work of van Aalst (2007), van
Aalst et al. (2008), in which SI is defined in several ways. The first is the mean intensity of
the lesion ROI relative to the mean intensity of the tissue surrounding the lesion. The second
is the mean intensity of the lesion ROI relative to the mean of the breast. The third is a
percentile of the intensities within the lesion ROI relative to the mean of the breast. Each of
these features also includes a variation in which the lesion segmentation mask is eroded prior to
feature extraction. The rationale for this is to mitigate partial volume effects on the periphery
of the lesion. The results of van Aalst (2007), van Aalst et al. (2008) show that the first
definition of signal intensity was most commonly selected in the feature selection experiment.
The original definition and the variant were selected approximately an equal number of times.
The third definition was selected only once, and the second definition was not selected at all.
Interestingly, it was also shown that the two features with the highest added accuracy to the
model was the third definition extracting the 6th percentile, and its variant extracting the 20th
percentile.
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4.2.2.2 Presence of oedema
Renz et al. (2008) categorise breast oedema based on location as follows: cutaneous/subcu-
taneous, perimamillar, perifocal, diffuse, prepectoral, and intramuscular pectoral. Using this
convention, a summary of eight publications reporting on breast oedema is presented in Table
4.1. Oedema is a hallmark of inflammatory breast cancer, a rare and aggressive form of breast
cancer characterised by the rapid development of aggressive inflammatory skin changes and
tumour growth in a previously healthy breast (Le-Petross et al. 2011). As shown in Table
4.1, inflammatory breast cancer has a high association with all categories of oedema, with the
possible exception of intramuscular pectoral oedema.
Malignant lesions that are not inflammatory breast cancer are more commonly associated with
oedema than benign lesions. A large variation can be observed in the three studies reporting on
perifocal oedema in malignant lesions, with Renz et al. (2008) reporting an incidence of 71%.
A possible reason for this is that this study only included locally advanced malignant lesions.
In a large study, Malich et al. (2005) found the presence of diffuse oedema to be a weak sign,
with 14% of malignant and 7% of benign lesions displaying this sign. The presence of perifocal
oedema was found in 41% of malignant cases and 12% of benign cases, and was assigned 2 points
(out of a possible 3) for predicting malignancy. In a study of more than 1000 lesions, Yang
& Kaiser (2006) concluded that “surrounding changes of the lesions detected by T2-weighted
images might be a useful addition to the dynamic MRM [magnetic resonance mammography]
protocol”.
To the author’s knowledge, only two approaches have been proposed for the quantitative meas-
urement of oedema in breast MRI. van Aalst (2007), van Aalst et al. (2008) proffer a feature
that quantifies the presence of oedema using peritumoural ratios. The feature is computed as
follows:
T2FOedema(↵,m) =
Perc↵(ST2S,m)
mean(ST2B )
(4.1)
where Perc↵(ST2S,m) is the ↵-percentile of the intensities within the surrounding tissue S
T2
S,m, and
ST2B are the T2w intensities within the breast. The surrounding tissue is determined using
anisotropic binary dilation (binary dilation of data with anisotropic voxel dimensions) of the
lesion segmentation to a radius of m millimetres. Van Aalst evaluated this feature, for a range
of ↵ and m values, both individually and in combination with features characterising DCE-
MRI. In feature feature selection experiments they found that the T2FOedema features were
repeatedly selected. The feature selection was performed using repeated cross validation (CV)
with different folds of the data. In every CV step, two oedema features were selected. The first
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Table 4.1: Prevalence of oedema (qualitative studies)
Category of
oedema
Occurrence (%, rounded to the nearest integer). The number in
brackets refers to the source (see below).
Inflammatory breast
cancer
Malignant lesions Benign lesions
Cutaneous/
subcutaneous 81 (1)100 (2)
29 (1)
Perimamillar 71 (1) 25 (1)
Perifocal 67 (1) 71 (1)
11 (3)
41 (4)
0 (3)
12 (4)
Diffuse 90 (1)
78 (5)
37 (1)
14 (4)
43 (6)
7 (4)
12 (6)
Prepectoral 73 (1)
100 (2)
72 (7)
39 (1)
12 (8)
0 (8)
Intramuscular
pectoral 42 (1)46 (5)
15 (1)
Sources:
(1) Renz et al. (2008) (48 inflammatory, 52 locally advanced cancer)
(2) Uematsu et al. (2012) (5 inflammatory)
(3) Uematsu & Kasami (2012) (85 malignant, 39 benign)
(4) Malich et al. (2005) (426 malignant, 215 benign)
(5) Le-Petross et al. (2011) (80 inflammatory)
(6) Yang & Kaiser (2006) (454 benign, 675 malignant)
(7) Renz et al. (2006) (36 inflammatory)
(8) Uematsu et al. (2013) (460 malignant, 129 benign)
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was generated with small m (2   6mm) and an ↵ of 86-94%. The second was generated with
a large m (16  20mm) and an ↵ of 92  98%.
A second feature characterising oedema, the intensity weighted point of gravity, was also pro-
posed by van Aalst (2007). However, unlike the peritumoural ratio features, this feature was not
frequently selected in the feature selection experiments. The maximum discriminatory power
of this feature individually was 0.63 ± 0.07 using a shell of 2mm radius, and was described as
not statistically significant.
4.2.2.3 Hook sign
The hook sign describes a hook-like spiculated dendrite connecting a lesion to the pectoralis
muscle (Kaiser 2009). It is most commonly observed on non-fat-suppressed T2w images.
The hook sign was studied by Malich et al., Fischer et al. in 2005. It was present in 63% of
malignant lesions, and only 14% of benign lesions, indicating that it is a strong sign. In 2008,
Renz et al. observed this sign in 35% of inflammatory cancers and 33% of locally advanced
cancers. In 2010, Dietzel, Baltzer, Vag, Gajda, Camara & Kaiser found that the hook sign
is significantly associated with malignancy (P < 0.001), particularly in the case of advanced
lesions.
To the author’s knowledge, no attempt has been made to quantify the hook sign to date. How-
ever van Aalst (2007) does suggest that the hook sign could be quantified using the minimum
cost path between the pectoralis muscle and a lesion.
4.2.2.4 T2w intensity distribution
The intensity distribution, within a lesion, in T2w images has been described in terms of the
presence of septations and texture. In 2001, Nunes et al. found that non-septated lobulated
masses with low T2 signal had a negative predictive value for malignancy (i.e. positive predictive
value for benignancy) of 100%. However, in 2006 Schnall et al. did not find the presence of
septations on T2w images to be a strong feature. In terms of qualitative texture analysis, a
2006 study by Okafuji et al. reported that homogenous high-intensity signal on STIR T2w
images may be useful in diagnosing pure mucinous carcinoma.
Relatively few studies have included quantitative features characterising the intensity distribu-
tion of T2w images. To the author’s knowledge, no quantitative features have been proposed
for the analysis of internal septations; possibly because of the lack of significant findings in
qualitative studies. In 2007, Klifa et al. proposed a feature of T2w homogeneity, defined as the
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standard deviation divided by the mean of the intensities in a lesion. No statistically significant
difference (P = 0.136) between benign and malignant lesions was found in this feature.
The 2011 study of Bhooshan et al. included several features characterising T2w intensity
distribution. The features included the radial gradient index feature of Gilhuijs et al. (1998), and
features derived from grey level co-occurrence matrices. The radial gradient index characterises
the degree of peripheral hyperintensity, which has been shown to correlate with early peripheral
enhancement in DCE-MRI (Kawashima et al. 2010). In a feature selection experiment, the most
commonly selected of the GLCM features were homogeneity, maximum correlation coefficient
and sum average. In combination with features derived from DCE-MRI, these features yielded
an AUC of 0.85± 0.03. DCE-MRI features alone achieved 0.80± 0.03.
4.2.2.5 Motivation for the new and variant T2w features
The motivation for the new and variant T2w features is as follows. Regarding signal intensity,
the features of van Aalst (2007) were selected. A limitation of this work was the manner in
which the intensity normalisation was performed. Signal intensity in the work of van Aalst was
not performed relative to a particular tissue type. Rather, it was performed relative to the whole
breast, or to the tissue surrounding the lesion. In this thesis, this limitation is addressed by
normalising to fat. Regarding the oedema features, peri-focal oedema is selected for quantitative
analysis. This selection is based on the results of Malich et al. (2005) and Uematsu & Kasami
(2012). The features characterising oedema are based on the peri-tumoural ratios of van Aalst
(2007), suitably normalised to the reference tissue. Given that non-fat-suppressed T2w images
were not available, quantitative features were not developed for the hook sign. Finally, the
best-performing features of of Bhooshan et al. (2011) were included as textural features.
4.2.3 Features derived from DCE-MRI
Features derived from DCE-MRI can be classified into the following categories: morphometric,
peripheral enhancement, centrifugal/centripetal enhancement, the blooming sign, texture, time-
intensity curves, and spatio-temporal. Each category is described below.
4.2.3.1 Morphometric features
Morphometric features (see Section 2.3.1) describe the size and shape of image objects. In breast
MRI, lesion segmentation is most commonly performed on contrast-enhanced images because
of its superior contrast. Thus morphometric features can be regarded as features derived from
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DCE-MRI. A compendium of existing quantitative morphometric features is presented in Table
4.2.
4.2.3.2 Peripheral (rim) enhancement
In a study in 2000, Matsubayashi et al. reported early rim enhancement (see Section 2.3.4.4) in
29% of malignant lesions, and delayed rim enhancement in 60% of malignant lesions. Yabuuchi
et al. (2008) found this sign to be among the strongest indicators of malignancy, with positive
rim enhancement in 32% of malignant lesions and 13% of benign lesions.
Mussurakis et al. proposed a quantitative feature for peripheral enhancement. It is computed
by separating the peripheral subregion (outer 25% of the region of interest) from the central
subregion (inner 25%) using a thinning algorithm. Peripheral enhancement is then computed
as follows:
PE(t) =
SP(t)  SC(t)p
 2P(t) +  
2
C(t)
(4.2)
where SP(t) and SC(t) are the mean values of the peripheral and central regions respectively at
time t, and similarly  P and  C are the standard deviations. The inclusion of features derived
from this ratio with other features derived from DCE-MRI resulted in increased sensitivity
without affecting specificity.
Agliozzo et al. (2012) proposed a variation on this idea. In their work, peripheral enhancement
is computed as follows. A hole filling operator is first applied to the lesion segmentation to fill
small holes, yielding mask B1 2 R3. A second mask, B2 2 R3 is generated by setting all voxels
greater than the median to foreground, and the remaining voxels to background. The function
H(d) is then computed as follows:
H(d) =
No. of foreground voxels in B2 at distance d
No. of foreground voxels in B1 at distance d
(4.3)
where d is the distance from the lesion border normalised by the maximum d within the lesion1.
A third order polynomial is fitted to H(d), and the second and third order coefficients are used
as quantitative features.
1 The equation given in Agliozzo et al. appears to be incorrect because it does not match the description in
the text therein. It has B1 in the numerator and B2 in the denominator.
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Table 4.2: Morphometric features
Source Feature name Description
Sinha et al.
(1997)
Shape
compactness
The square of the perimeter divided by the area
Total bending
energy
The integral of the curvature of the contour
Radial length
ratio
Radial lengths are the distances from the centre of
the lesion to each point on the boundary. Radial
length ratio is the ratio of the maximum radial
length to the minimum.
Radial length
entropy
The entropy of the histogram of all radial lengths
Gilhuijs et al.
(1998)
Circularity The ratio of the number of voxels within a fitted
sphere divided by the volume of the VOI
Irregularity The deviation of the surface from a fitted sphere
Gibbs &
Turnbull (2003)
Lesion volume The volume of the lesion
Arbach et al.
(2004)
Normalised
radial length
sum
The sum of the Euclidean distances from the lesion
centre to the boundary
Spiculation The standard deviation of the radial length
Perimeter
length
The integral of the VOI edge voxels
Mayer et al.
(2006)
Number and
volume of holes
The number and volume of holes in the VOI,
defined using N61 connectivity
Gal et al. (2011) Mean fractal
dimension
Mean of the fractal dimension of the boundary
Fractal
dimension
entropy
Entropy of the fractal dimension of the boundary
Eccentricity The eccentricity of the ellipse that has the same
second moments as the lesion
Solidity The ratio of the number of pixels in the VOI to the
number of pixels in the convex hull of the VOI
Srikantha et al.
(2013)
Projected
variance
The orientation of the lesion towards the nipple
1 6-connected neighbours share a face with the centre voxel.
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4.2.3.3 Centrifugal/centripetal enhancement
Bahreini et al. (2010) recently proposed a method to quantitatively characterise centrifugal/-
centripetal enhancement (see Section 2.3.4.5) by computing the change in perimeter between
the first and last post-contrast stack. The edge contour of the lesion in each stack is computed
using a gradient vector flow snake segmentation. The contour is denoted “decreasing” (indic-
ating centripetal enhancement) if the perimeter at the first post-contrast time point is larger
than the perimeter at the final post-contrast time point. Conversely, the contour is denoted
“increasing” (indicating centrifugal enhancement) if the perimeter increases between the first
and final post-contrast time point. It must be noted that this method does not quantify cent-
ripetal and centripetal enhancement as per the definition of Kaiser (2009). Kaiser states that
in centripetal enhancement, “the enhancement is initially more pronounced at the centre of the
mass and then spreads toward the periphery (filling in from inside to outside)”. Rather, the
feature of Bahreini et al. returns the sign of the rate of change of the size of the lesion over
time. This is more closely related to the blooming sign (discussed next) than centripetal/cent-
rifugal enhancement. This feature would not be sensitive, for example, to a lesion displaying
centripetal/centrifugal enhancement in which the perimeter does not change over time, but the
distribution of contrast agent within the lesion does.
4.2.3.4 Blooming sign
The blooming sign (see Section 2.3.4.3) is a typical feature of invasive carcinomas, and rare in
benign lesions. It has a reported sensitivity of 58-63% and a specificity of 84-86% (Fischer et al.
2004, Malich et al. 2005, Renz et al. 2006), but a reduced sensitivity (40%) in small lesions
(Dietzel, Baltzer, Vag, Gröschel, Gajda, Camara & Kaiser 2010). Malich et al. (2005) conclude
that “the interpretation of the blooming sign is, at least in part, subjective and requires further
objective analysis”.
To the author’s knowledge, only one attempt has been made to quantify the blooming sign. Un-
fortunately, the algorithm of Penn et al. (2006) is not rigorously described, omitting important
details. Moreover it has several shortcomings. The algorithm’s ambiguities and shortcomings
are as follows:
1. The feature considers only the first post-contrast image stack, quantifying early enhance-
ment margin sharpness rather than the unsharpening of lesion margins over time. There-
fore, it does not quantify the blooming effect as described by Kaiser (2009).
2. Although the feature purports to quantify 3D blooming, it is simply the maximum of the
weighted average of a 2D blooming feature computed in each of three 2D slices.
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3. The algorithm terminates when a region of interest expands to include “a large portion
of the breast”. This phase is ambiguous.
4. The initial cluster size of 25mm2 seems to have been set arbitrarily, and does not consider
lesions that are smaller than 25mm2.
5. The use of a bounding box imposes arbitrary geometry.
6. Binary thresholding is performed at a “successively lower intensity level”. This phrase is
ambiguous, and the step size is not provided.
4.2.3.5 Textural features
An exhaustive analysis of textural analysis (see Section 2.3.4.2) approaches in breast DCE-MRI
is presented by Holli et al. (2010). Here, 300 textural features were evaluated. These included
those based on histograms, grey level co-occurrence matrices (GLCMs), run length matrices,
autoregressive models, and wavelet transforms. They concluded that GLCM-derived features
were superior to other textural features. GLCM derived features are widely used in breast MRI
classification. A summary of publications is presented in Table 4.3.
Existing approaches using GLCM-derived features have used a variety of histogram tuning
parameters. In the work of Nagarajan (2013) and Milenković et al. (2013), histogram bin
parameters were chosen based on the grey levels in all lesions. In the former, the bins were
defined to span intensities between the minimum and maximum intensity in all VOIs. In the
latter, the bins spanned ±3 standard deviations. However, this approach does not account for
individual variation in brightness. Chen et al. (2007) and Gibbs & Turnbull (2003) address
this by performing histogram equalisation for each lesion in turn (i.e. replacing each grey value
with a new value to ensure that all grey levels are equiprobable).
The choice of image for GLCM analysis remains an open question. Commonly, features are
derived from the first post-contrast, the first post-contrast minus the pre-contrast, and relative
enhancement. Holli et al. (2010) reported that the first post-contrast minus the pre-contrast
yielded the highest number of statistically significant features between benign and malignant
lesions.
4.2.3.6 Features derived from enhancement curves
Approaches for extracting features from time-intensity curves (see Section 2.3.4.1) can be clas-
sified into three categories: model free approaches, empirical models, and pharmacokinectic
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models. All three approaches aim to be invariant to differences in signal intensity from tun-
ing and scaling factors between scanners or between sessions on the same scanner. They are
discussed below, in order of complexity.
Model free approaches extract information from time-intensity curves without fitting any model
to the data. Examples of the parameters that are extracted include: time to peak, intensity of
peak, wash-in slope, wash-out slope, area under wash-in, area under wash-out, and area under
entire curve (Fusco 2013). Benefits of this approach are that parameters can be computed
quickly, and it does not make any assumptions about the underlying signal. One drawback
of this approach is that it requires high temporal resolution to return accurate parameters
(particularly for the time-to-peak parameter).
Empirical model based approaches use simple models, typically with between two and four para-
meters, to describe time-intensity curves. Examples of these include the linear slope (Schaben-
berger 2002), simplified gamma variate (Chan & Nelson 2004), Hayton (Hayton et al. 1997),
Ricker (Ricker 1958), Gal (Gal et al. 2007a), and Agliozzo (Agliozzo et al. 2012) models. The
advantages of these models is that they can be fit with relatively few data points (i.e. they are
suited to acquisitions with low temporal resolution), and provide a degree of noise attenuation.
A disadvantage of these models is that they are relatively inflexible, and may not fully capture
physiologically important characteristics of the curve.
Pharmacokinetic models are based on the exchange of contrast agent between tissue compart-
ments. In breast MRI, the major compartments are the vascular plasma, the extra-cellular and
extra-vascular space. Several models have been proposed to capture the interactions between
the compartments, including those of Tofts et al. (1995) and Brix et al. (2004). The advantage
of pharmacokinetic models is that they allow direct quantification of parameters such as flow,
capillary wall permeability, extraction fraction, and mean capillary transit time. Unfortunately,
they also require high temporal resolution due to the large number of fitting parameters, and
often require an estimate of the arterial input function. Another weakness is the assumption
of linearity between relative enhancement and contrast agent concentration. The reader is
directed to the PhD thesis of Fusco (2013) for more information on pharmacokinetic modelling.
4.2.3.7 Spatio-temporal features
Spatio-temporal features describe simultaneously the temporal characteristics and spatial dis-
tribution of contrast agent of the lesion.
Gilhuijs et al. (1998) described quantitative parameters derived from the variance of MR intens-
ities within the lesion, and on the lesion margin. Spatio-temporal features were derived from the
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time-curves of these parameters. These concepts were further developed in the enhancement-
variance features of Chen et al. (2004).
Zheng et al. (2009) proposed and evaluated several new spatio-temporal features, including
those derived from the Fourier transform of enhancement curves, rotation-invariant moments
and Gabor filters.
The spatio-temporal features of Gal et al. (2011) included features derived from mean time-
intensity curves and gradient correlation of pre-contrast and maximum-intensity images.
Agliozzo et al. (2012) proposed nine features derived from the spatial derivative of intensities.
This involves calculating the Jacobian matrix at every voxel and computing its trace. For each
voxel, maps of the mean, standard deviation and range (maximum minus minimum) of the trace
at all time points are generated. For each of the three maps, the mean, standard deviation and
entropy within the lesion VOI are used as features.
4.2.3.8 Motivation for new and variant DCE-MRI features
New features were developed for both centrifugal/centripetal enhancement and the blooming
sign. This was motivated by the limitations of the existing algorithms (discussed above). In the
case of blooming, the new algorithm is based on the signal enhancement in a shell around the
lesion. In the case of centrifugal/centripetal enhancement, the new algorithm is an extension
of the peripheral enhancement feature of Agliozzo et al.. In the case of textural features, the
selected image stack for feature extraction was the first post-contrast stack. This image stack
has been used several times in the literature for GLCM analysis (see Table 4.3) and was shown
to yield a high number of statistically significant features by Holli et al. (2010). In the case of
features derived from enhancement curves, empirical models were selected. The motivation for
this was partly driven by the available data, which has a low temporal resolution. Additionally,
it has been shown that the linear slope model fits DCE-MRI data better than the standard
pharmacokinetic model (Mehnert et al. 2010).
4.3 New multimodal MRI features
The new features presented in this section include variations on existing features and features
inspired by both the American College of Radiology BI-RADS (Breast Imaging Reporting and
Data System) lexicon(American College of Radiology 2008) and Kaiser’s compendium of signs
in MR-mammography. Table 4.5 lists the features sorted by MR modality and then by category.
Unless otherwise stated, all features are computed in 3D. Each is described in detail below.
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Table 4.5: New and variant features. Where a citation has been provided the feature is a variant
on the original definition. VOI is an acronym for the volume of interest corresponding to the lesion.
MR modality Feature
category
Feature
identifier
Description
T1w T1w intensity A1, A2 Mean and standard deviation in VOI
relative to fat
Anatomical A3 Fat volume fraction
T2w T2w intensity B1, B2 Mean and standard deviation in VOI
relative to fat (Klifa et al. 2007)
B3 Mean of eroded VOI (van Aalst et al.
2008)
B4, B5 20th and 90th percentile in VOI (van
Aalst et al. 2008)
Oedema B6, B7 Presence of oedema (92nd percentile
in 2mm shell, and 98th percentile in
20mm shell) (van Aalst et al. 2008)
B8 Presence of oedema in non fatty
tissue (van Aalst et al. 2008)
T2w texture B9, B10, B11 Texture features: Homogeneity,
maximum correlation coefficient, and
sum average (Bhooshan et al. 2011)
B12 Radial gradient index (Bhooshan
et al. 2011)
DCE-MRI Morphometric D1, D2 Taller-than-wide sign
Vascularity D3, D4 Breast vascularity
D5 Adjacent vessel sign
Enhancement
model
D6, . . . , D17 Whole lesion model parameters
D18, . . . , D53 Cluster-wise model parameters
Other
DCE-MRI
D54 Blooming sign
D55, . . . , D61 Centripetal/centrifugal enhancement
(Agliozzo et al. 2012)
D62, . . . , D72 Post-contrast textural features
(Sinha et al. 1997, Bhooshan et al.
2011, Gibbs & Turnbull 2003, Chen
et al. 2007, Nie et al. 2008)
D73, D74 Pre-contrast mean and standard
deviation in VOI relative to fat
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Figure 4.1: Example of fat segmentation. (a) T1w slice with the boundary of the breast mask,
B, overlaid (right breast only shown). (b) Histogram of the T1w values within the mask and the
threshold selected by the Otsu method. (c) Segmented image showing fat (white) and non-fat (grey).
(d-f) Boundary of the fat mask, F , overlaid on the corresponding T2w slice, b = 0 DW slice, and
the first post-contrast (DCE-MRI) slice.
4.3.1 Notation
To facilitate the description of the new features the following notation is used. Let fT1(x)
denote the T1w image stack (axial slices) where x = (x1, x2, x3) is the voxel located at row x1
and column x2 in slice x3. Similarly let fT2(x), fDW0(x), and fDWb(x) refer to the T2w stack,
the diffusion-weighted stacks for b-value zero and b respectively. Finally let fDCEi(x) denote
the i-th DCE-MRI stack where i 2 {0, 1, . . . ,M}, i = 0 is the pre-contrast stack, i = 1 is
the first post-contrast stack and so on. Note that it is assumed that fT1(x), fT2(x), fDW0(x),
fDWb(x) and fDCEi(x) are all spatially co-registered. Let B ⇢ Z3 denote the binary mask of
both breasts. Let Bi and Bc denote the ipsilateral breast mask (containing the lesion) and
the contralateral breast mask respectively obtained by partitioning B about the mid-sagittal
plane. Let F denote the mask of the breast fat obtained by thresholding fT1 using Otsu’s
method (Otsu 1979) to obtain the hyper-intense voxels, and intersecting the result with the
breast volume mask B (see Fig. 4.1). Finally let V ⇢ Z3 denote the binary mask or volume of
interest (VOI) corresponding to the lesion.
In performing fat segmentation using simple thresholding, we make the following assumptions:
1. That every breast in the data set contains a region of fat, and that it is possible to detect
and delineate these regions using thresholding of T1w images
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2. That the fat suppression has been applied in a consistent manner to all of the T1w and T2w
images.
3. That the MR properties of mammary fat are consistent between patients, and so are the
intensities of other tissues relative to fat.
4.3.2 T1w Features
4.3.2.1 Signal intensity
Features A1 and A2 are inspired by the observation of Kaiser (2009) that increased lesion signal
intensity in non-contrast-enhanced T1w images is “almost always a benign sign”. A1 and A2
are extracted from the anatomical T1w stack. This stack is first normalised with respect to fat
to yield f 0T1(x) as follows:
f 0T1(x) =
fT1(x)
1
|F |
X
y2F
fT1(y)
(4.4)
where |F | denotes the cardinality of F . A1 and A2 are the mean and standard deviation,
respectively, of the values in f 0T1(x) within the VOI.
4.3.2.2 Other T1w features
Feature A3, fat volume fraction, is related to mammographic density which in turn is a known
risk factor for breast cancer (MacKenzie et al. 2007). This feature is computed as follows:
A3 =
|F \ Bi|
|Bi| . (4.5)
4.3.3 T2w Features
All of the T2w features are variants on existing features. The variation concerns the manner in
which the T2w data are normalised. Bhooshan et al. (2011) do not perform any normalisation.
van Aalst et al. (2008) perform normalisation with respect to the entire breast volume. However,
this does not take breast anatomy into account and is sensitive to the presence of breast
implants, cysts or oedema. Our approach is to perform normalisation with respect to fat to
yield f 0T2 (in the same manner that f 0T1 was defined in equation 4.4). This is similar to the
approach taken by Kelcz (2006).
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4.3.3.1 T2w intensity
Features B1   B5 quantify the signal intensity of the lesion in the f 0T2 images. Features B1
and B2 are the mean and standard deviation respectively of the normalised signal in the VOI.
Features B3, B4 and B5 are the mean in the eroded VOI, and the 20th and 90th percentiles in
the VOI respectively. These are essentially the features proposed by van Aalst et al. (2008),
normalised to the intensity of fat.
4.3.3.2 Oedema
Features B6 and B7 are the peritumoural oedema features of van Aalst et al. (2008). Per-
itumoral oedema is a sign of malignancy with relatively low sensitivity but high specificity
(Malich et al. 2005). Both features are computed from a shell (i.e. thick margin) defined
around the VOI. A shell with a radius of r mm around the VOI V is defined
Sr = {x | d(x, V )  r} \ V c (4.6)
where d(x, V ) assigns to x its shortest distance to V in mm. Feature B8 is a variation on feature
B7. Our variation is that we exclude fat voxels in the shell from the feature computation.
Feature B8 is defined:
B8 =
1
|S20 \G|
X
x2S20\G
f 0T2(x) (4.7)
where G = B   F = B \ F c is the mask of the non-fat breast voxels.
4.3.3.3 T2w texture
Features B9, B10, and B11 are the grey-level co-occurrence texture features homogeneity,
maximum correlation coefficient, and sum average respectively derived from the f 0T2 stack.
Feature B12 is the radial gradient index of the normalised data. These features, albeit computed
from unnormalised T2w data, were found to improve classification performance in conjunction
with features derived from DCE-MRI in a study by Bhooshan et al. (2011).
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4.3.4 DCE-MRI features
4.3.4.1 Morphometric
Taller-than-wide sign The taller-than-wide sign of Kaiser (2009) refers to the situation
where the anteroposterior (axial) diameter of a lesion is larger than its left-right (transverse)
diameter. The idea is that the anteroposterior diameter is parallel to the ductal structures
and should it be larger than the anti-parallel diameter then the lesion is more likely to be
malignant. This then is the motivation for feature D2 defined to be the axial diameter of a
lesion divided by its transverse diameter. Feature D1 originates from ultrasonography (Stavros
et al. 1995) and is defined to be the axial diameter divided by the maximum of the sagittal and
transverse diameters. The diameters for features D1 and D2 are derived from the dimensions
of the bounding box (rectangular prism) of the VOI.
4.3.4.2 Vascularity
Absolute and relative breast vascularity Breast vascularity refers to the volume and
concentration of blood vessels within the breast. Increased vascularity is a known positive sign
for breast cancer (Schmitz et al. 2008). Features D3 and D4 correspond to the absolute and
relative vascularity of the breast respectively. The blood vessels are segmented using the Frangi
vesselness filter (Frangi & Niessen 1998) as described in Section 3.4. Let H ⇢ Z3 denote the
blood vessel mask. Absolute vascularity concentration D3 is defined as follows:
D3 =
|Bi \H|
|Bi| (4.8)
Relative vascularity D4 is defined as follows:
D4 =
|Bi\H|
|Bi| /
|Bc\H|
|Bc| =
|Bc| |Bi \H|
|Bi| |Bc \H| . (4.9)
Recall that Bi and Bc refer to the ipsilateral and contralateral breast segmentation masks
respectively.
Adjacent vessel sign The adjacent vessel sign is positive if a blood vessel is present in the
vicinity of a lesion. To date this sign has been assessed through visual inspection, a subjective
and time-consuming process (Dietzel, Baltzer, Vag, Herzog, Gajda, Camara & Kaiser 2010).
Feature D5 is the proposed quantification of the adjacent vessel sign. It is defined as the
diameter of the largest vessel within a 10 mm shell around the lesion, as follows:
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D5 = 2⇥ max
x2S10
{d (x, Hc)} (4.10)
Recall from Equation 4.6 that d (x, Hc) is the distance transform (in mm). Hc refers to the
complement of H (i.e. voxels that are not part of the blood vessel mask).
4.3.4.3 Enhancement model
The DCE-MRI enhancement model features D6-D53 are derived from the parameters of several
different parametric models of contrast enhancement, described in Table 4.6, fitted to the DCE-
MRI data. The variable t represents the time since injection of the contrast agent. These
models are displayed using two example time-intensity data sets in Figure 4.2. In both of these
examples, the Ricker model has much higher mean square error than any other model. However,
it (along with the Agliozzo model) has the benefit of having only two fitting parameters. The
remaining models have three fitting parameters. In addition, two of the other models (Gamma
Variate and Agliozzo) use the Ricker model for parameter initialisation.
The models are not fitted voxel-wise but rather to clusters of voxels. Moreover the fitting is
not directly to signal intensity but rather to relative enhancement. The partitioning of a VOI
into clusters is described in Algorithm 4.1.
Let cluster Ci ✓ V denote the i-th cluster. The mean of the values in fDCEj(x) within the
cluster is given by:
µCi,fDCEj =
1
|Ci|
X
x2Ci
fDCEj(x) (4.11)
The relative enhancement for cluster Ci ✓ V for the j-th DCE-MRI stack is computed as
follows:
RCi(j) =
µCi,fDCEj   µCi,fDCE0
µCi,fDCE0
(4.12)
4.3.4.4 Whole lesion model parameters
Features D6-D17 are derived from models fitted to the relative enhancement for the VOI as
whole; i.e. Equation. 4.12 with C1 = V . The features are respectively the linear slope model
parameters  1 and  2; Hayton model parameters A, a, and b; Ricker model parameters ↵ and
 ; simplified gamma variate model parameters A, ↵ and  ; and the Agliozzo model parameters
A and D (see Table 4.7).
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Algorithm 4.1 Using the DCE-MRI data to partition a VOI into clusters
Input:
• DCE-MRI stack, fDCE(x)
• Spatial bandwidth hs
• Range bandwidth hr
Output:
• Set of clusters, {Cj ⇢ Z3 | j = 1, . . . , N}
Steps:
1. For each DCE-MRI stack in turn, the voxels within the VOI (lesion) are normalised to
z-scores (i.e. zero mean, unit standard deviation).
2. For each VOI voxel in turn, a feature vector is defined by concatenating voxel spatial
coordinates and the corresponding DCE-MRI post-contrast z-scores (one from each stack).
3. Mean-shift (Comaniciu &Meer 1999) clustering with a Gaussian kernel, spatial bandwidth
hs, and range bandwidth hr is applied to obtain a set of clusters {Cj ⇢ Z3 | j = 1, . . . , N}.
Mean shift clustering is described in Appendix B. A similar approach has previously been
employed for breast MRI feature extraction (Stoutjesdijk et al. 2007, 2012). The major
difference here is the features that are extracted from the mean shift clusters.
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Figure 4.2: Examples of parametric model fitting.
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Table 4.7: Feature identifiers for cluster-wise DCE-MRI enhancement model features
Model name Whole VOI Small
clusters
Medium
clusters
Large
clusters
Linear slope model  1 D6 D18 D30 D42
Linear slope model  2 D7 D19 D31 D43
Hayton model A D8 D20 D32 D44
Hayton model a D9 D21 D33 D45
Hayton model b D10 D22 D34 D46
Ricker model ↵ D11 D23 D35 D47
Ricker model   D12 D24 D36 D48
Simplified gamma variate
model A
D13 D25 D37 D49
Simplified gamma variate
model ↵
D14 D26 D38 D50
Simplified gamma variate
model  
D15 D27 D39 D51
Agliozzo model A D16 D28 D40 D52
Agliozzo model D D17 D29 D41 D53
4.3.4.5 Cluster-wise model parameters
Features D18-D53 are derived from models fitted to the relative enhancement for individual
clusters within the VOI. A multiset is constructed for each model parameter by taking the union
of |Ci| repetitions of fitted values over all i. In the case of the linear slope model parameter
 1 and the gamma variate model parameter ↵, the 10th percentile is extracted. For all other
parameters, the 90th percentile is extracted. The idea in selecting these percentiles is to identify
the most malignant-appearing portion of the lesion, robust to outliers. D18-D29 are identically
these percentiles (in the same order as D6-D17) for small clusters, D30-D41 for medium sized
clusters, and D42-D53 for large clusters.
4.3.4.6 Other DCE-MRI features
4.3.4.6.1 Blooming sign A positive blooming sign refers to a lesion in which the margins
are well-defined in the first post-contrast image and then become increasingly unsharp in later
post-contrast images. It is a common sign in invasive carcinoma (Kaiser 2009). Feature D54
is our proposed quantification of this sign. It is defined in terms of post-contrast peri-tumoral
ratios, excluding tissue corresponding to fat. The peri-tumoral ratio for the j-th DCE-MRI
stack is defined:
Y (j) =
µV,fDCEj
µP,fDCEj
(4.13)
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where P = S10 \G. D54 is defined to be the slope of the regression line fitted to (tj, Y (j)) for
j = 1, 2, · · · ,M (i.e. the post-contrast stacks only).
4.3.4.6.2 Centripetal and centrifugal enhancement In the case of centripetal enhance-
ment, the periphery enhances before the centre of the lesion, indicative of malignancy (Kaiser
2009). In the case of centrifugal enhancement the centre enhances first and the enhancement
then spreads to the periphery. This is atypical of malignant lesions.
The proposed features for characterising centripetal and centrifugal enhancement are an ex-
tension of the peripheral uptake features of Agliozzo et al. (2012) to include all post-contrast
stacks (see Fig. 4.3). The new features are derived from a polynomial fit to the function
H(d, tj) =
# of foreground voxels in Vselected at distance d
# of foreground voxels in Vfilled at distance d
(4.14)
where tj is the time since contrast agent injection that fDCEj was acquired (see the caption for
Table 4.6), Vfilled is the VOI V after hole filling and Vselected is a new binary mask created from
the subtraction volume fDCEj   fDCE0 “by setting the voxels with intensities greater than the
median contrast value inside the lesion to foreground and the remaining voxels to background”
(Agliozzo et al. 2012). The fitted polynomial is is defined:
H(d, t) = p00 + p10d+ p01t+ p20d
2 + p11dt+ p30d
3 + p21d
2t (4.15)
Features D55-D61 are identically the seven fitted coefficients, p00, p10, . . . , p21.
4.3.4.6.3 DCE-MRI texture features Texture features in DCE-MRI derived from grey
level co-occurence matrices (GLCMs) are well established in providing complementary inform-
ation for breast lesion classification (Sinha et al. 1997, Gibbs & Turnbull 2003, Chen et al. 2007,
Nie et al. 2008, Bhooshan et al. 2011). The idea behind this is that benign lesions tend to have
smooth, homogenous intensities compared to malignant lesions.
Features D62-D72 are grey level co-occurrence matrix (Haralick et al. 1973) texture features
extracted from the first post-contrast stack. More specifically features D62-D72 are contrast,
correlation, sum of squares: variance, sum average, sum variance, sum entropy, entropy, dif-
ference in variance, difference in entropy, homogeneity, and maximum correlation coefficient
respectively. They are essentially the features proposed by Bhooshan et al. (2011), suitably
quantised individually for each lesion (see Section 7.4).
Pre-contrast signal intensity Features D74 and D75 are the analogues of the T1w features
A1 and A2 respectively, but computed from the pre-contrast T1w stack (Kaiser 2009). The
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Figure 4.3: Proposed centripetal/centrifugal enhancement features illustrated for a malignant lesion
(invasive ductal carcinoma) demonstrating fast peripheral, but slow central enhancement. (a-f)
First, second and final post-contrast subtracted images (central slice of the lesion) with corresponding
binary mask Vselected. (g) The function H(d, t) and the fitted polynomial surface. The features are
identically the fitted coefficients.
differences between the two pairs of features reflect the differences in the acquisitions of the
T1w anatomical stack and the pre-contrast DCE-MRI stack.
4.4 Summary and Conclusion
This chapter focussed on features derived from T1w, T2w and DCE-MRI data. In particu-
lar it reviewed existing state-of-the-art qualitative and quantitative features and signs, and
proffered several new quantitative features. The proposed features include both new features
(e.g. blooming, centripetal/centrifugal enhancement, and the adjacent vessel sign) and vari-
ants on existing features (normalisation variants of existing T1w and T2w features). Features
derived from diffusion-weighted MRI are described in the following chapter. An evaluation of
the efficacy and performance of these features is the subject of Chapter 7.
Chapter5
Features derived from diffusion-weighted MRI
The preceding chapter focussed on features derived from T1w, T2w and DCE-MRI data. This
chapter focuses on the extraction of quantitative features from diffusion-weighted (DW) MRI1.
An empirical evaluation of the efficacy and performance of these features for the discrimination
of benign and malignant lesions is presented in Chapter 7.
The features in this chapter are primarily derived from the apparent diffusion coefficient (ADC)
volume/map computed from the DW-MRI data. Several studies (Tsushima et al. 2009) have
demonstrated that the mean ADC value is a useful feature for differentiating malignant breast
tumours from benign lesions and normal tissue. In particular the evidence suggests that the
mean ADC for malignant lesions is lower. However, methods for selecting a suitable region-
of-interest (ROI) within a lesion for computation of the mean ADC are varied and subjective.
This chapter presents an automatic method for selecting an ROI of hypointensity, from which
to compute the mean ADC, based on a novel generalisation of the converging squares (CS)
algorithm (O’Gorman & Sanderson 1984), that we call generalised converging squares (GCS)2.
The method was presented by the author at the 20th Annual Meeting & Exhibition of the
International Society for Magnetic Resonance in Medicine (ISMRM 2012) and published in
the conference proceedings (McClymont et al. 2012a). The remaining DW-MRI features de-
scribed in this chapter are also described in a paper entitled “Multimodal features for improved
breast MRI CAD”, submitted by the author to the Journal of Medical Imaging on 6/5/2014.
Earlier work was presented at the 2010 Digital Image Computing: Techniques and Applications
(DICTA) conference (McClymont et al. 2010) and ISMRM 2011 (McClymont et al. 2011).
1 DW-MRI uses an entirely different contrast mechanism to T1- and T2-weighted (relaxivity) imaging that
reflects tissue microstructure.
2 The generalisation, based on Mathematical Morphology, permits not only extension to three- or more di-
mensions but also to images defined on arbitrarily shaped domains and images defined on other than the
Cartesian lattice.
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The remainder of this chapter is organised as follows. In the next section a review of quantitative
DW-MRI features is presented that includes a discussion of different strategies for computing a
representative ADC value from a suspicious lesion. Section 5.2 presents several new and variant
DW-MRI features developed by the author. Section 5.3 presents the generalised converging
squares algorithm developed by the author. Finally Section 5.4 presents a summary of the
chapter.
5.1 Review of quantitative features in DW-MRI
This section reviews existing quantitative features in DW-MRI. See Section 2.1.13 for an intro-
duction to DW-MRI. A selection of these features is used in Chapter 7 for the classification of
lesions. Section 7.3 describes which of these features were included.
5.1.1 The Apparent Diffusion Coefficient
From the images that are acquired in DW-MRI it is possible to compute an apparent diffusion
coefficient (ADC) volume or map that reflects the voxel-wise net effects of random Brownian
motion (bulk diffusion) of water molecules in the tissue. High ADC values indicate regions
of unimpeded water diffusion, while low values indicate hindered and restricted motion of
water. Histological examinations of malignant and benign breast lesions show that the former
are hypercellular3. This suggests that DW-MRI is useful to characterise this change in tissue
microstructure. Indeed it has been found that, in general, malignant lesions have lower ADC
values than benign lesions (Partridge, Mullins, Kurland, Allain, DeMartini, Eby & Lehman
2010). Furthermore several studies have demonstrated that the representative ADC value is
a useful criterion in the differentiation of malignant breast tumours from benign lesions and
normal tissue (Tsushima et al. 2009).
Table 5.1 presents a summary of publications describing the sensitivity and specificity of ADC
values for discriminating benign and malignant lesions. All included studies were performed
at 1.5T . Where studies stratified the data into mass-like and non-mass-like categories, the
reported statistics refer to mass-like lesions. Figure 5.1 is a plot of the sensitivity/specificity
pairs from Table 5.1. It might be supposed that the points would be operating points on one
and the same ROC curve. However, it can be seen that this is not the case and that the large
variation in sensitivity and specificity is not entirely due to the selection of the threshold ADC
value. Two important differences between these studies are the choice of b-value(s) and the
method used to compute a representative ADC value.
3 Hypercellularity refers to an abnormal increase in the number of cells present
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In the first case, Tsushima et al. (2009) found that there is a negative linear correlation between
the maximum b factor and the representative ADC value. Overall, they recommend a threshold
value of 1.23 ⇥ 10 3mm2/s and a maximum b factor of 1000s/mm2 to distinguish between
benign and malignant lesions (i.e. lesions with a representative ADC lower than the threshold
are classified as malignant). Meta-analysis of 12 quantitative ADC studies yielded a sensitivity
of 89% and a specificity of 77%. A related meta-analysis of 25 quantitative ADC studies in both
English and Chinese by Chen et al. (2010) yielded similar results, with an overall sensitivity of
84% and specificity of 79%.
In non-mass-like lesions, the reported sensitivity is lower, with Imamura et al. (2010) reporting
a sensitivity of 69% and a specificity of 73% at a threshold of 1.1 ⇥ 10 3mm2/s. Partridge,
Mullins, Kurland, Allain, DeMartini, Eby & Lehman (2010) reported a sensitivity of 92% and
specificity of 47% at a high threshold (1.6⇥10 3mm2/s) for non-mass-like lesions, and a similar
sensitivity and specificity for small ( 1cm) lesions.
In these second case, methods for determining a representative ADC value for a suspicious
lesion are highly varied with no consistent methodology. These are briefly reviewed in the next
subsection.
5.1.1.1 Review of methods of selecting a representative ADC value for a lesion
A list of the various methods that have been proposed for computing a representative ADC
value from a lesion is presented in Table 5.2. The simplest approach is to compute the mean
ADC value over the entire lesion to obtain a representative ADC value (Englander et al. 1997,
Partridge et al. 2001). Another is to compute the mean ADC within one or more regions
of interest (ROIs) defined on the suspicious lesion. Early examples of this approach involve
manually defining ROIs of hypointensity to be as large as possible, but constrained within the
lesion (Guo et al. 2002, Sinha & Sinha 2002), and such that areas of necrosis are avoided in
large lesions (Rubesova et al. 2006). More recent examples of this approach involve placing one
or more smaller ROIs of hypointensity within a suspicious lesion and computing, for example,
the global minimum (Yabuuchi et al. 2008, Cheng et al. 2013) or mean (Kim et al. 2009, Pereira
et al. 2009). This appears to provide better separation between benign and malignant lesions. A
possible explanation for this is the high degree of heterogeneity within malignant breast lesions.
The use of the minimum ADC ensures that the lesion is represented by its “most aggressive
tissue component” (Cheng et al. 2013).
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Table 5.1: Sensitivity and specificity (each rounded to the nearest integer) of the representative
ADC for the discrimination of benign and malignant breast lesions
Reference No. of b
factors
Maximum
b factor
(s/mm2)
Threshold
ADC
value
(10 3
mm2/s)
Sensitivity
(%)
Specificity
(%)
Number of
samples
(malignant,
benign)
Guo et al.
(2002)
5 1000 1.3 93 88 30M, 17B
Rubesova
et al. (2006)
5 1000 1.13 86 86 65M, 22B
5 1000 0.95 43 100
Wenkel et al.
(2007)
4 800 1.26 98 93 49M, 15B
Marini et al.
(2007)
2 1000 1.1 80 81 42M, 21B
2 1000 1.31 100 67
Huang et al.
(2008)
2 500 1.32 91 92 32M, 24B
2 1000 1.25 88 92
Yabuuchi
et al. (2008)
3 1000 1.1 85 86 155M, 31B
Hatakenaka
et al. (2008)
3 1000 1.48 84 81 124M, 16B
Yili et al.
(2009)
2 500 1.24 93 100 35M, 22B
2 1000 1.20 96 97
Pereira et al.
(2009)
5 1000 1.21 93 92 26M, 26B
Baltzer et al.
(2009)
3 1000 1.23 87 83 39M, 35B
2 800 1.24 77 89
Baltzer et al.
(2010)
3 1000 1.23 91 77 54M, 27B
Gouhar &
Zidan (2011)
2 1000 1.46 93 98 27M, 51B
Bassiouny
et al. (2012)
2 1000 1.33 88 79 51M, 42B
Sonmez et al.
(2011)
5 1000 1.0 95 100 25M, 20B
Sahin &
Aribal (2013)
2 800 1.03 89 100 35M, 16B
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Figure 5.1: Plot of the sensitivity and specificity pairs in Table 5.1. Data labels state the ADC
threshold for the sensitivity/specificity combination. The line where sensitivity equals specificity is
also displayed.
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Table 5.2: ADC selection methods
Reference ROI selected
on image:
Number of
ROIs
Processing of
ROIs
Size of ROIs
Yabuuchi et al.
(2008)
DW 3 Minimum of
the mean
ADC in the
ROIs
Each typically
30-100mm2, never
smaller than
15mm2
Pereira et al.
(2009)
ADC 2
(circular)
Mean of the
mean ADC in
the ROIs
Mean area1 of
61mm2
Kim et al.
(2009)
ADC 3 Mean of the
mean ADC in
the ROIs
-
Partridge,
Mullins,
Kurland, Allain,
DeMartini, Eby
& Lehman
(2010)
DW 1
(drawn
freehand)
Mean ADC in
the ROI
As large as possible
Peters et al.
(2010)
DW
(baseline)
1
(circular)
ADC
computed
from mean
signal in ROI
in each DW
image
Homogenous part
of lesion
Imamura et al.
(2010)
DW if
possible,
otherwise
DCE-MRI
1 Mean of the
ADC in the
ROI
Selected to
minimally cover
areas showing high
SI on DW- and
DCE-MRI
Kazama et al.
(2012)
DW 1 Mean of the
ADC in the
ROI
-
Parsian et al.
(2012)
DW if
possible,
otherwise
DCE-MRI
1
(drawn
freehand)
Mean of the
ADC in the
ROI
3.9-1315mm2 in a
region of
hyperintensity
Cheng et al.
(2013)
DW or
DCE-MRI
subtraction
up to 6 Minimum of
the mean
ADC in the
ROIs
At least 3 pixels
(18.5mm2)
1 The study specifies “a mean diameter of 61mm2”. Presumably they intended to write area,
not diameter.
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5.1.2 DW-MRI signal intensity
As with T1w or T2w MRI, it is desirable to normalise the DW-MRI signal intensity to a refer-
ence tissue to facilitate inter-subject comparison. Several groups of researchers have proposed
the contrast to noise ratio (CNR) for this purpose. Three different definitions can be found in
the literature. The first is :
CNR1 =
µlesion   µtissuep
 2lesion +  
2
tissue
(5.1)
where µlesion and µtissue are the mean DW-MRI signal intensities, for a given b-value, for the
lesion and normal tissue ROIs respectively, and  lesion and  tissue are the corresponding ROI
standard deviations. The CNR was used by Bogner et al. (2009) (with b = {0, 50, 100, . . . 1250}
s/mm2 and homogenous breast parenchyma as the reference tissue) for the discrimination of
benign lesions, malignant lesions and cysts, and by Rahbar et al. (2011) (with b = 600s/mm2
and fibroglandular tissue as the reference tissue) for the characterisation of DCIS. In the latter
case it was noted that similar results could be obtained using b = 0s/mm2.
The second definition of CNR, used by Yuen et al. (2009) in the analysis of the impact of
contrast agents on ADC values, is:
CNR2 =
µlesion   µtissue
1
2(µlesion + µtissue)
(5.2)
Yuen et al. (2009) used b = {0, 1000}s/mm2 and fat as the reference tissue.
The third definition of CNR is (Wisner et al. 2013):
CNR3 =
µlesion
µtissue
(5.3)
(Wisner et al. 2013) calls this the lesion-to-background contrast feature and uses b = 800s/mm2
and fibroglandular tissue in the contralateral breast as the reference tissue.
5.1.3 Peri-tumoral ADC ratios
Yili et al. (2009) proposed the peri-tumoural ADC ratio, i.e. the ratio of the mean ADC in a ROI
to the adjacent tissue. This involved defining ROIs in a single sagittal plane with a diameter of
5mm, radially outwards from the lesion borders. In malignant lesions, a statistically significant
difference was found between ADC values in the following:
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Figure 5.2: Illustration of the impact that spatial co-registration of the DW-MRI data can have on
the estimation of ADC values. (a) Histogram of ADC values in the lesion ROI shown on the ADC
map computed from the DW-MRI data before spatial co-registration. (b) The histogram for the same
ROI obtained from the ADC map computed from the DW-MRI data after spatial co-registration.The
histogram is narrower and the image intensities inside the lesion are more homogenous. NOTE: The
ADC maps are scaled by 10 3mm2/s.
• The lesion ROI and each of the peri-tumoural tissue ROIs
• The innermost peri-tumoural tissue ROI and the second innermost peri-tumoural tissue
ROI
• The innermost peri-tumoural tissue ROI and normal contralateral breast tissue
5.2 New and variant features
This section describes several new features and variations on existing features developed by the
author. These are summarised in Table 5.3. The majority of these features stem from new
methods for determining representative ADC values within a VOI. The remaining are variants
of the contrast to noise ratio, and peri-tumoral ADC ratios. Each feature is described in detail
below using the notation introduced in Chapter 4. Unless otherwise stated, all features are
computed in 3D. Let fDW0(x), and fDWb(x) denote the diffusion-weighted stacks for b-value
zero and b respectively where x = (x1, x2, x3) is the voxel located at row x1 and column x2 in
slice x3. It is assumed that fDW0(x) and fDWb(x) are spatially co-registered to fT1(x), fT2(x),
and fDCEi(x). The impact that registration can have on the computation of ADC values is
illustrated in Figure 5.2.
5.2.1 Lesion representative ADC value
As discussed in Section 5.1.1, methods for computing a representative ADC value for a lesion are
highly varied with no consistent methodology. The variability stems from the method chosen
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Table 5.3: New and variant features derived from diffusion weighted images
Class of input
data
Feature
category
Feature
identifier
Feature name
DW-MRI Lesion ADC C1 Voxel-wise ADC mode
C2, C3, C4 10th percentile of ADC in
clusters
C5 Whole lesion mean ADC
C6, C7, C8 Mean ADC in cluster of
maximum initial mean
enhancement
C9, C10, C11 Mean ADC in cluster with
maximum mean value in
the b = 0 stack
C22 Minimum ADC by
generalised converging
squares
Other DW-MRI C12 Contrast to noise ratio of
the b = 0 stack
C13, C14, C15 Peri-tumoral ADC ratios
to select one or more ROIs within a lesion and the chosen ADC statistic (mean, maximum,. . . )
computed from these ROIs.
In this section several new or variant “representative ADC” features are presented. Each is
computed from one or more clusters of voxels within the VOI. In the case of C1 the cluster is
the VOI as a whole. In the case of features C2 C11 the clusters are determined using mean-
shift (see Algorithm 4.1 and Appendix B). Finally in the case of C22 the cluster is determined
using generalised converging squares (described in Section 5.3).
5.2.1.1 Mode of the ADC values in the VOI
The voxel-wise ADC values are computed as follows:
fADC(x) =  1
b
log
✓
fDWb(x)
fDW0(x)
◆
(5.4)
Feature C1 is the mode of the fADC values within the VOI after they have been suitably
quantised.
5.2.1.2 10th percentile of cluster ADC values
Features C2-C11 are representative ADC values computed from one or more clusters of voxels
within the VOI (these values are necessarily less sensitive to minor registration errors and
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noise than the voxel-wise ADC values). The same notation as in Equation 4.11 is used, and is
repeated below.
Let cluster Ci ✓ V denote the i-th cluster. The mean of the values in fDWb(x) within the
cluster is given by:
µCi,fDWb =
1
|Ci|
X
x2Ci
fDWb(x) (5.5)
The value µCi,fDW0 is similarly defined. The cluster ADC, ↵, for cluster Ci is computed as
follows:
↵Ci =  
1
b
log
 
µCi,fDWb
µCi,fDW0
!
(5.6)
Features C2-C4 and C6-C11 are obtained from clusters of voxels exhibiting similar enhance-
ment in DCE-MRI. The clusters are specifically obtained by defining a feature vector for each
voxel by concatenating its spatial coordinates and DCE-MRI values, and then applying mean-
shift clustering (see Appendix B for details). Let {Ci | i = 1, · · ·N} denote the set of clusters.
Through judicious choice of the range and spatial bandwidths it is possible to obtain a parti-
tioning of the VOI into small, medium, or large clusters. Refer to Algorithm 4.1 for details.
Features C2-C4 are derived as follows. For each cluster Ci, ↵Ci is computed. A multiset of
cluster ADC values is then constructed by taking the union of |Ci| repetitions of ↵Ci over all i.
Features C2-C4 are the 10th percentiles of the elements in this multiset for small, medium and
large clusters respectively.
5.2.1.3 Whole lesion representative ADC
Feature C5 is trivially ↵V ; i.e. the cluster ADC for the whole VOI.
5.2.1.4 Mean ADC in the cluster of maximum initial mean enhancement
Features C6-C8 generalise the idea of computing the mean ADC in a region of maximum
initial contrast enhancement (Yabuuchi et al. 2008). First the initial contrast enhancement is
computed for each cluster viz.:
 Ci =
µCi,fDCE1   µCi,fDCE0
µCi,fDCE0
(5.7)
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The cluster with the maximum initial contrast enhancement is Cimax , where
imax = argmax
i2{1,··· ,N}
 Ci . (5.8)
Features C6-C8 are identically µCimax ,fADC (see equation 5.5) for small, medium and large
clusters.
5.2.1.5 Mean ADC in cluster with maximum mean value in the b = 0 stack
Features C9-C11 are derived as follows. The cluster with the highest mean value in the fDW0
stack (Partridge, Demartini, Kurland, Eby, White & Lehman 2010) is Ckmax , where
kmax = argmax
k2{1,··· ,N}
µCk,fDW0 . (5.9)
Features C9-C11 are identically µCkmax ,fADC for the small, medium and large clusters.
5.2.1.6 Representative ADC by generalised converging squares
Feature C22 is the minimum ADC by generalised converging squares, as described in the
following section. The input to the algorithm is the fADC(x) stack, with the domain D equal
to the VOI V . The structuring elements used for the 3D erosions are shown in Figure 5.4. A
stopping criterion (minimum volume) of 2mm3 is used. To ensure that the algorithm converges
to an ROI of hypointensity the algorithm should either be applied to the negative of the ADC
map or argmax should be replaced with argmin in the algorithm.
Feature C22 is identically the mean of the ADC values in the region G generated by generalised
converging squares.
5.2.2 Other DW-MRI Features
5.2.2.1 Contrast to noise ratio
Feature C12 is the contrast to noise ratio (CNR) of the fDW0 stack defined as follows:
C12 = CNRfDW0 =
µCa,fDW0   µCb,fDW0q
 2Ca,fDW0
+  2Cb,fDW0
(5.10)
where Ca = V (i.e. the VOI), Cb = Bc \G (i.e. the non-fat voxels in the contralateral breast),
and sv2 is the variance. This feature is derived from the definition of CNR by Bogner et al.
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(2009) and Rahbar et al. (2011). The difference here is that the feature is computed with fDW0 ,
and an automatically segmented reference tissue.
This definition of contrast to noise ratio was selected from the three presented in Section 5.1.2
because it takes into account the spread of intensities in the lesion and tissue, rather than the
mean only.
5.2.2.2 Peri-tumoural ratio
Features C13-C15 are ratios of the mean ADC within the VOI to the mean ADC within a shell
around the VOI. They are variations on features proposed by Yili et al. (2009) for peri-tumoral
regions manually defined in a single sagittal plane. The ratios are computed using the following
equation:
LC1,C2 =
µC1,fADC
µC2,fADC
(5.11)
Feature C13 is LC1,C2 for C1 = V and C2 = S20   S5 (see Equation 4.6). Feature C14 is LC1,C2
for C1 = S5 and C2 = S20   S5. Feature C15 is LC1,C2 for C1 = S5 and C2 = Bc \G.
5.3 Generalised Converging Squares
For the task of finding the minimum ADC value (i.e. the most aggressive area) of the lesion,
a 3D minimum-seeking algorithm that is robust to noise is required. The converging squares
algorithm of O’Gorman & Sanderson (1984) appears, at first glance, to posses the desired
properties. It is a computationally efficient algorithm for locating peaks in sampled data of
two dimensions or higher. It is used to determine the region of greatest intensity within the
region of greatest density, rather than simply converging to the highest intensity in an image.
However, the algorithm is constrained to a square domain which limits its utility in certain
situations, such as when searching for a peak within elongated objects. Herein a generalisation
of the algorithm, called generalised converging squares (GCS), is presented. The generalisation
not only removes this restriction but also permits application to images defined on other than
Cartesian lattices.
In this section the original converging squares algorithm O’Gorman & Sanderson (1984) is
briefly reviewed and then a reformulation in terms of Mathematical Morphology is presen-
ted. Next this reformulation is generalised to arbitrary dimensions and to permit convergence
to other than a square domain. Finally it is shown that the generalised converging squares
algorithm can be applied to digital images arranged on a hexagonal lattice.
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5.3.1 The converging squares algorithm
Converging squares (CS) is an algorithm originally devised by O’Gorman & Sanderson (1984)
for finding the peak within a 2D intensity image. The peak is defined “not as the point of
maximum value, but as the point of maximum value within the region of maximum density”
(O’Gorman & Sanderson 1984). The algorithm takes as input a 2D intensity image defined on
a square domain. This domain is then used to define four square sub-domains. Each is defined
by stripping a pair of orthogonal sides from the original domain; i.e. the left column and top
row from the original domain, the left column and bottom row from the original domain, and
so on. The intensity sum is computed for each sub-domain and the sub-domain corresponding
to the maximum sum is then used as the input to the next iteration. The algorithm terminates
when it has converged to a square of an a priori specified size. The CS algorithm represents
an instance of a multi-resolution algorithm that performs processing at progressively higher
resolutions (O’Gorman et al. 2008).
The CS algorithm contains inherent low pass filtering because in each iteration the square sub-
domain with the maximum intensity sum, or equivalently with the highest mean, is selected for
input to the next iteration. Consequently the algorithm is robust to many types of noise and
in particular additive noise. It can also be implemented in an efficient manner because at each
iteration the four sub-domains have a high degree of overlap. Moreover only integer arithmetic
is required because each sub-domain contains the same number of pixels and so it suffices to
compute the sum for each rather than the mean. The resulting peak is unambiguous, and the
algorithm can easily be extended to higher dimensions.
The algorithm does however impose an arbitrary geometry, i.e. a square domain of convergence,
and because it is based on stripping rows and columns it can converge in a “consistent, but
undesirable” manner (O’Gorman & Sanderson 1984) as illustrated in Figure 5.3.
5.3.2 Reformulation using Mathematical Morphology
The process of stripping rows and columns in the original CS algorithm can be equivalently,
and more formally, defined in terms of erosions by appropriately defined structuring elements.
The erosion of a binary image X ✓ Zn by a structuring element B ✓ Zn is defined as Soille
(2003):
X  B = {x | Bx ✓ X} (5.12)
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Figure 5.3: Illustration of the undesirable converging behaviour of the traditional converging
squares algorithm. Zero valued pixels are denoted by •. The colours correspond to iterations of
the algorithm, and are displayed using red, green, and blue (repeated until convergence). The green
region shows the final iteration. The algorithm incorrectly converges to the top structure, even
though the bottom structure is larger and has a higher maximum intensity.
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where Bx = {x+ b | b 2 B}. If D represents the input domain in an iteration of the traditional
CS algorithm, then the four sub-domains are given by D  B1, D  B2, D  B3, and D  B4
where
B1 =
264 1 0 00 1 0
0 0 0
375 , B2 =
264 0 0 10 1 0
0 0 0
375
B3 =
264 0 0 00 1 0
1 0 0
375 , B4 =
264 0 0 00 1 0
0 0 1
375
(5.13)
with the origin at centre. The CS algorithm can thus be formally written as shown in Al-
gorithm 5.1. The computation at step 3 can be implemented very efficiently bearing in mind
the significant number of pixels the four sub-domains have in common.
Algorithm 5.1 Reformulation of the original converging squares algorithm using Mathematical
Morphology.
Require:
• Greyscale image f : D ! G where D ✓ Z2 is square,
• size k 2 Z+ of the square to converge to,
• B1, B2, B3, B4
1: while |D| > k2 do
2: ⌦ = {D  Bi | i = 1, . . . , 4}
3: D = argmaxX2⌦
X
x2X
f(x)
4: end while
5.3.2.1 Extension to higher dimensions
The reformulation of the CS algorithm can easily be extended to higher dimensions. For
example, to implement converging cubes in three dimensions it suffices to define eight unit
vector structuring elements of the form shown in Figure 5.4.
5.3.3 The generalised converging squares algorithm
By design and definition the CS algorithm takes as input a square image and in each iteration
outputs a smaller square image until an a priori specified minimum size is met. This behaviour
is not always desirable; e.g. when the image contains elongated objects, as shown in Figure 5.3.
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Figure 5.4: One of eight three dimensional structuring elements needed to define converging cubes.
However, the reformulation of the CS algorithm shown in Algorithm 5.1 can be modified in a
straightforward manner to remove this restriction on domain shape. Firstly, it is necessary to
divide the summation in step 3 by |X| because we are no longer guaranteed that the cardinality
of each erosion will be the same. Secondly, and for the same reason, it makes sense to exclude
from the summation the elements in common to the set of erosions. Finally, the stopping
criterion needs to be appropriately defined. Some possibilities include stopping when |D| meets
some pre-specified size, or stopping whenD Bi = Ø for some i. The behaviour of the algorithm
can be further modulated by the choice of structuring elements used. Collectively these changes
give rise to the generalised converging squares (GCS) algorithm shown in Algorithm 5.2.
Algorithm 5.2 The generalised converging squares algorithm
Require:
• Greyscale image f : D ! G where D ✓ Zn ,
• stopping criterion,
• set of structuring elements {Bi ✓ Zn | i = 1, . . . , k}
1: while stopping criterion is not satisfied do
2: C =
k\
i=1
D  Bi
3: ⌦ = {(D  Bi) \ C | i = 1, . . . , k}
4: D = argmaxX2⌦
1
|X|
 X
x2X
f(x)
!
5: end while
Figure 5.5 illustrates the improved behaviour of the GCS algorithm over the CS algorithm for
elongated objects.
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Figure 5.5: Improved behaviour of the GCS algorithm for elongated objects. Pixels that were
excluded from the initial search domain are shaded grey. The colours correspond to iterations of
the algorithm, and are displayed using red, green, and blue (repeated until convergence). The blue
region shows the final iteration. Note that the benefits of this algorithm result from prior knowledge
of ROIs within the image.
The traditional CS algorithm is guaranteed to converge to a single peak. Similarly the GCS
is guaranteed to converge to a single set D. However it is possible for this set to comprise
disjoint connected components; i.e. the algorithm can effectively converge to more than one
peak simultaneously. If this behaviour is not desirable then one possibility is to exclude from
the set ⌦ in step 3 all those erosions D  Bi that generate multiple connected components.
5.3.3.1
5.4 Summary and conclusion
This chapter focussed on features derived from diffusion-weighted MRI data. In particular it
reviewed existing state-of-the-art features and signs, and proffered several new qualitative fea-
tures. These features describe representative ADC values, DW-MRI contrast-to-noise ratio, and
5.4 Summary and conclusion 118
peri-tumoural ADC ratios. This chapter also presented a novel generalisation of the converging
squares algorithm using Mathematical Morphology. This permits the use of the algorithm in
arbitrary dimensions and to allows convergence to other than a square domain. Generalised
converging squares is applied to the problem of extracting a representative ADC value. An
evaluation of the efficacy and performance of these features is the subject of Chapter 7.
Chapter6
Automated bilateral analysis of the
cross-sectional diameter of the internal
mammary vessels
In a recent study Schipper et al. (2013) found that the vascular cross-sectional area of the
internal mammary vessels is significantly larger on the side with breast cancer compared to the
contralateral side. This chapter investigates the veracity of this finding. To this end the chapter
presents (i) a method for automating the manual approach taken by Schipper et al. for the
detection and measurement of the internal mammary vessels; and (ii) an empirical evaluation,
using the proposed method, of the finding of Schipper et al. based on routine clinical breast
MRI data.
The remainder of this chapter is organised as follows. The next section reviews the study of
Schipper et al. (2013). Section 6.2 then proffers a new method for the automatic detection and
measurement of the internal mammary vessels. Section 6.3 presents an empirical evaluation
of the new method on clinical MRI data. Section 6.4 presents an empirical evaluation of the
findings of Schipper et al., the results of which are presented in Section 6.5. Finally Section 6.6
presents a summary of the chapter.
6.1 Review of the study of Schipper et al.
The internal mammary vessels—also known as internal thoracic vessels—comprise four vessels:
a pair comprising a vein (IMV) and artery (IMA) either side of the sternum. The internal
mammary artery perfuses approximately 67% of the breast (Doughty et al. 1996). Schipper
et al. investigated whether in patients with a confirmed breast cancer on one side, the sizes of the
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vessel pair on the ipsilateral side are larger than their corresponding vessels on the contralateral
side. The study was performed using breast MRI data from 135 subjects, including 44 subjects
with malignancies and 91 control subjects.
The data comprised axial T2-weighted Turbo Spin Echo images with voxel size 0.96 ⇥ 0.96 ⇥
1mm3. Two independent readers manually detected and measured these vessels in the T2w
images. Vessels and ribs were observed on coronal reconstructions, and vessel cross-sectional
area (CSA) was measured in the axial plane. Vessel CSAs were measured in the second and
third intercostal space (before most vessel branching occurs). Inter-observer agreement was
computed using the intraclass correlation coefficient, with results indicating a high degree of
reproducibility (unweighted Cohen’s kappa values of 0.716 for the left breast and 0.728 for the
right breast). Linear mixed model analysis was performed to investigate differences between left
and right vessel diameters, accounting for possible correlation between the diameter and ana-
tomical variation, age, breast volume and breast density (measured on digital mammograms).
Results indicated a statistically significant enlargement of the IMA on the ipsilateral side in
the malignant group (p = 0.000   0.007, depending on reader and location of measurement),
but did not indicate significant difference between left and right IMA CSA in the control group
(p = 0.058  0.340).
This is contrary to the findings of Feng (1997), who reported significantly larger IMA and IMV
diameters on the right side compared to the left in patients undergoing breast reconstruction.
In this work, external diameters of IMA and IMVs were measured by means of a calliper at the
third costal cartilage. In 19 patients undergoing bilateral reconstructions, the right IMA was
significantly larger than the left IMA (p = 0.046), and the right IMV was significantly larger
than the left IMV (p = 0.002). A more recent study (Chang et al. 2013) of over 1300 subjects
found no significant difference in the left and right IMA diameters (2.44mm and 2.47mm
respectively, no p value given), but the left IMV is significantly smaller than the right IMV
(2.47mm versus 2.93mm, p = 0.038).
Schipper et al. (2013) acknowledge that their study results may be biased because of the manner
in which they visualised the tumour. Ideally, tracing of the IMA and IMV should be performed
without knowledge of the location of any lesions to avoid bias in the measurement. Schipper
et al. performed tracing on T2-weighted images, in which it is difficult to detect lesions, in order
to mitigate this bias. Nevertheless, a possible source of bias may be observer bias because human
readers were used in the study rather than automated quantitative imaging. The veracity of
the result of Schipper et al. thus remains an open question.
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6.2 Proposed method for the automatic detection and meas-
urement of the internal mammary vessels
Herein we propose a fully automatic method for segmenting and measuring the sizes of the
mammary vessels in dynamic contrast-enhanced MRI of the breast. The rationale for this is
to eliminate the biases associated with manual interpretation described above. The proposed
method comprises four steps:
1. The vessels are detected in the stack formed by the voxel-wise mean of all post-contrast
stacks minus the pre-contrast stack.
2. The internal mammary vessels are labelled as the IMA or IMV.
3. The ribs are detected using the pre-contrast image stack in order to determine which
slices should be used for IMA and IMV measurement.
4. The diameters of the IMA and IMV pair on each side are computed.
These steps are described in more detail below.
6.2.1 Step 1: Vessel detection
A volume of interest (VOI) that contains the internal mammary vessels is first defined as shown
in Figure 6.1. In each slice, its axial extent is defined to be 7 mm anterior and 35 mm posterior
to the interface between the pectoral muscle and the breast tissue. This contour is determined
using the method described by Hayton et al. (1997). All subsequent processing is performed
individually for the left and right sides, splitting the volume about the mid-sagittal plane.
A subtraction stack is defined using the same notation as in Section 3.4.2.
m(x) =
1
t2   t1
⌧2X
j=⌧1+1
fj(x)  ft1(x) (6.1)
where t1 denotes the first stack (pre-contrast) and t2 denotes the final stack in the dynamic
series.
The Frangi vesselness filter (Frangi & Niessen 1998), described in Chapter 3 Equation 3.7, is
applied to the 3D subtraction stack, as shown in Figure 6.2, yielding F(x).
Dijkstra’s algorithm (Dijkstra 1959) is applied to the vesselness volume in 3D to find the
minimum-cost path in the superior-inferior direction. This involves representing each voxel as
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Figure 6.1: A single axial slice from the first post-contrast volume, for one of the subjects in the
study. The internal mammary vessels can be clearly seen (indicated with arrows). The search space
described in Step 1 is also displayed.
a vertex, with edges between voxels in a 26-connected neighbourhood. The starting points are
the axial plane corresponding to the inferior edge of the field of view. The ending points are
the axial plane corresponding to the superior edge of the field of view.
The cost associated with each edge {x1,x2} is equal to e-↵F(x2) · d(x1,x2) where d(x1,x2) is
the Euclidean distance between vertices (in mm) and ↵ is a free parameter. Therefore, the
minimum-cost path is found by maximising F while penalising indirect paths between the start
and end planes. It is denoted S1 ⇢ Z3.
The second vessel on each side is found by repeating the above procedure using F2(x) in place
of F(x) as follows:
F2(x) =
8<:0 x 2 S1   BF(x) otherwise (6.2)
where   represents dilation, and B is a sphere of 6mm diameter (typically internal mammary
vessels are smaller than 6mm in diameter (Feng 1997)). The second path is denoted S2 ⇢ Z3.
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(a) Maximum intensity projection (MIP) in the coronal plane of the mean post-contrast stack minus
the pre-contrast (restricted to the VOI).
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(b) MIP of the vesselness volume in the corresponding VOI.
Figure 6.2: Coronal MIPs of subtraction stacks before and after vesselness filtering.
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Figure 6.3: The different DCE-MRI enhancement patterns for the IMA and IMV. The IMA typ-
ically exhibits faster initial enhancement, followed by washout. The IMV typically exhibits slower
initial enhancement followed by persistent enhancement.
6.2.2 Step 2: Vein and artery labelling
Anatomical variation from individual to individual means that it is not possible to differentiate
which vessel is the IMA and which the IMV on the basis of spatial location alone; sometimes
the IMV is closer to the sternum than the IMA and vice versa. However, we observed that the
two vessels demonstrate significantly different contrast enhancement patterns (see Figure 6.3).
In the case of the IMA there is an initial sharp increase in contrast enhancement, followed by
washout. In the case of the IMV the initial rate of enhancement is slower, and this is followed
by persistent enhancement. Using the notation of Equation 4.11, contrast enhancement for
vessel (path) Si found in Step 1 is computed as follows:
ESi(j) = µSi,fDCEj   µSi,fDCE1 . (6.3)
Time-to-peak is defined as ti = argmaxj ESi(j). The vessel with the lower time-to-peak (i.e.
with the faster initial enhancement) is labelled as the IMA, and the vessel with the higher
time-to-peak (slower initial enhancement) is labelled as the IMV. This is similar to the vessel
labelling approach of Yuan et al. (2013).
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Figure 6.4: Overview of the bony thorax. Figure reproduced from Christchurch Osteopathy, UK
(http://www.christchurchosteopathy.co.uk/019.html)
6.2.3 Step 3: Rib detection
Schipper et al. (2013), based on the recommendation of Tuinder et al. (2012), measured the
sizes of the internal mammary vessels in the second intercostal space (ICS) because, if branching
occurs, it is after the second intercostal space. The intercostal spaces are numbered based on
the rib superior to the space, meaning that the second intercostal space is between the second
and third ribs, shown in Figure 6.4.
The ribs are bones and thus appear hypointense in T1w and T2w MR images. However the
costal cartilage appears bright in the pre-contrast T1-weighted images as shown in Figure 6.5.
Detection of the costal cartilage is achieved as follows. First a coronal MIP (anterior-posterior,
restricted to the domain of the VOI) of the pre-contrast stack is computed. A coronal MIP of the
vessel path, Si, is also computed, and denoted Sci ⇢ Z2. This notation should not be confused
with the set complement. Next the mean intensity of the pre-contrast MIP is computed in a
m⇥ n (equivalent to the axial slice ⇥ column dimensions) window around each element of Sci .
An example of this is shown in Figure 6.6. High intensity corresponds to locations in which the
vessel is behind costal cartilage, and low intensity corresponds to locations in which the vessel
is behind the intercostal space.
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Figure 6.5: Coronal MIP (anterior-posterior) of the pre-contrast volume restricted to the domain
of the VOI (shown in Figure 6.1).
The pre-contrast intensity function is median filtered using a window of length of 10mm (the
approximate width of a rib). Empirically it was determined that the second intercostal space
is positioned approximately 40mm from the superior edge of the field of view (i.e. the first slice
of the axial image stack). Hence, the local minimum of pre-contrast intensities that is closest
to this position is deemed to be the second intercostal space.
6.2.4 Step 4: Vessel diameter computation
For the slice corresponding to the middle of the second intercostal space and for 5mm superior
and inferior, the diameter of each for the four vessels is computed in turn. Each slice is
resampled to a polar grid using cubic spline interpolation, with the origin at the centre of the
vessel. The derivative (first order finite difference) of this resampled image is computed in the
radial dimension and normalised to z-scores. Dijkstra’s algorithm, as described in Step 1, is
used to determine the contour. The difference here is that the algorithm is performed in 2D,
with 8-connectivity. The cost of each vertex, and the resulting contour, are shown in Figure
6.7.
The area, A, of each vessel in each slice is computed by integrating the contour in polar
coordinates. The diameter is computed by assuming each vessel is circular, such that d = 2
q
A
⇡ .
The median diameter over the slices of interest is returned for each vessel.
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Figure 6.6: Pre-contrast intensity of intercostal cartilage versus distance from the superior edge of
the field of view (first superior axial slice). Note that the x-axis corresponds to rows in Figure 6.5.
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Figure 6.7: The cost function of the vesselness image in polar co-ordinates for the larger of the two
vessels (vein) shown to the right.
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6.3 Empirical evaluation of the algorithm
6.3.1 Breast MRI data
The MRI data used in this experiment were sourced from routine clinical breast MRI examin-
ations of 145 women performed by Queensland X-Ray. The examinations included screening
cases (high risk category), problem-solving cases, and cases that had previous surgery. The
examinations were performed using a 1.5T GE Signa HDxt scanner using an eight-channel
breast coil with the patient lying in the prone position. They were selected because in each
case the reporting radiologist identified at least one suspiciously enhancing lesion whose status
was subsequently verified by cyto- or histopathology. The images were acquired as three to
four stacks of T1-weighted images, with fat suppression, using a 3D FSPGR sequence (TE =
3.4ms, TR = 6.5ms and flip angle of 10 ). Images were acquired axially with a field of view
of 32cm, a 360 ⇥ 360 acquisition matrix, and slice thickness of 1mm. Subjects with bilateral
lesions were excluded from this study. The reason for this is that the evaluation considers only
subjects with unilateral lesions. The data from subjects with bilateral lesions were used for
algorithm training, as described below.
6.3.2 Implementation, and tuning of algorithm parameters
Values for the algorithm parameters were selected based on data from 15 subjects (additional
to those described above) with bilateral breast lesions. In summary:
• In step 1, the range of Frangi vesselness filter scales J = [1, 2] voxels and ↵ = 10.
• In step 3, (m,n) = (5, 5).
• In step 4, the image was resampled with 10 samples per pixel at 1  intervals.1
Given the low temporal resolution of the experimental data, in step 2 many curves exhibited
the same time-to-peak. In these cases, the curve with the greater contrast enhancement at the
first post-contrast time point was labelled as the artery.
6.3.3 Segmentation evaluation
The segmentation algorithm was applied to each DCE-MRI stack in turn. Performance was
evaluated visually, with the author verifying vessel segmentation using coronal maximum in-
tensity projections.
1 These parameters influence the circularity of the contour
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6.3.4 Results
In 86 of the 145 subjects, all vessels were accurately detected and measured. In the remaining
59 cases, one or more of the four vessels were not accurately segmented. The most common
reasons for the failure of the algorithm were:
1. The spatial resolution of the image not being sufficient to separate vessels and arteries
running closely parallel to each other;
2. The presence of bifurcations prior to the third rib; and
3. The presence of small, shallowly enhancing vessels that were not detected by the vesselness
filter.
6.4 Empirical evaluation of the findings of Schipper et al.
Two experiments were performed to investigate the veracity of the findings of Schipper et al.
(2013) In the first, vessel diameters from a malignant and control set are compared. In the
second, regression analysis is performed to determine which factors (age, breast density, etc)
influence IMA and IMV diameter.
6.4.1 Breast MRI data
The data described in Section 6.3.1 was again used for this evaluation. The data was divided
into two sets. The first set, hereinafter called the malignant set, comprises subjects with a
breast cancer in the left breast only or the right breast only. The second set, hereinafter called
the control set, comprises subjects with a benign lesion in the left breast only or the right
breast only. In contrast the control set of Schipper et al. (2013) contained only cases with no
abnormalities in either breast. Such data was not available for our evaluation. The assumption
in our evaluation is that benign lesions do not significantly affect the internal mammary vessel
diameters, or at least not to the same extent as malignant lesions.
The data comprised 33 subjects with benign lesions and 53 subjects with malignant lesions.
Thirty-eight of these were on the left side, and the remaining 48 of these were on the right side.
6.4.2 Experiment 1: Analysis of malignant and control data
The aim of this experiment was to determine whether the diameters of the internal mammary
vessels are larger on the side with breast cancer compared to the contralateral side. Given that
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in healthy subjects the internal mammary vessels are typically larger on the right side than the
left (Feng 1997, Chang et al. 2013), left side and right side breast cancers were investigated
separately.
Vessel diameter ratios (VDRs) were used to compare left and right diameters in the malignant
set and the control set. The IMA VDR for subjects with a lesion in the left breast is defined
as follows:
V DRIMA, left lesion =
dleft IMA
dright IMA
(6.4)
where dleft IMA and dright IMA are the diameters of the left and right IMAs respectively.
Similarly, the IMA VDR for subjects with a lesion in the right breast is defined as follows:
V DRIMA, right lesion =
dright IMA
dleft IMA
(6.5)
IMV VDRs are similarly defined. For each of the ratio computed, a Mann Whitney U test,
four in total, was performed. The null hypothesis was that the median VDR for the malignant
set is equal to the median VDR for the control set versus the alternative hypothesis that the
median for the malignant set is greater. The level of significance was chosen to be ↵ = 5%.
6.4.3 Experiment 2: Regression and feature importance
Random forest regression (Liaw & Wiener 2002) was used to determine which features can be
used to predict internal mammary vessel diameters. The included features are described in
Table 6.1. For each subject, each of the four vessels was treated as a sample in the random
forest model. The random forest was constructed with 8000 trees, and the parameter mtry = 4.
Variable importance is measured by the increase in mean squared error (MSE) when each
variable is randomly permuted. Larger values of increase in MSE indicate that the variable is
more important.
6.5 Results
6.5.1 Diameter evaluation
6.5.1.1 Experiment 1: Analysis of malignant and control data
The mean diameters for the left and right internal mammary vessels, as reported in the literature
and determined by the method described above, are reported in Table 6.2. The malignant class
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Table 6.1: List of features evaluated for the prediction of internal mammary vessel diameter
Feature Variable details
Vessel side Categorical (“Left” or “Right”)
Artery or vein Categorical (“Artery” or “Vein”)
Breast volume mm3
Breast density As a percentage of breast volume, described in
Section 4.5
Age years
Weight kg
Lesion volume mm3
Lesion class Categorical (“Benign” or “Malignant”)
Lesion side Categorical (“Left” or “Right”)
Table 6.2: Results of experiment 1. Diameters are reported in mm (mean ± standard deviation).
Vessel Lesion
side
Diameter reported by
Feng (1997)
Mean malignant
diameter
Mean control
diameter
IMA Right 2.52± 0.51 2.48± 0.88 2.67± 1.14
IMA Left 2.30± 0.55 2.19± 0.50 2.18± 0.49
IMV Right 2.89± 0.56 3.09± 0.99 3.42± 1.13
IMV Left 2.31± 0.48 2.33± 0.52 2.18± 0.44
diameter is not significantly larger than the control class diameter in any of the four vessels.
Indeed, for both vessels on the right side, the mean of the control class diameter is larger than
that of the malignant class. It is important to note, however, that the standard deviation of
the diameters in both cases is large relative to the mean.
The median VDRs for the left and right IMA and IMV are reported in Table 6.3. This is
also shown graphically in Figure 6.8. P -values for all four tests are greater than 5%. Thus,
we cannot reject the null hypothesis that the median VDR in the control set is equal to the
median VDR in the malignant set in each vessel/side combination.
6.5.1.2 Experiment 2: Regression and feature importance
Figure 6.9 displays the percentage increase in MSE for the features in Table 6.1. Of these,
the artery/vein and vessel side features have a very high increase in MSE. Of the remaining
Table 6.3: Results of experiment 1. Median and inter-quartile range VDRs are reported.
Vessel Lesion side Median malignant VDR Median control VDR P -value
IMA Right 1.10± 0.33 1.02± 0.24 0.28
IMA Left 0.96± 0.19 0.94± 0.32 0.50
IMV Right 1.66± 0.87 1.36± 0.80 0.63
IMV Left 0.65± 0.52 0.74± 0.42 0.81
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Figure 6.8: Results of experiment 1. Box plots of VDR for the IMA and IMV
0.5 1 1.5 2 2.5
IMA Right Malignant
IMA Right Benign
IMA Left Malignant
IMA Left Benign
IMV Right Malignant
IMV Right Benign
IMV Left Malignant
IMV Left Benign
features, only breast volume yielded a mean increase in model accuracy. All other features
yielded a mean decrease in model accuracy. We can therefore conclude that these features are
not useful in the prediction of internal mammary vessel diameters.
6.6 Discussion and conclusion
In this chapter, a fully automatic method for the segmentation of internal mammary vessels
was presented and evaluated. The method was used to investigate the veracity of the recent
findings of Schipper et al. (2013) that the vascular cross-sectional area of the internal mammary
vessels is significantly larger on the side with breast cancer compared to the contralateral side.
The segmentation algorithm was tested on 145 subjects, and vessel diameters were analysed on
86 of these. The results indicate that typically the internal mammary vessel is larger than the
internal mammary artery, and that vessels on the right are larger than those on the left. They
also indicate that subject age and weight do not influence vessel diameter. Most importantly,
however, the results do not indicate any relationship between vessel diameter and variables
relating to lesion malignancy or size.
Several limitations of this study must be acknowledged. Firstly, the segmentation algorithm has
a success rate (i.e. detection of all four vessels) of only 59%. This is primarily due to variation in
patient anatomy, particularly the presence of bifurcations before the second intercostal space.
Poor image quality was an issue in some cases, particularly when detecting small vessels in
the presence of noise. It is possible that the measurements provided in this study are biased
towards larger vessels, because some small vessels were not able to be detected.
6.6 Discussion and conclusion 133
Breast density
Lesion volume
Age
Lesion side
Weight
Lesion class
Breast volume
Vessel side
Artery or vein
0 50 100
Percent increase in mean squared error
Figure 6.9: Increase in MSE in the random forest regression model
Secondly, the absence of a true “control” group is a limitation. Subjects with benign lesions
were used as a control set in lieu of a set of subjects without any abnormality.
Thirdly, the method for labelling veins and arteries relies on a simple heuristic (DCE-MRI
time-to-peak). A more robust approach, used by Schipper et al. (2013), is to trace vessels back
to their origins. However, this would not always be possible because of the limited field of view
in the DCE-MRI data set. Additionally, it would require segmentation of structures within the
chest, which would add another layer of complexity to the method.
In conclusion, we have presented a method for segmenting and measuring internal mammary
vessels without observer bias. Results do not indicate that vessels are larger in the presence of
malignant lesions, but are primarily predicted by the side (left/right) and type (vein/artery) of
the blood vessel. These results are in contrast to those of Schipper et al. (2013), who found that
vessels are larger in the presence of malignant lesions. Further research is needed to determine
exactly which circumstances result in enlarged internal mammary vessels.
Chapter7
Empirical evaluation of the proposed features
In the previous two chapters several new multi-modal quantitative features for breast MRI CAD
were presented. In this chapter an empirical evaluation, based on clinical breast MRI data from
107 subjects, of the efficacy of these features and state-of-the-art features for discriminating
benign and malignant lesions is presented. This includes separate experiments for features
extracted from both manually segmented (delineated) and automatically segmented lesions, as
well as mass-like and non-mass-like lesions, and for different combinations of MRI modalities1.
The experiments are grouped into two studies. In the first study, three classification approaches
are used to determine the generalisation performance and most important features. Namely,
these approaches are (i) a logistic regression classifier with cross validation (LRCV), (ii) a
random forest classifier with cross validation (RFCV), and (iii) a random forest classifier with
out-of-bag performance (RFOOB). In the second study the discriminatory power of each class
(i.e. T1w, T2w, DCE-MRI, and DW-MRI) of input data is investigated. In this study, only
automatically segmented mass-like lesions are considered, and are evaluated using the RFOOB
approach.
The material in this chapter, and chapters 4 and 5, form the basis of a paper submitted by
the author to the Journal of Medical Imaging on 6/5/2014. The remainder of the chapter is
organised as follows. Section 7.1 describes the clinical data used in these studies. Section 7.2
describes how this data was pre-processed including lesion segmentation, spatial co-registration,
and bias field correction. In section 7.5, the methodology of Studies 1 and 2 are presented. The
results of these studies are presented and discussed in turn. Finally, the chapter is concluded
with a comparison of these results to those of related studies in the literature.
1 To the author’s knowledge this is the first time that evaluate the efficacy of the fusion of features derived
from T1w, T2w, DW, and DCE-MRI modalities.
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7.1 Breast MR data
The MRI data used in this study were sourced from routine clinical breast MRI examinations of
107 women performed by Queensland X-Ray. The examinations included screening cases (high
risk category), problem-solving cases, and cases that had previous surgery. The examinations
were performed using a 1.5T GE Signa HDxt scanner using an eight-channel breast coil with
the patient lying in the prone position. They were selected because in each case the reporting
radiologist identified at least one suspiciously enhancing lesion (BI-RADS 2+, see Appendix A)
whose status was subsequently verified by cyto- or histopathology. Each lesion was individually
biopsied under either MRI or ultrasound guidance. The T1w anatomical, T2w anatomical,
diffusion-weighted and the DCE-MRI data from each examination were used in this study.
Approval from the Human Ethics Unit at the University of Queensland was obtained for this
study.
The imaging protocol was as follows. The T1w anatomical images were acquired axially, without
fat suppression, using a two-dimensional (2D) tailored radio frequency sequence (TE = 8ms, TR
= 480ms and flip angle of 90 ). The acquisition matrix was 512 ⇥ 512. The T2w anatomical
images were acquired axially, with fat suppression, using a 2D short tau inversion recovery
sequence (TE = 46ms, TR = 6600ms and flip angle of 90 ). The acquisition matrix was
320⇥ 224. In both cases the field of view was 32cm and the slice thickness was 4mm.
The DW-MRI data comprises two stacks of fat-suppressed diffusion weighted images, one with
a b-value of zero and the other with a b-value between 500 and 1000 (typically 600) s/mm2 ).
The images were acquired axially using an echo planar imaging sequence (typically TR = 10s,
TE = 75ms, flip angle of 90 ). The acquisition matrix was typically 256 ⇥ 192. The field of
view was 32mm, with a typical slice thickness of 5mm.
The DCE-MRI images were acquired as five stacks of T1w images, with fat suppression, using
a 3-dimensional (3D) fast spoiled gradient-echo (FSPGR) sequence (TE = 3.4ms, TR = 6.5ms
and flip angle of 10°). The first stack contains baseline pre-contrast images and the remaining
stacks correspond to post-contrast images acquired after injection of Gadopentate dimeglumine,
0.2mmol/kg, administered at a rate of about 2ml/s using a pressure injector. Each stack was
acquired in around 90 seconds with a 45 second delay between the pre-contrast and the first
post-contrast stack. All of the stacks, except the second last stack, were acquired axially with a
field of view of 32cm, a 360⇥360 acquisition matrix, and a slice thickness of 1mm. The number
of slices ranged from 116 to 182 with a median of 150. The second last stack was discarded
because it was acquired in a sagittal orientation with a different field of view to the axial stacks
(see Figure 7.1).
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Figure 7.1: Timing diagram for the DCE-MRI scan. The times ⌧0, ⌧1, . . . ⌧4 are derived from the
Content Time tag (0008,0033) in the DICOM file for the first image in each stack respectively minus
that from the pre-contrast stack. From these values it is possible to compute the time ⌧a taken to
acquire a single axial stack, and ⌧s to acquire the sagittal stack. The time since injection of contast
agent for each stack reflects the time at which the centre of k-space is acquired.
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Table 7.1: Lesion Pathology
Pathology Mass-like Non-mass-
like
Total
Benign
Fibrocystic change 4 5 9
Fibroadenoma 9 0 9
Other 11 18 29
Total benign 24 23 47
Malignant
Ductal carcinoma in situ 14 11 25
Invasive ductal carcinoma 20 4 24
Invasive lobular carcinoma 3 2 5
Other 16 4 20
Total malignant 53 21 74
In total, the 107 examinations contain 121 lesions, of which 74 are malignant and 47 are benign
(see Table 7.1).
7.2 Lesion segmentation and data pre-processing
7.2.1 Lesion segmentation
Each lesion was segmented in 3D both manually and automatically. The manual segmentation
was performed by a radiographer with more than 12 years experience in breast MRI, guided
by the findings of the original reporting radiologist. This was performed on a subtraction
volume (first post-contrast stack minus the pre-contrast stack from the DCE-MRI scan) using
the region-growing tool in Osirix (http://www.osirix-viewer.com). In difficult cases, where
region-growing yielded an oversegmentation (for example by including surrounding enhancing
tissue or blood vessels), the lesion was viewed using a 3D maximum intensity projection and the
3D region-growing mask was cropped using the freehand scissor tool. A morphological closing
by a 3×3×3 cube was then performed on each 3D connected component to fill small holes.
The resulting 3D volumes-of-interest (VOIs) were taken to be the segmentation ground truth.
For each lesion, the radiographer also noted whether or not it is mass-like, as defined by the
American College of Radiology BI-RADS lexicon (American College of Radiology 2008).
The automatic segmentation was performed using the algorithm presented in Section 3.4. The
method identifies several candidate VOIs. Only the VOIs coinciding with the manual VOIs
were retained.
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Figure 7.2: Bias field correction. (a) A representative axial slice of the T1w stack showing con-
siderable bias field effects. (b) The bias field, as computed by the N4 algorithm. Here, a value of
1 indicates that there is no scaling from the bias field. (c) The same slice as in (a), with bias field
correction (i.e. (a) divided by (b)).
7.2.2 Registration and bias field correction
For each examination the data were spatially co-registered and bias field correction performed
in 3D as follows (refer to Section 4.3.1 for a description of the notation). The fT1, fT2, fDW0 ,
and fDCEi stacks were spatially co-registered to the fDCE1 stack using the fast non-rigid B-spline
registration module in 3D Slicer Version 4.2.0 (Fedorov & Beichel 2012) (which uses mutual
information as the similarity metric). The registration parameters were as follows: spatial
samples = 70,000; grid size = 5; and number of iterations = 20. Given that fDWb is attenuated
with respect to fDW0 , the deformation field obtained for the fDW0 stack was applied to the fDWb
stack (together with rigid registration of the fDWb stack to the fDW0 stack using normalised cross
correlation) in order to achieve co-registration with the first post-contrast stack of the DCE-
MRI data. The registration was validated by manual inspection of lesions in three orthogonal
planes. Where the registration failed, it was repeated with different input parameters until it
succeeded. This generally involved increasing the grid size, or manually translating the input
images such that they were closer to the solution.
Bias field correction was applied to the fT1 anatomical stack, using the N4 algorithm (Tustison
et al. 2010) with a 4th order B-spline. An example is shown in Figure 7.2.
7.2.3 Segmentation of the ipsilateral and contralateral breast volumes
Hayton’s algorithm (Hayton et al. 1997) was applied slice-wise to the T1w anatomical images,
as described in Section 3.5.2, to obtain a 3D mask B ⇢ Z3 of both breasts. This mask was
partitioned about the mid-sagittal plane to define an ipsilateral breast mask Bi (containing the
lesion), and a contralateral breast mask Bc.
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Table 7.2: State-of-the-art DCE-MRI features
Feature
category
Feature identifier Feature description
Morphometric D75, . . . , D79 Eccentricity, Solidity, Irregularity, Mean fractal
dimension, Entropy of mean fractal dimension (Gal
et al. 2011)
D80 Lesion volume (in mm3) (Gibbs & Turnbull 2003)
D81, D82 Radial length ratio, radial length entropy (Sinha
et al. 1997)
D83 Projected variance (Srikantha et al. 2013)
D84, D85 Number and volume of holes in VOI (Mayer et al.
2006)
Other
DCE-MRI
D86, D87 Variance of uptake and change in variance of
uptake (Gilhuijs et al. 1998)
D88, D89 Radial gradient index (early and maximum)
(Gilhuijs et al. 1998)
D90, D91 Peripheral uptake (Agliozzo et al. 2012)
D92, . . . , D100 Spatio-temporal features:
Mean(MeanTr)
Std(MeanTr)
Entropy(MeanTr)
. . .
Entropy(RangeTr) (Agliozzo et al. 2012)
D101, . . . , D103 Margin gradient (maximum, early and variance)
(Gilhuijs et al. 1998)
D104, D105 Spatio-temporal features: MI entropy, gradient
correlation in MI (Gal et al. 2011)
D106 Pre-contrast gradient correlation (Gal et al. 2011)
7.3 Included state-of-the-art features
Existing state-of-the art features included in the evaluation are described in Table 7.2 and 7.3.
These features were selected because they are representative of feature categories, or have been
shown to be useful in prior studies. The features derived from diffusion-weighted images are
statistics of the voxel-wise apparent diffusion coefficient (ADC) values.
7.3.1 A comment on projected variance (feature D83)
Projected variance was proposed by Srikantha et al. (2013) for the characterisation of breast
lesions. The feature requires that the nipple be automatically located. However Srikantha et al.
do not provide a method for doing this. A fully automatic method for nipple detection, using
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Table 7.3: State-of-the-art diffusion-weighted features
Feature
category
Feature identifier Feature description
Lesion ADC C16 10th percentile (Singer et al. 2012)
C17 Mean (various - see Table 5.2)
C18 Standard deviation (Englander et al. 1997)
C19, C20 Skewness and kurtosis (Singer et al. 2012)
C21 Difference value (range) (Singer et al. 2012, Mori
et al. 2013)
mathematical morphology, was developed by the author. The method and a formal description
of the projected variance feature are presented in Appendix C.
7.4 Feature extraction
Both the new features described in Chapters 4 and 5, and the state-of-the-art features described
above, were implemented in MATLAB Version 2012a (The MathWorks Inc 2012). The features
were extracted for the data described in Section 7.1. An additional random feature (values
drawn from a standard normal distribution) E1 was also included as a benchmark for feature
importance ranking.
Data from 28 breast MRI cases2, additional to the 107 cases described above, were used to
empirically determine: (i) the bounds for fitting the parametric models of contrast enhancement
(using trust-region-reflective optimisation) shown in Table 4.6; (ii) the D parameter in the
Agliozzo model in Table 4.6 (all the other models are either self-starting, initialised with the
recommended values in the literature, or initialised with the parameters from another model)
and (iii) to tune parameter values (e.g. mean-shift bandwidths).
In the mean eroded intensity feature (B3), the erosion was performed by a 6-neighbour 3D
structuring element, as used by van Aalst (2007).
For the GLCM-derived features B9, B10, B11 (homogeneity, maximum correlation coefficient
and sum average), the GLCM was constructed with grey values between 0 and 8 in steps of
0.25.
The radial gradient index B12 was computed from a histogram with a bin width of 0.02 (the
upper and lower bounds were 0 and 1 respectively).
2 This data included images from nine subjects with benign lesions and 19 with malignant lesions. The benign
lesions consisted of three fibroadenomas, one subject with a cyst, duct debris, fibrocystic change, fat necrosis,
hyperplasia, and sclerosing adenosis. The malignant lesions consisted of seven invasive ductal carcinomas,
four DCIS, two LCIS, two adenocarcinoma, and four malignancies of unknown type.
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Figure 7.3: The effect of bandwidth size on clusters. (a-c) Pre-contrast, first post-contrast and
last post-contrast slices of a malignant lesion (invasive ductal carcinoma). (d-f) Clusters resulting
from small, medium and large bandwidths (randomly coloured). (g-i) Mean relative uptake in the
first post-contrast image in each cluster. (j-l) Mean ADC in each cluster.
In the case of feature C1, ADC values were quantised by rounding to the nearest 2 ⇥ 10 5
mm2/s. Features C16-C21 correspond to the 10th percentile, mean, standard deviation, skew-
ness, kurtosis and difference value (i.e. maximum minus minimum(Mori et al. 2013)) of fADC
within the VOI.
The bandwidths chosen to generate the small, medium and large clusters (needed to compute
several of the features with identifiers starting with C and D) were (1, 1), (2, 2) and (3, 3)
respectively where the first element of the tuple is the spatial bandwidth hs (in mm), and the
second element is the range bandwidth hr. We note that the bandwidth (1,1) has been used
previously for breast lesion classification(Stoutjesdijk et al. 2007). Figure 7.3 demonstrates the
effect of bandwidth size on clusters.
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For features D62-D72 , GLCMs were constructed using 26-connectivity. Grey levels were
quantised into 32 bins of first post-contrast intensities in the VOI. The lowest bin contains all
values lower than the 5th percentile, and the highest bin contains all values greater than the
95th percentile.
7.5 Studies
7.5.1 Study 1: Discriminating benign and malignant lesions
The aim of this study was to determine the performance of the superset of proposed features
(Table 4.5) and state-of-the-art features (Tables 7.2 and 7.3) for discriminating benign and
malignant lesions, and to identify the most discriminatory subset of these features. Mass-like
(ML) lesions only, non-mass-like (NML) lesions only, and all lesions were investigated separ-
ately. Likewise manually segmented VOIs and automatically segmented VOIs were investigated
separately. Thus six different experiments were performed.
Three classification approaches were considered; these are logistic regression with cross valid-
ation, random forests with out-of-bag error, and random forests with cross validation. These
are described below. The R code for this study can be found in Appendix D.
7.5.1.1 Logistic regression with cross validation (LRCV)
In this experiment, the generalisation performance of the features was evaluated using a logistic
regression classifier and repeated cross validation. The data was split into five folds in the cross
validation step and the experiment was repeated 100 times as shown in Figure 7.4. Stepwise
model selection was applied using Akaike information criterion (AIC) penalisation with k =
log(n) where n refers to the number of samples. AIC with this specific choice of parameter k
is known as the Bayesian information criterion or Schwarz’s Bayesian criterion. The model is
initialised with an intercept-only model, and features are iteratively added to and subtracted
from the model, seeking to minimise the AIC. Practically, this was implemented by the stepAIC
function in the MASS (Modern Applied Statistics with S) library of Venables & Ripley (2002)
with the argument direction set to “both”.
The mean area under the curve (AUC) of the receiving operating characteristic (ROC) curve
over all folds is reported. The importance coefficient of each feature is the number of times it
is selected.
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Figure 7.4: Schematic diagram of five-fold cross validation with 100 repetitions.
7.5.1.2 Random forests with out-of-bag error (RFOOB)
The random forest classifier was chosen because it is currently one of the most accurate classi-
fication methods and it can handle large numbers of features (curse of dimensionality is not an
issue)(Breiman 2001). An important property of the random forests algorithm is that it yields
estimates of the importance of individual variables, and generates an internal estimate of the
generalisation error during the construction of the forest (no need for cross-validation) (Touw
et al. 2013, Breiman 2001).
Each random forest classifier was constructed using 2000 trees and the parameter mtry, which
controls the number of variables randomly sampled as candidates at each split, was set to 3.
Each experiment was repeated 100 times. The mean AUC and mean importance coefficient
of each feature was recorded. The AUC was generated from the out-of-bag (OOB) posterior
probabilities (Liaw & Wiener 2002). The importance coefficient for each feature was taken to
be its mean decrease in Gini coefficient. The features with the 10 highest mean importance
coefficients are reported.
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7.5.1.3 Random forests with cross validation (RFCV)
Although the random forest algorithm generates an estimate of generalisation error in the OOB
AUC, this algorithm over-estimates the generalisation error when the number of variables is
much greater than the number of samples (i.e. it is pessimistically biased when n⌧ p)(Mitchell
2011). To address this, the RF experiment was repeated using cross validation rather than OOB
error. As in RFOOB, no feature selection was performed.
This experiment was performed with 100 repetitions of five fold cross-validation. As in the
RFOOB experiment, the RF was constructed with 2000 trees, and the parameter mtry set to
3. The AUC was generated from the held out samples in each fold. The mean AUC over the
500 folds is reported. The importance coefficient for each feature is the mean of the importance
coefficient over all folds.
7.5.2 Study 2: Investigation of the discriminatory power of T1w,
T2w, DW-MRI, and DCE-MRI features
Given the set of four classes of input data {DCE-MRI, T1w, T2w, DW-MRI} the aim of this
experiment was to investigate the discriminatory power of each single class (4C1 = 4 cases),
each pair of classes (4C2 = 6 cases), each combination of three classes (4C3 = 4 cases) , and all
four classes together (4C4 = 1 case). The RFOOB methodology from Study 1 was employed.
However only the mass-like lesions and features extracted from their automatically segmented
VOIs were considered.
7.6 Results
7.6.1 Study 1: Results
The results for Study 1 are presented in Table 7.4 and 7.5. They show that classification with
features from the automatically segmented VOIs yields very similar performance to classification
with features from the manually segmented VOIs. In all experiments, the logistic regression
classifier did not perform as well as the random forest classifiers. This is not unexpected given
the relative simplicity of the logistic regression classifier. As expected, the RFCV approach
yielded a slightly higher AUC than the RFOOB approach in all experiments. The feature
rankings were very consistent between the two RF approaches, but differed slightly in the LR
approach.
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Table 7.4: Study 1 results: AUC
VOI Lesion type LRCV RFOOB RFCV
Manual
ML 0.789± 0.051 0.874± 0.038 0.885± 0.037
NML 0.655± 0.083 0.677± 0.081 0.732± 0.077
Combined 0.673± 0.048 0.741± 0.044 0.758± 0.043
Automatic
ML 0.814± 0.048 0.873± 0.039 0.889± 0.036
NML 0.651± 0.083 0.663± 0.082 0.716± 0.078
Combined 0.663± 0.049 0.764± 0.042 0.777± 0.041
For mass-like enhancement with the RFOOB approach, seven of the top 10 features are com-
mon to both segmentation approaches. Moreover, half of the features in common are ADC
features. For non-mass-like enhancement, four of the top 10 features are common to both clas-
sification approaches. Moreover, most of these are intensity statistics or texture features of the
ADC, T1w, and DCE-MRI post-contrast stacks. The results also show that the classification
performance for non-mass-like enhancement is much poorer than for mass-like enhancement.
The importance coefficients for all features in the case of mass-like enhancement and automat-
ically segmented VOIs are shown in Figure 7.5. The importance score of 0.179 (to 3 decimal
places) for the random feature (E1) serves as a cutoff for what can be considered a useful
feature. The motivation behind this is the assumption that if any feature has an importance
score that is less than the random feature, it cannot possibly be useful. Interestingly, none
of the anatomical T1w features appear to be important. Surprisingly many of the proposed
cluster-wise DCE-MRI features (D6 D53) do not appear, at first glance, to be important. We
hypothesised that this may be because of a high degree of redundancy in this set of features
because they are derived from fitting five distinct models to the same data. To investigate, we
discarded all of these features except those derived from the Hayton model and repeated the
classification experiment. The results show that the number of important Hayton cluster-wise
features increases from one to eight out of twelve, with feature D46 attaining an importance
coefficient of 0.57. This suggests that the hypothesis is correct.
The highest ranked T2w feature is the radial gradient index with an importance score of 0.470.
The highest ranked DW-MRI feature is the minimum ADC by converging squares with an
importance score of 0.627. Of the features derived from DCE-MRI, D80 (lesion volume) has
the highest importance coefficient (0.598). Of the new or variant DCE-MRI features, D58
(characterising centripetal and centrifugal enhancement) has the highest importance coefficient
(0.521).
The importance coefficients for non-mass-like is shown are Figure 7.6. In general, the highest
ranked non-mass-like features do not necessarily overlap with the highest-ranked mass-like
features. An example of this is the feature C18 (ADC standard deviation), which is the highest
ranked feature in the non-mass-like enhancement set, but ranked only slightly higher than the
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Table 7.5: Study 1 results: Most important features
Lesion type Classifier Most important features
Manual
ML
LRCV C22⇤, B9⇤, B12⇤, D57⇤, D46⇤, D72⇤, D83, D48⇤, D59⇤, D56⇤
RFOOB C22⇤, C4⇤, C3⇤, C16, C2⇤, D83, B9⇤, C17, D80, C5⇤
RFCV C22⇤, C4⇤, C3⇤, C2⇤, C16, D83, B9⇤, C17, D80, C5⇤
NML
LRCV D83, A2⇤, D104, D90, B4⇤, C17, D106, C8⇤, D1⇤, D2⇤
RFOOB C18, D104, A2⇤, D83, D74⇤, D71⇤, D90, C21, D88, D89
RFCV C18, D104, A2⇤, D83, D71⇤, D74⇤, C21, D90, C9, D88
Combined
LRCV C22⇤, D12⇤, D5⇤, B10⇤, B11⇤, D63⇤, B4⇤, D83, D70⇤, D57⇤
RFOOB C22⇤, D104, D53⇤, D48⇤, D83, C16, B10⇤, C2⇤, B9⇤, C3⇤
RFCV C22⇤, D48⇤, D53⇤, D104, C16, D83, B10⇤, C2⇤, C3⇤, B9⇤
Automatic
ML
LRCV C22⇤, D80, D45⇤, D58⇤, B12⇤, D57⇤, D55⇤, B9⇤, C4⇤, D60⇤
RFOOB C22⇤, D80, C4⇤, D83, C3⇤, C2⇤, D58⇤, C1⇤, C19, C16
RFCV C22⇤, C4⇤, D80, D83, C3⇤, C2⇤, C1⇤, C16, C5⇤, D58⇤
NML
LRCV D83, D22⇤, C5⇤, C17, D81, D2⇤, D72⇤, D68⇤, D100, A2⇤
RFOOB C18, D83, D71⇤, A2⇤, C7⇤, C11⇤, D72⇤, D48⇤, C21, D80
RFCV C18, D83, D71⇤, A2⇤, C7⇤, C11⇤, C21, D48⇤, D72⇤, D80
Combined
LRCV D5⇤, D56⇤, D43⇤, B4⇤, D48⇤, D88, D55⇤, B11⇤, D24⇤, B12⇤
RFOOB D56⇤, D58⇤, D71⇤, D83, C22⇤, D36⇤, D48⇤, C19, D46⇤, D60⇤
RFCV D56⇤, D58⇤, D71⇤, C22⇤, D83, C19, D48⇤, D36⇤, D60⇤, D46⇤
* New or variant features
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Figure 7.5: Importance coefficients for each feature for discriminating mass-like lesions (RFOOB
classifier).
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Figure 7.6: Importance coefficients for each feature for discriminating non-mass-like lesions
(RFOOB classifier).
random feature in the mass-like enhancement set. Interestingly, the T1w feature A2 (standard
deviation) is among the highest ranked features. As for the mass-like enhancement experiment,
the radial gradient index (B12) was the highest ranked T2w feature. D83 (projected variance)
was the highest ranked DCE-MRI feature.
The importance coefficients for the set of all lesions (mass-like and non-mass-like) are shown in
Figure 7.7. The highest ranked feature is D56 (centripetal/centrifugal enhancement feature).
The highest ranked feature from DW-MRI is C22 (ADC by generalised converging squares).
The highest ranked T2w feature is the GLCM-derived maximum correlation coefficient, B10.
The highest ranked T1w feature is A2 (standard deviation).
7.6.2 Study 2: Results
The results for Study 2 are presented in Table 7.6. For the single modality case, DCE-MRI
features yield the best performance, and T1w features yield the worst performance.
For the two-modalities case it can be seen that the addition of DW-MRI features to the DCE-
MRI features yields the best classification performance. In the three-modalities case it can be
seen that the addition of T2w features to the DCE-MRI and DW-MRI features yields the best
performance. Interestingly, there are no T2w features in the 10 most important features. In
the four-modalities case, the 10 best features are identical to those chosen for the best three-
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Figure 7.7: Importance coefficients for each feature for discriminating all lesions (RFOOB classifier).
modalities case and yield the same overall best performance. Of these, half are new or variant
features. Overall, the results suggest that the addition of anatomical T1w features offers little
if any improvement in classification performance.
Selected ROC curves from Study 2 are presented in Fig. 7.8. In order to investigate the added
predictive value of DW, T2w and T1w features, the net reclassification improvement (NRI)
approach of Pencina et al. (2008) was applied. The model from the DCE features alone was
compared to that of the DCE features in conjunction with DW, T2w and T1w features in
turn. Positive NRI indicates a net improvement to the model, whereas negative NRI indicates
a reduction in accuracy. A p-value of 5% was considered statistically significant.
The NRI of DCE and DW features was 0.64 (p = 0.0086). The NRI of the DCE and T2w
features was 0.36 (p = 0.13). The NRI of the DCE and T1w features was  0.28 (p = 0.25).
The positive NRI from the DW and T2w features indicates that these features are useful,
although only the DW features had a statistically significant improvement on classification
performance. The negative NRI of the T1w features indicates that these features do not add
value to the model.
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Table 7.6: Results of Study 2: AUC and most important features
Modality AUC 10 most important features
T1w 0.597 ± 0.068 A2⇤, A3⇤, A1⇤
T2w 0.729 ± 0.058 B10⇤, B12⇤, B9⇤, B4⇤, B8⇤, B2⇤, B5⇤, B11⇤, B1⇤, B6⇤
DW-MRI 0.788 ± 0.051 C19, C22⇤, C4⇤, C3⇤, C1⇤, C2⇤, C16, C5⇤, C21, C17
DCE-MRI 0.824 ± 0.046 D80, D83, D94, D89, D58⇤, D88, D76, D56⇤, D77, D68
T1w, T2w 0.699 ± 0.061 B10⇤, B12⇤, B9⇤, B4⇤, B8⇤, B11⇤, A2⇤, B2⇤, B5⇤, B1⇤
T1w,
DW-MRI
0.800 ± 0.050 C19, C22⇤, C4⇤, C3⇤, C1⇤, C2⇤, C16, C5⇤, C17, C21
T1w,
DCE-MRI
0.824 ± 0.047 D80, D83, D94, D58⇤, D89, D88, D76, D56⇤, D77, D68
T2w,
DW-MRI
0.830 ± 0.046 C22⇤, C4⇤, B12⇤, C19, B10⇤, B9⇤, C3⇤, C1⇤, C2⇤, C16
T2w,
DCE-MRI
0.838 ± 0.045 D80, D83, D58⇤, D94, D89, B12⇤, D88, B10⇤, D56⇤, B9⇤
DW-MRI,
DCE
0.868 ± 0.040 D80, C22⇤, C4⇤, C3⇤, D83, C2⇤, D94, C16, D58⇤, C19
DCE-MRI,
T1w, T2w
0.839 ± 0.044 D80, D83, D58⇤, D94, D89, B12⇤, D88, B10⇤, D56⇤, B9⇤
DCE-MRI,
T1w,
DW-MRI
0.867 ± 0.040 C22⇤, D80, C4⇤, D83, C3⇤, D94, C2⇤, D58⇤, C16, C19
DCE-MRI,
T2w,
DW-MRI
0.873 ± 0.039 C22⇤, C4⇤, D80, C3⇤, D83, C2⇤, C16, D58⇤, C19, C1⇤
T1w, T2w,
DW-MRI
0.826 ± 0.046 C22⇤, C4⇤, C19, B12⇤, B10⇤, C3⇤, B9⇤, C2⇤, C1⇤, C16
DCE-MRI,
T1w, T2w,
DW-MRI
0.873 ± 0.039 C22⇤, D80, C4⇤, D83, C3⇤, C2⇤, D58⇤, C1⇤, C19, C16
* New or variant features
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Figure 7.8: Selected ROC curves from Study 2. These curves were generated using the pROC
package in R, with (left) no smoothing applied, and (right) using binormal smoothing.
7.7 Discussion
In Study 1, classification performance was evaluated using three classification approaches. Lo-
gistic regression and random forest classification (both out-of-bag and cross-validated) were
used to obtain both an estimate of classification performance on unseen data, and to identify
the 10 most important features (ranked according to importance score). The results show
that the classification performance for both segmentation approaches is very similar and thus
demonstrates the efficacy of the automated segmentation method. As expected, the random
forest classifiers perform better than the logistic regression classifier. Interestingly, in random
forests classification, the proportion of features in common in the top 10 features for each seg-
mentation approach is 70% for mass-like lesions, 50% for non-mass-like lesions, and only 30%
for the combination of lesions. This trend is possibly because of the larger variation between
automatic and manual delineations for non-mass-like lesions. Overall the results show that the
classification performance for non-mass-like lesions is much poorer than for mass-like lesions.
This is perhaps not surprising given that features are typically designed with mass-like lesions
in mind. Indeed this concurs with the findings of Newell et al. (2010) and Jansen et al. (2008).
Among the most promising new features for mass-like enhancement are those derived from
partitioning the data into mean-shift clusters, and those describing centripetal and centrifugal
enhancement.
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In Study 2, the discriminatory power of features derived from each individual modality, each
pair of modalities, each combination of three modalities, and all four modalities collectively
were considered. The results show that the best single modality class of features is DCE-MRI,
classification performance improves with the addition of DW-MRI features and then again with
the addition of T2w features, while the addition of T1w features offers little if any improvement
in classification performance.
7.8 Conclusion
In the previous chapters several new features for characterising tissue morphology, perfusion,
and diffusion properties—extracted from DCE-MRI, T1w, T2w, and DW-MRI data—were
proposed for the discrimination of benign and malignant breast lesions. In this chapter the
efficacy of these features, together with existing state-of-the-art features, was evaluated using
routine clinical breast MRI data. These features were extracted separately from automatically
segmented lesions (segmented using the algorithm described in chapter 3) and from manually
segmented lesions.
It is difficult to compare the classification performances obtained in this work with performances
reported in other studies because of differences in the data sets used. For example, the results
reported here are on a par with studies such as Renz et al. (2012), Bhooshan et al. (2011),
Stoutjesdijk et al. (2007), Newell et al. (2010), Eyal et al. (2009), Agner et al. (2011), Gal et al.
(2011), Stoutjesdijk et al. (2012), Chang et al. (2012), Fusco et al. (2013), but subpar to studies
such as Agliozzo et al. (2012), Zheng et al. (2009). In the latter set of studies it can be observed
that relatively few benign lesions (fewer than 20 in both cases) were included.
Several of the newly proposed features (specifically those describing oedema, the taller-than-
wide sign, vascularity, the blooming sign, and pre-contrast intensity) did not yield importance
coefficients higher than the random feature in mass-like or non-mass-like enhancement. Al-
though they have not been shown to be useful in separating benign and malignant lesions, it is
possible that these features will be useful in multi-class problems. For example, the presence
of oedema could be used to characterise inflammatory breast carcinoma (Renz et al. 2008).
Several limitations of this work must be acknowledged. First, feature selection was not per-
formed in the classification experiment. Although random forest classifiers do not require
feature selection to be performed (to avoid the curse of dimensionality), several algorithms
have been proposed (particularly in the genomics field) for this purpose and shown to im-
prove classification performance (Deng & Runger 2013, Hapfelmeier & Ulm 2013, Genuer et al.
2010). Secondly, several tuning parameters associated with feature extraction were determined
empirically (e.g. the neighbourhood radius in the blooming sign, mean-shift bandwidths) in an
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ad-hoc manner. It is possible that better classification results could be achieved by employing
more sophisticated tuning strategies; e.g. a gridded search.
In this work, normalisation of T1w and T2w images was performed relative to fat. Fat seg-
mentation was performed by thresholding the T1w MR values. One issue with this approach
is the assumption that a single threshold can distinguish between fat and non-fat. Another is
that, as discussed by Boston et al. (2005), it ignores partial volume effects.
In conclusion, our experimental results, based on the superset of the proposed features and
state-of-the-art features, show that DCE-MRI features in combination with T2w features and
DW-MRI features yield the best classification performance. To the author’s knowledge this is
the first study to investigate the efficacy of combinations of features drawn from DCE-MRI,
DW-MRI, T1w, and T2w images.
Chapter8
Summary and Conclusions
This chapter presents a brief summary of each chapter of the thesis, describes the key contri-
butions and findings, outlines the limitations of the research undertaken, and finally describes
opportunities for future research.
8.1 Summary of chapters
Chapter 1 introduced the field of breast MRI CAD, and described the limitations of the
current technology. One significant limitation is that CAD has not yet been shown to improve
the sensitivity and specificity of an experienced radiologist and so their interpretation remains
essential. This was the motivation for the hypothesis of the thesis, namely that multi-modal
magnetic resonance imaging coupled with novel multi-parametric computer-assisted diagnosis
(CAD) techniques can improve the sensitivity and specificity of breast MRI and obviate the
need for interpretation by an experienced radiologist. The aim of this research was to test this
hypothesis. To this end, the research had the following objectives:
1. To develop an algorithm for automatically segmenting (i.e. detecting and delineating) sus-
picious tissue in spatially co-registered multi-modal MR images including anatomical T1-
and T2-weighted images, perfusion images (DCE-MRI), and diffusion-weighted images
(DW-MRI);
2. To develop features that quantitatively characterise the suspicious tissue (morphology,
microvasculature, and microstructure) and other breast cancer signs from these images;
and
3. To evaluate the resulting CAD tools using clinical breast MRI data.
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Chapter 2 presented background material in support of subsequent chapters. In particular the
chapter provided an introduction to magnetic resonance imaging, including the formation of
images, methods of controlling the contrast, and MR hardware; described breast anatomy and
breast cancer; described the appearance of several common types of lesions in MRI; described
the typical characteristics of malignant and benign lesions in MRI; and finally provided an
overview of the statistical pattern recognition tools used in the thesis.
Chapter 3 addressed the first and third objectives. The chapter reviewed current methods for
breast lesion segmentation and it was noted that (i) all methods utilise information only from
DCE-MRI, despite the complementary information offered by other MRmodalities, and (ii) that
none of the methods addresses both detection and delineation. The chapter then presented two
new methods for fully automatic lesion detection/segmentation. The first is a novel extension
to multi-spectral co-occurrence, addressing lesion detection only (i.e. not seeking to delineate
suspicious tissue). The second is based on mean-shift clustering and graph-cuts, and utilises
information from T1w, T2w, and DCE-MRI. Both methods were validated on clinical MR
data. The results demonstrate that the second method yielded regions-of-interest that closely
matched those drawn manually by an experienced radiographer, based on the findings of the
reporting radiologist, and the false-positive rate is nearly 50% better than previously reported
for a fully automatic breast lesion detection system. To the author’s knowledge the algorithm
is the first fully automatic method for breast lesion detection and delineation in breast MRI.
Chapter 4 addressed the second objective. It began with a review of qualitative and quantit-
ative features for breast lesions derived from T1w, T2w, and DCE-MRI. Next, several new and
variant features were proposed. In the case of T1w and T2w features, the variations pertain
to the manner in which MR intensity normalisation is performed. In the case of DCE-MRI
features, the new features include those derived from partitioning the lesion into small regions
using mean-shift clustering, as well as features charactering, among others, the blooming ef-
fect, centripetal/centrifugal enhancement, and vascularity. Many of these qualitative signs (for
example, the adjacent vessel sign) have never before been quantified.
Chapter 5 addressed the second objective. The chapter reviewed existing features derived
from diffusion-weighted imaging in breast cancer. It was noted that the manner in which
representative ADC values are computed are highly variable. Several new quantitative features
for diffusion-weighted images were then presented. A new method for selecting a region of ADC
hypointensity within a suspicious lesion was also presented. The method is based on a novel
extension of the converging squares (minima finding) algorithm devised by the author based
on mathematical morphology.
Chapter 6 addressed the second and third objectives. The chapter reviewed the recent study
by Schipper et al. which reported that the internal mammary vessels are enlarged in breasts
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with a malignant lesion. The chapter then presented a fully automatic method for detection,
segmentation and measurement of the internal mammary vessels and presented an evaluation
of the veracity of the findings of Schipper et al. using this method. The results do not support
their findings.
Chapter 7 addressed the third objective. The quantitative features described in chapters 4 and
5 were computed for clinical breast MR data from 121 subjects, using regions-of-interest drawn
manually and generated by the method described in chapter 3. The classification perform-
ance of these features was computed using three classification approaches. The generalisation
performance and most important features in each case were reported. Results indicated that
T2w and DW features improve the classification performance compared to DCE-MRI alone,
but T1w features do not. In addition, features generated using automatically-generated (see
Chapter 3) regions-of-interest yielded the same generalisation performance as features generated
from manually drawn regions.
8.2 Key contributions and findings
The key contributions and findings of this thesis are:
1. A new method for fully automatic lesion detection using a novel extension to the concept
of multi-spectral co-occurrence, yielding a mean performance (AUC) of 0.915± 0.001.
2. A new method for fully automatic segmentation based on mean-shift clustering and graph-
cuts. This method yielded 100% lesion detection, with an average of 4.5 false positives
per subject. The median Dice coefficient between the fully automatic segmentation and
the ground truth was 0.76.
3. A new method for fully automatic segmentation and measurement of the internal mam-
mary vessels.
4. Empirical evidence to suggest that internal mammary vessels are not enlarged in the
vicinity of malignant lesions.
5. A novel extension to the converging squares algorithm based on mathematical morphology.
6. New features for characterisation of breast lesions, using T1w, T2w, DW and DCE-MRI,
and a framework for the evaluation of these features.
7. Empirical evidence that features computed from lesions segmented using the fully auto-
matic approach described in Chapter 3 results in lesion classification that is as good
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as that achieved using expert manual segmentation. Mass-like lesions were classified as
benign or malignant with a generalisation performance (AUC) of 0.87± 0.04.
8. Empirical evidence that features computed from T2w and DW images improve the clas-
sification performance compared to DCE-MRI alone, but T1w features do not.
8.3 Limitations
Several algorithms in this thesis, in particular the mean-shift and graph-cuts segmentation
algorithm, have parameters whose values must be determined empirically. These include a
threshold on pre-contrast intensity, signal increase in post-contrast images, and vesselness.
While the use of empirical parameters is not uncommon in this field, it does limit the applicab-
ility of the algorithm to new data sets without re-tuning of parameters. Note that this algorithm
was tested on two different vendor’s scanners (GE and Siemens), with results indicating that
the selected parameters worked well without re-tuning. However there is the potential that
better results could be achieved with retuning.
Additionally, the ground truth segmentation in Chapter 3 was decided by a single radiographer.
The evaluation of the delineation algorithm would be improved by using at least two segment-
ation masks from different observers. This would not only provide a better ground truth by
merging the masks, but would also provide the level of inter-observer variability.
The clinical data in this study was acquired over a period of more than three years, and
the acquisition protocol was changed several times to meet the requirements of the reporting
radiologists. An example of this is the upper b-value in the diffusion-weighted images, which
ranged from 500 to 1000s/mm2. The assumption that the ADC is independent of the choice
of b-values is only valid under Gaussian diffusion and zero noise. In practice, higher b-values
are associated with lower ADC values (Tsushima et al. 2009). This has led some researchers to
suggest that ADC should be normalised against a reference tissue (Park et al. 2007, Sahin &
Aribal 2013).
The absence of a true “control” dataset was a limitation in two sections of the thesis. In the case
of the lesion segmentation algorithm in Chapter 3, it is not known how many false positives
would be detected in a breast with no lesions. In the case of the internal mammary vessel
measurements in Chapter 6, subjects with benign lesions were used in lieu of subjects with no
abnormalities. This differs from the study of Schipper et al. (2013) where healthy controls were
used.
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8.4 Future research
Alternatives to the conventional T1w, T2w, DCE-MRI, and DWI MRI techniques that have
been investigated for breast MRI include diffusion tensor imaging (DTI) (Partridge, Ziadloo,
Murthy, White, Peacock, Eby, DeMartini & Lehman 2010), susceptibility weighted imaging
(SWI) (Fatemi-Ardekani et al. 2009), and magnetic resonance spectroscopy (MRS) (Sinha &
Sinha 2009). Future research should consider incorporating information from a wider range of
MRI modalities, and possibly other imaging modalities such as ultrasound and X-ray mammo-
graphy.
A recent breast MRI CAD “wish list” by Kelcz (2012) offers several additional avenues for further
research including the development of improved tools for the registration and visualisation of
diffusion weighted images, and algorithms for the automatic detection and segmentation of
fat, particularly in the vicinity of lesions where it may be interspersed with suspicious tissue,
artificially reducing the ADC.
Finally, future research should focus on further developing quantitative features for lesser-known
signs in MR mammography. An example of a potentially promising qualitative sign is the rim
sign in DW-MRI described in a recent study by Kang et al. (2014). Given the amount of
inter-observer variability and the 3D nature of this phenomenon, it is an ideal candidate for
quantitative feature development. Another potentially useful family of features come from the
analysis of texture using local binary patterns (Ojala et al. 2002). While considerable research
(see Table 4.3) has focussed on grey level co-occurrence matrices, to the best of the author’s
knowledge there have been no investigations to date on the usefulness of local binary patterns
in breast MRI. Using the random forest classification framework described in Chapter 7, the
inclusion of new features, even redundant or random features, does not degrade classification
performance. Hence, more quantitative features describing a wide range of phenomena will
invariably lead to improved performance.
In summary, the CAD tools developed in this thesis permit fully automatic detection and de-
lineation of suspicious lesions, the extraction of lesion features—including several new features
characterising vascularity, blooming, and centripetal/centrifugal enhancement—from multi-
modal MR images, and the classification of lesions as benign or malignant. The experimental
results show that classification performance based on automatically segmented lesions is as
good as that for manually segmented lesions. This suggests that it is indeed possible for fully
automatic CAD to achieve the sensitivity/specificity of an experienced radiologist; i.e. obviating
the need for their interpretation.
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AppendixA
BI-RADS reference card
The ACR BI-RADS® Atlas provides a standard terminology and reporting structure for breast
MRI, X-ray mammography and ultrasound. A sample of this altas is presented on the follow-
ing page. The reader is directed to www.acr.org/Quality-Safety/Resources/BIRADS for more
information.
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Figure A.1: The ACR BI-RADS reference card for MRI
AppendixB
Mean-shift Segmentation
Mean-shift segmentation is based on the concept of mean-shift (Comaniciu & Meer 1999),
which is an iterative hill-climbing procedure for finding the modes (stationary points) of a
multi-dimensional feature distribution.
Let xi 2 Zd | i = 1, . . . .N denote a set of feature vectors in d-dimensional space. The feature
vectors are formed by concatenating the voxel spatial and (multi-value) range domains. From
a starting point y1 the method proceeds according to the following update rule:
yj+1 =
PN
i=1 xik
   yj xi
h
   PN
i=1 k
   yj xi
h
    (B.1)
where k : [0, 1] ! R is the kernel profile and h is the bandwidth vector. The update rule is
applied until a maximum number of iterations or convergence to a stationary point is reached
(i.e. when yj+1 = yj).
The joint–domain kernel Khs,hr is defined as the product of spatial and range domain symmetric
kernels, as follows
Khs,hr(x) =
c
hdsh
p
r
k
     xshs
    2
!
k
     xrhr
    2
!
(B.2)
where xs and xr are the spatial and range components of x, hs and hr are the bandwidth
parameters for the spatial and range domains respectively, and c is a normalising constant.
Each mode is given a unique numeric label, and each voxel that converges to the mode is
assigned the label of the mode.
AppendixC
Algorithm for computing the projected variance
feature D83
The projected variance feature of Srikantha et al. (2013) is requires as an input the location
of the nipple. However Srikantha et al. (2013) do not present an algorithm for doing this. A
fully automatic nipple detection algorithm, developed by the author, is presented in Algorithm
C.1. A formal presentation of the projected variance feature, extended to account for non-cubic
voxels, is presented in Algorithm C.2.
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Algorithm C.1 Nipple detection algorithm
Input:
• Ipsilateral breast volume mask, Bi 2 Z3
Output:
• Centre of nipple, y = (y1, y2, y3)
Steps:
1. Perform morphological closing on Bi, and subtract result from Bi. This leaves only the
connected components that do not fit in the breast volume. This yields nipple candidates
C = Bi   (Bi  D), where D is a sphere of radius 15mm. See Figure C.1a.
2. Perform size thresholding on C, discarding all connected components smaller than 2mm3,
or connected components that are more than 2cm posterior to the apex of the breast.
3. Retain the connected component that is maximally anterior to the chest wall.
(a) If none exist, repeat steps 1-3 with a larger sphere (increasing the radius in steps of
1mm)
4. The nipple centre y corresponds to the centre of the 3D connected component
Structuring
element
Nipple
candidates
Breast mask
a) b)
Figure C.1: Projected Variance
a) The nipple detection step on a single slice of the breast mask. Voxels remaining after an
opening by the spherical structuring element are displayed in white.
b) An axial maximum intensity projection of the first post-contrast stack displaying the lesion
and nipple centroid.
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Algorithm C.2 Projected variance
Inputs:
• Centre of lesion x = (x1, x2, x3)
• Centre of nipple y = (y1, y2, y3)
• VOI V 2 Z3
• Voxel dimensions d = (d1, d2, d3), corresponding to the row, column and slice dimensions
respectively in axial images
Output:
• Projected variance feature
Steps:
1. Define the unit vector between x and y, uˆ = y x|y x|
2. For each voxel v 2 V , do:
(a) Define v0 = v   x
(b) Project each v onto the line between x and y as follows: f(v) = v0 · uˆ
(c) Convert to real-world dimensions as follows: f 0(v) = f(v) ⇤ |d · uˆ|
3. Return the variance of f 0(v).
AppendixD
R scripts
D.1 Logistic regression with repeated cross validation
# load the r equ i r ed l i b r a r i e s
l ibrary ( " ca r e t " )
l ibrary ( "MASS" )
l ibrary ( " s t epP l r " )
l ibrary ( "pROC" )
# Import data   rows = pa t i en t s , columns = f e a t u r e s
# Headings are at the top o f each column (A1, A2 . . . )
# The c l a s s l a b e l (C) i s in the f i n a l column
mydata <  read . csv ( "NEW_AUTO_f e a t u r e s . csv " )
# Li s t the cases wi th mass  l i k e enhancement
# ( the s e were s e l e c t e d by Dominic Kennedy )
mass l i ke <  c (2 , 3 , 4 , 6 , 7 , 8 , 9 , 11 , 12 , 16 , 21 , 22 , 25 ,
26 , 27 , 28 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 38 , 40 , 41 , 42 ,
45 , 46 , 47 , 48 , 50 , 51 , 53 , 56 , 59 , 60 , 61 , 64 , 65 , 66 ,
67 , 69 , 70 , 71 , 73 , 75 , 78 , 80 , 81 , 84 , 85 , 86 , 89 , 90 ,
93 , 94 , 95 , 96 , 98 , 100 , 101 , 103 , 104 , 106 , 108 , 110 ,
111 , 113 , 114 , 115 , 116 , 117 , 119 , 120 , 121 , 122)
# In t h i s example , we keep only the cases wi th mass  l i k e
# enhancement . To run the experiment wi th non mass  l i k e
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# enhancement , r ep l a c e the f o l l ow i n g l i n e wi th "mydata . mass
# <  mydata[ mass l ike , ] " . To run the experiment wi th a l l
# data , comment out the l i n e be low .
mydata . mass <  mydata [ mass l ike , ]
mydata . mass . de sc r <  mydata . mass [ ,  ncol (mydata . mass ) ]
NUMBER.OF.FOLDS = 5
NUMBER.OF.REPS = 100
AUC.ALL <  matrix (data = NA, nrow = NUMBER.OF.REPS,
ncol = NUMBER.OF.FOLDS)
parsed . f e a t u r e s <  l i s t (NUMBER.OF.REPS ∗ NUMBER.OF.FOLDS)
counter <  1
for ( rep . number in 1 :NUMBER.OF.REPS)
{
cat ( "∗∗∗∗￿Rep￿number" , rep . number , "￿∗∗∗∗\n" )
# Create a new s e t o f f o l d s in each i t e r a t i o n
f = c r ea t eFo ld s (mydata . mass$C, NUMBER.OF.FOLDS,
l i s t = FALSE)
for ( f o l d . number in 1 :NUMBER.OF.FOLDS)
{
cat ( "∗∗∗∗￿Fold￿number" , f o l d . number , "￿∗∗∗∗\n" )
# Define t r a i n i n g and t e s t i n g data f o r t h i s f o l d
t r a i n i n g <  mydata . mass [ f != f o l d . number , ]
t e s t i n g <  mydata . mass [ f == f o l d . number , ]
t r a i n i n g . de sc r <  mydata . mass . de sc r [ f !=
f o l d . number , ]
t e s t i n g . de sc r <  mydata . mass . de sc r [ f ==
f o l d . number , ]
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# Define the formula "C ~ A1 + A2 + . . . "
# conta in ing a l l f e a t u r e names
my. formula <  formula (paste ( "C￿~￿" ,
paste (colnames ( t r a i n i n g . de sc r ) , sep = "" ,
c o l l a p s e = "￿+￿" ) ) )
# Begin wi th an i n t e r c e p t on ly model
my.glm <  glm(C ~ 1 , data = tra in ing ,
family=binomial ( l ink = " l o g i t " ) )
# Pena l i sed growth o f the model (BIC)
# ( This s u c c e s s i v e l y adds v a r i a b l e s to the model ,
# but p ena l i s e s based on the number o f
# v a r i a b l e s )
glm .AIC <  stepAIC (my.glm , scope = my. formula ,
k = log (nrow( t r a i n i n g ) ) ,
d i r e c t i o n = "both" )
# d i s p l a y the model
print (glm .AIC)
# Test on the he ld out f o l d
po s t e r i o r . p r o b a b i l i t i e s <  predict (glm .AIC ,
newdata = t e s t i n g . descr , type=" l i n k " )
my. roc <  roc ( t e s t i n g$C,
p o s t e r i o r . p r o b a b i l i t i e s , smooth=FALSE)
# Uncomment t h i s l i n e to v i s u a l i s e the ROC curve
# p l o t (my. roc )
cat ( "∗∗∗∗￿AUC￿=" ,my. roc$auc , "￿∗∗∗∗\n" )
AUC.ALL[ rep . number , f o l d . number ] <  my. roc$auc
parsed . f e a t u r e s [ [ counter ] ] < 
names(glm .AIC$coef f ic ients )
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counter <  counter + 1
}
}
cat ( " Lo g i s t i c ￿ r e g r e s s i o n : ￿mean￿AUC￿=￿" , mean(AUC.ALL) )
# Standard error
A <  mean(AUC.ALL)
Na <  sum(mydata . mass$C == "Malignant" )
Nn <  sum(mydata . mass$C == "Benign" )
Q1 <  A / (2 A)
Q2 <  2∗ A^2 / (1 + A)
top <  A∗(1 A) + (Na   1)∗ (Q1   A^2) + (Nn   1)∗ (Q2 A^2)
bottom <  Na ∗ Nn
SE = sqrt ( top / bottom )
cat ( "SE￿=￿" , SE)
# Disp lay the t a b l e o f the most common f e a t u r e s
table ( unlist ( parsed . f e a t u r e s ) )
D.2 Random forest classification with repeated cross val-
idation
# load the r equ i r ed l i b r a r i e s
l ibrary ( " ca r e t " )
l ibrary ( "MASS" )
l ibrary ( "RRF" )
l ibrary ( "pROC" )
# Import data   rows = pa t i en t s , columns = f e a t u r e s
# Headings are at the top o f each column (A1, A2 . . . )
# The c l a s s l a b e l (C) i s in the f i n a l column
mydata <  read . csv ( "NEW_AUTO_f e a t u r e s . csv " )
# Li s t the cases wi th mass  l i k e enhancement
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# ( the s e were s e l e c t e d by Dominic Kennedy )
mass l i ke <  c (2 , 3 , 4 , 6 , 7 , 8 , 9 , 11 , 12 , 16 , 21 , 22 , 25 ,
26 , 27 , 28 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 38 , 40 , 41 , 42 ,
45 , 46 , 47 , 48 , 50 , 51 , 53 , 56 , 59 , 60 , 61 , 64 , 65 , 66 ,
67 , 69 , 70 , 71 , 73 , 75 , 78 , 80 , 81 , 84 , 85 , 86 , 89 , 90 ,
93 , 94 , 95 , 96 , 98 , 100 , 101 , 103 , 104 , 106 , 108 , 110 ,
111 , 113 , 114 , 115 , 116 , 117 , 119 , 120 , 121 , 122)
# In t h i s example , we keep only the cases wi th mass  l i k e
# enhancement . To run the experiment wi th non mass  l i k e
# enhancement , r ep l a c e the f o l l ow i n g l i n e wi th "mydata . mass
# <  mydata[ mass l ike , ] " . To run the experiment wi th a l l
# data , comment out the l i n e be low .
mydata . mass <  mydata [ mass l ike , ]
mydata . mass . de sc r <  mydata . mass [ ,  ncol (mydata . mass ) ]
NUMBER.OF.FOLDS = 5
NUMBER.OF.REPS = 100
AUC.ALL <  matrix (data = NA, nrow = NUMBER.OF.REPS,
ncol = NUMBER.OF.FOLDS)
parsed . f e a t u r e s <  l i s t (NUMBER.OF.REPS ∗ NUMBER.OF.FOLDS)
counter <  1
for ( rep . number in 1 :NUMBER.OF.REPS)
{
cat ( "∗∗∗∗￿Rep￿number" , rep . number , "￿∗∗∗∗\n" )
# Create a new s e t o f f o l d s in each i t e r a t i o n
f = c r ea t eFo ld s (mydata . mass$C, NUMBER.OF.FOLDS,
l i s t = FALSE)
for ( f o l d . number in 1 :NUMBER.OF.FOLDS)
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{
cat ( "∗∗∗∗￿Fold￿number" , f o l d . number , "￿∗∗∗∗\n" )
# Define t r a i n i n g and t e s t i n g data f o r t h i s f o l d
t r a i n i n g <  mydata . mass [ f != f o l d . number , ]
t e s t i n g <  mydata . mass [ f == f o l d . number , ]
t r a i n i n g . de sc r <  mydata . mass . de sc r [ f !=
f o l d . number , ]
t e s t i n g . de sc r <  mydata . mass . de sc r [ f ==
f o l d . number , ]
RF <  RRF( t r a i n i n g . descr , f lagReg = 0 , t r a i n i n g$C,
mtry = 3 , nt ree = 2000)
# d i s p l a y the model
print (RF)
# Test on the he ld out f o l d
po s t e r i o r . p r o b a b i l i t i e s < predict (RF,
newdata = t e s t i n g . descr , type="prob" )
my. roc <  roc ( t e s t i n g$C,
p o s t e r i o r . p r o b a b i l i t i e s [ , 2 ] , smooth=FALSE)
# Uncomment t h i s l i n e to v i s u a l i s e the ROC curve
# p l o t (my. roc )
cat ( "∗∗∗∗￿AUC￿=" ,my. roc$auc , "￿∗∗∗∗\n" )
AUC.ALL[ rep . number , f o l d . number ] <  my. roc$auc
# Store the importance score s
parsed . f e a t u r e s [ [ counter ] ] <  RF$ importance
counter <  counter + 1
}
}
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# Compute the sum of importance score s
imp <  parsed . f e a t u r e s [ [ 1 ] ]
for (c in 2 : (NUMBER.OF.REPS∗NUMBER.OF.FOLDS) )
{
imp <  imp + parsed . f e a t u r e s [ [ c ] ]
}
cat ( "Random￿ f o r e s t s : ￿mean￿AUC￿=￿" , mean(AUC.ALL) )
# Standard error
A <  mean(AUC.ALL)
Na <  sum(mydata . mass$C == "Malignant" )
Nn <  sum(mydata . mass$C == "Benign" )
Q1 <  A / (2 A)
Q2 <  2∗ A^2 / (1 + A)
top <  A∗(1 A) + (Na   1)∗ (Q1   A^2) + (Nn   1)∗ (Q2 A^2)
bottom <  Na ∗ Nn
SE = sqrt ( top / bottom )
cat ( "SE￿=￿" , SE)
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# load the r equ i r ed l i b r a r i e s
l ibrary ( " ca r e t " )
l ibrary ( "MASS" )
l ibrary ( "RRF" )
l ibrary ( "pROC" )
# Import data   rows = pa t i en t s , columns = f e a t u r e s
# Headings are at the top o f each column (A1, A2 . . . )
# The c l a s s l a b e l (C) i s in the f i n a l column
mydata <  read . csv ( "NEW_AUTO_f e a t u r e s . csv " )
# Li s t the cases wi th mass  l i k e enhancement
# ( the s e were s e l e c t e d by Dominic Kennedy )
mass l i ke <  c (2 , 3 , 4 , 6 , 7 , 8 , 9 , 11 , 12 , 16 , 21 , 22 , 25 ,
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26 , 27 , 28 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 38 , 40 , 41 , 42 ,
45 , 46 , 47 , 48 , 50 , 51 , 53 , 56 , 59 , 60 , 61 , 64 , 65 , 66 ,
67 , 69 , 70 , 71 , 73 , 75 , 78 , 80 , 81 , 84 , 85 , 86 , 89 , 90 ,
93 , 94 , 95 , 96 , 98 , 100 , 101 , 103 , 104 , 106 , 108 , 110 ,
111 , 113 , 114 , 115 , 116 , 117 , 119 , 120 , 121 , 122)
# In t h i s example , we keep only the cases wi th mass  l i k e
# enhancement . To run the experiment wi th non mass  l i k e
# enhancement , r ep l a c e the f o l l ow i n g l i n e wi th "mydata . mass
# <  mydata[ mass l ike , ] " . To run the experiment wi th a l l
# data , comment out the l i n e be low .
mydata . mass <  mydata [ mass l ike , ]
# Define f e a t u r e c l a s s e s ( used in Study 2)
DCE. f e a t u r e s <  c ( seq (1 , 13) , seq (53 , 55) , seq (57 , 143))
T2 . f e a t u r e s <  seq (14 , 25)
T1 . f e a t u r e s <  c ( seq (26 , 30) , 56)
DW. f e a t u r e s <  seq (31 , 52)
random . f e a tu r e <  144
# In t h i s example , we are us ing a l l f e a t u r e s
f e a t <  mydata . mass [ , c (DCE. f e a tu r e s , T1 . f e a tu r e s ,
T2 . f e a tu r e s , DW. f ea tu r e s , random . f e a t u r e ) ]
NUM.REPS <  100
# Define the r e s u l t s arrays
auc . rep <  numeric (NUM.REPS)
dims <  c (ncol ( f e a t ) , NUM.REPS)
imp <  array (data = NA, dims )
for ( reps in 1 :NUM.REPS)
{
# Perform random f o r e s t c l a s s i f i c a t i o n on ALL data
RF <  RRF( feat , f lagReg = 0 , mydata . mass$C, mtry = 3 ,
nt r ee = 2000)
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# Store the importance score s
imp [ , r eps ] <  RF$ importance
# Evaluate the OOB performance
my. roc <  roc (mydata . mass$C, RF$votes [ , 1 ] )
auc . rep [ r eps ] <  my. roc$auc
}
cat ( "Mean￿AUC￿=￿" , mean( auc . rep ) )
# Standard error
A <  mean( auc . rep )
Na <  sum(mydata . mass$C == "Malignant" )
Nn <  sum(mydata . mass$C == "Benign" )
Q1 <  A / (2 A)
Q2 <  2∗ A^2 / (1 + A)
top <  A∗(1 A) + (Na   1)∗ (Q1   A^2) + (Nn   1)∗ (Q2 A^2)
bottom <  Na ∗ Nn
SE = sqrt ( top / bottom )
cat ( "SE￿=￿" , SE)
# Disp lay the mean o f the importance score s
names = colnames ( f e a t )
for ( i in 1 : ncol ( f e a t ) )
{
cat (names [ i ] , " , ￿" , mean( imp [ i , ] ) , "\n" )
}
